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Bacterial infection is a growing concern in hospital and community settings, where the 
issue of biofilms is a major problem. Most current methods of preventing microbial 
attachment and biofilm formation are limited due to application, process or inherent 
flaws. It was proposed that thin films containing an organometallic element could be 
deposited using plasma, a quick, clean surface modification technique; to create 
antimicrobial films which could then be applied to a range of substrates. 
Several novel antimicrobial monomer systems were synthesised and characterised 
based on silver, copper and zinc as the active constituent with phosphines, phosphites, 
maleimide and a novel Schiff base among the ligand systems. All monomers were 
found to greatly inhibit the growth of P. aeruginosa and S. aureus in solution and on 
solid media. Successful monomers were deposited onto suitable substrates (glass, gold, 
plastics, non­woven polypropylene) using continuous wave and pulse plasma, with the 
films characterised and low levels of active metal found in analysis using XPS and 
SIMS. Films were tested against solutions of pathogenic bacteria using a number of 
traditional and modern microbiological techniques and found to inhibit growth under a 
range of conditions, potentially due to the synergistic action of metal and ligand on 
bacterial cells. Effective control of bacteria was exhibited at times varying from 1h to 
24h+. Highly volatile compounds were produced which allowed quick deposition of 
plasma films, which showed excellent activity against bacteria (99.9%+ growth 
reduction), indicating viability for potential application. All films tested showed no 
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Chapter 1: Introduction 
1.1 Bacterial infections 
1.1.1 Hospital­acquired infections 
Nosocomial, or hospital­acquired infections (HAIs) and community­acquired 
infections are a growing health hazard, particularly in intensive care units, the 
chronically ill and imuno­compromised people. Infections are becoming 
increasingly prevalent with the advent of micro­organisms which can resist 
antibiotic action, known as hospital ‘superbugs’
1 
e.g. methicillin­resistant 
Staphylococcus aureus (MRSA) and C. difficile. Indeed, infectious diseases are the 
second highest cause of death worldwide,
2 
of which bacteria account for around 
3 4­5 
two­thirds. Approximately 5­10% of hospitalised patients experience an HAI
and the average time­period for bacterial blood­stream infection in hospitals is 
thirteen days from admission, with a mortality rate of 12%, increasing to 80% in 
intensive care units.
6 
Not only are infections a major personal danger, they also 
create financial and logistical problems for hospitals and health organisations as 
hospitalisation time can be prolonged by up to thirty­two days by infection, costing 
the NHS over one billion pounds a year and resulting in the deaths of thousands of 
people in the process.
7­8 
Despite this, several criteria must be assessed by a health 
service or hospital when considering the feasibility of implementing new infection 
controls; the most important of which are effectiveness and cost relative to non­
prevention.
4 
Propensity for infection is directly correlated to bacterial colonisation on surfaces.
9 
In open systems such as solid/air and solid/liquid interface, bacteria may or may not 
be able to propagate but can pose a bio transfer threat in either case e.g. MRSA on 
hands in hospitals, Salmonella in food industry
10
. Surfaces with potential for bio 
transfer include gloves, ward curtains and hospital scrubs; although the outright 
transfer source of nosocomial infections in general is still unclear.
11 
A way of 
avoiding contamination is to create antimicrobial materials or impart antimicrobial 
activity onto existing surfaces. The importance of engineering antimicrobial surfaces 
                             
                         
                   
 
       
                       
                       
                   
                       










                         
 
 
                       
                         
                           
                     
                           
                       
               
 
                     
                       
is clear in this context alone, yet there are a multitude of applications for such 
solutions. The aim of this work was to create novel antimicrobial molecules and 
incorporate them into thin films using plasma deposition for this purpose. 
1.1.2 Causes of infection 
Many pathogenic bacteria exist, yet some are more deadly than others. Variables 
such as toxin production, biofilm­forming tendency and prolific nature of growth can 
influence pathogenicity of different species of bacteria towards humans. Action of 
bacteria also slows or prevents healing of wounds.
5 
Common human pathogens and 
their prevalence in intensive care units (ICUs) is summarised in fig. 1.1. 
13%
 
Staphylococcus aureus 29% 








Figure 1.1: The prevalence of pathogens in intensive care units in Western Europe
12 
Staphylococcus aureus, the most prevalent pathogen in ICUs is commonly found on 
human skin and hair
9 





Around 20% of the population carry S. aureus at all times and are 
known as persistent carriers; 60% are intermittent carriers and 20% are non­
carriers.
15 
MRSA, the resistant strain of S. aureus accounting for up to 50% of 
clinical isolates in some cases
16 
is typically resistant to all antibiotics bar 
vancomycin and teicoplanin, causing major problems for treatment.
15 
Pseudomonas aeruginosa, a prolific biofilm­forming pathogen
1 
is known as a factor 
in the mortality of immunocompromised patients and those with cystic fibrosis and 
                       
                     
                     
                             
                      
 
                           
                             
                           
                         
                       
                       
                 





                 
                   
                        
                         
                          
                         
                       
                         
                             




Most cystic fibrosis patients have their lower respiratory tract colonised by 
P. aeruginosa by adolescence or adulthood.
18 
Proteases released by P. aeruginosa 
are thought to damage host tissues and upset antibacterial defence mechanisms.
19 
This second most commonly found strain found in ICUs was shown to be present in 
sink drains
11 
in hospitals, which is a potential source of infection. 
P. aeruginosa can only survive for a relatively short period of time as individual 
cells so transfer must occur rapidly from infection source to the body. S. aureus have 
been shown as much hardier organisms, surviving for up to two days on abiotic 
surfaces in comparison to around seven hours for P. aeruginosa. Studies have shown 
differences between bacteria found in endogenous flora of patient’s skin and those 
found on abiotic surfaces of hospitals, suggesting many nosocomial infections can be 
self­administered. Concurrently, other studies have shown incidence of moist 
materials hosting a variety of bacterial strains in hospitals including MRSA and P. 
aeruginosa. 
1.1.3 Infection sites 
1.1.3.1 Implant­based infection 
Infection is easily contracted in hospital via surgical procedures or implanted 
medical devices such as joint replacements,
20 
heart valve prosthesis and 
21 22­23 
pacemakers (category I); or IV lines and catheters (category II). These devices 
can be colonised by bacteria prior to application if not thoroughly cleaned,
22 
by 
inoculation from patient’s skin or the hands of surgical staff.
21 
Category I devices 
only carry an infection threat at implantation, whereas category II devices carry a 
cumulative risk.
24 
Despite best sterilisation efforts, infection is a major cause of 
implant failure.
25 
For instance in the case of urinary catheters, bacteria may migrate 
along the surface of a patient’s skin where glycoprotein has built up, onto the device 
22,24 
and build up subcutaneously as an infection.




                                   
                           
   
 
           
                   
                         
                             
                         
                       
               
                       
                          
 
       
                          
                     
                           
                       
                           
                       
                       
                       
                       
Figure 1.2: Pyelonephritis, a kidney disorder caused by bacterial infection of the 
urinary tract
26 
Three million catheters are used on a yearly basis in the US alone and lead to up to 
23 24 
one million infections, 20% of which are serious, with a mortality rate of 28%.
Studies have shown that catheter­associated urinary tract infection (CAUTI) 
27­28 
contributes >40% of all institutionally acquired infections, between 250,000 and 
500,000 in the United States annually
29 
and a quarter of all catheterised patients 
become infected within a week, with a cumulative daily risk of 5%.
30 
Removal of a 
severely infected device is difficult, unpleasant to the patient and expensive,
20 
with a 
large quantity of CAUTIs (e.g. fig. 1.2) caused by antibiotic­resistant pathogens such 
as Enterobacter, Pseudomonas aeruginosa, Proteus mirabilis and various 
staphylococci.
31 
The prevalence of CAUTIs has been proven to increase death rates 
23,32 21,29 
in hospitals, with up to a quarter of these infections classed as fatal.
1.1.3.2 Burns and wounds 
Burns and wounds are prime sites of infection for opportunistic pathogens, where P. 
33­34 
aeruginosa and S. aureus are of the greatest importantance with Staphylococcus 
the most prevalent coloniser of burn sites.
35 
The surface of a burn is protein­rich 
which provides an excellent environment for bacteria to propagate.
34 
MRSA cells are 
frequently found in burns units, with incidence rising to 64% from 18% in regular 
hospital wards.
11 
An exotoxin released by S. aureus, toxic shock syndrome toxin­1 
(TSST­1) can cause a disease in burns patients, particularly young children who 
possess lower levels of TSST­1 antibodies than the general populous, called toxic 
shock syndrome (TSS).
36 
TSS is a severe systemic illness characterised by shock, 
                   
                         




                             
                   
                   
                       
  
 
                       
                      
                       
                       
                           
                         
                   
   
 
                   
                           
                       
                           
                     
                   




pyrexia, rash, gastrointestinal disturbance and lethargy or irritability.
37 
P. aeruginosa 
has also been associated with TSS
35 
and the condition is associated with high 
mortality rate of up to 50%,
38 
so eradication of bacteria from burn sites is of 
paramount importance. 
1.1.3.3 Dermatological infection 
Outside of hospitals nappy rash, or diaper dermatitis is a source of infection in the 
community, accounting for 20% of dermatological cases in childhood. Commonly 
17,39­40 
thought of as ammonia­mediated, recent work has shown the influence 
microorganisms such as S. aureus and Candida albicans can have in such 
environments. 
Intact human skin naturally preserves body fluid homeostasis and contains a natural 
34,41 
defence mechanism of bactericidal lipids which kill bacteria such as streptococci.
However, skin moistened by damp materials is damaged by rubbing motion and 
subsequent increased permeability allows skin irritants access to the lower layers of 
the skin. It has been postulated
42 
that increased pH caused by urine allows the 
activity of lipases and proteases of micro­organisms to act on the skin. Indeed, 
people with dermatitis show increased susceptibility to secondary­type infections of 
41,43 
S. aureus.
The top layer of modern disposable nappies typically consists of non­woven 
polypropylene that allows movement of liquid away from the skin surface in order to 
prevent skin dampening. Non­wovens are also used in wound dressings and other 
hospital applications; with greater than half of all surgical gowns used in the United 
States composed of non­woven material. However, non­wovens can also serve to 
pool microorganisms which cause infection,
44 
creating problems for both hospital 
patients and in the community at large. 
   
                               
                     
                       
                               
                       
 
                       
                           
                        
                       
                       
                           
                       
  
 
                     
                         
                         
                           
          
 
 
   
 
       
1.2 Biofilms 
A major factor in the pathogenicity of bacterial infection is that more than 99% of all 
bacteria are contained in biofilms, which prolong inflammation in chronic wounds 
by secretion of enzymes, toxins and extracellular substances.
45 
Of all the diseases 
treated in the 1990s, 60% were reported as the result of biofilm infection
20 
and it is 
believed that beneficial or pathogenic biofilms are present in all chronic wounds.
45 
A biofilm is defined as a structured; viscoelastic community of bacterial cells 
enclosed in a self­produced polymeric matrix adhered to an inert or living surface at 
46­50 
a solid­liquid interface (fig. 1.3). These sessile communities are very hardy and 
48­51 
have been proven to withstand extreme antibiotic treatment, much more so than 
20,46,48 49
planktonic cells (up to 1000 times ), possibly due to the difference in diffusion 
of antibiotics or complex changes in physiology of the film.
48 
It is perhaps because 




CAUTIs and prosthetic infections for instance are generally caused by biofilm 
formation, as implanted surfaces can be easily colonised due to the high availability 
of nutrients and appropriate fluid for growth at the liquid/solid interface in the 
body.
52 
In addition to localised infection, cells may detach from a biofilm to seed 





Figure 1.3: Biofilm structure
52 
     
                     
                     
                             
                     
 
                      
             
                   
             
               
                       
   
 
                   
 
 
       
 
 
                       
                           
                           
                           
                         
 
 
1.2.1 Biofilm formation 
Biofilms were only recently discovered.
52 
Previously, it was assumed that all 
bacteria are planktonic (free swimming
56
), but in the 1970s microbial communities 
were reported
46 
and in recent years much work has been done to establish the nature 
and structure of biofilms. Current understanding of biofilm formation is as 
57­59 
follows:
(i) Initial, reversible attachment of bacteria to substrate. (Net product of 
electrostatic forces, Brownian motion and flagella propulsion.
56
) 
(ii) Attachment becomes irreversible upon movement of bacteria using twitching 
motility and production of extracellular polysaccharides (EPS). 
(iii) Microcolony formation by reproduction and twitching motility. 
(iv) Biofilm matures via increased synthesis of EPS matrix and formation of 
complex structure. 
A schematic of biofilm formation is shown in fig. 1.4.
 
Figure 1.4: Biofilm formation
46 
57 60­61 
Twitching motility via type IV pili allow initial attachment and movement of 
bacteria on a surface. Pili are helical polymeric fibres 6nm in diameter and several 
micrometers long attached to the outside of a bacterial cell,
60 
which act by extension, 
tethering and retraction in a similar way to a grappling hook. Twitching motility also 
plays a role in host colonisation and pathogenesis, including activation of host cell 
62 
responses. 
                 
                         
                 
                     
                   
                         
                             
                     
                         
                     
          
 
         
                       
                     
                       
                     
                     
                   
                       
                       
                        
                       
                     
                 
 
Physiological co­operativity between cells contributes greatly to shaping biofilms.
52 
Cell­to­cell signalling has been shown to be a factor in differentiation of biofilm 
structure, with two systems identified in Pseudomonas aeruginosa,
51 
lasR­lasI and 
rhlR­rhlI. Both gene products direct synthesis of homoserine lactones, which at 
sufficient population density reaches the concentration required for gene activation. 
Gene regulation of this kind is known as ‘quorum sensing’,
63 
which also allows 
bacteria to react as a group in response to stimuli. Communication in this manner, it 
has been reported
54 
allows the release of degradative extracellular enzymes and 
cytotoxins. Unlike planktonic cells where signals may be diluted and taken away in 
medial flow, the diffusion­limiting nature of a biofilm environment allows lactones 
to reach critical concentration level.
64 
1.2.2 Biofilm structure and growth 
Biofilm structures can be heterogeneous, in that several species of bacterium may 
46,50 
form a cohesive unit. Within these communities, different species of bacteria 
may interact and exchange such information as genes.
65 
The morphology of mature 
biofilms is such that bacteria are embedded in differentiated mushroom­ and pillar­
like structures consisting of EPS matrix or glycocalyx, separated by water 
channels.
51 
Within the matrix, each bacterium occupies a specific microenvironment 
determined by surrounding cells, proximity to water channel and the EPS matrix 
54,65 
itself. Channels provide the flow of nutrients dissolved in bulk solution necessary 
47,54 54 
to allow bacterial growth and removal of waste products. Such is the 
complexity of channel systems in biofilms, they have been compared to circulatory 
systems and biofilms may even be considered as primitive multicellular organisms,
50 
as evidenced by their complex nature summarised in fig. 1.5. 
              
  
 
                     
                         
                     
                             
                   
                 
 
 
                     
                       
                         
                       
                       
                     
        
 
Figure 1.5: The complexity of biofilm environment
18 
Despite the growing work on biofilms, knowledge is limited about interactions 
between EPS secreted by two different bacteria and how they form a cohesive 
matrix. Recent work has shown that electrostatic interactions between like charged 
3+ 3+ 
polymer stands bridged by multivalent counter ions such as Fe and Al may play a 
part, 
66 
but other models include electrostatics between oppositely charged polymer 
chains, hydrogen bonding, covalent bonding, chain entanglement and hydrophobic 
interactions.
67 
Hydrodynamics regulate the growth of a mature biofilm, with accumulation rate 
determined by the net result of bacterial attachment, detachment and growth rates.
47 
For instance, attachment is controlled by the flow of microbes, detachment rate by 
erosion (shear stress) and growth by nutrient transport. Biofilm structure in turn 
determines the rate of nutrient transport to lower layers, which therefore controls 
bacterial growth and the rate of biofilm colonisation.
68 
Hydrodynamics and biofilm 
structure are therefore co­dependent. 
                           
                       
                         
                     
                     
                   
 
 
                         
                       
                     
             
 
         
                       
     
 
       
                         
                       
                           
                     
         
 
                     
                     
                       
              
 
                      
                       
                           
                     
                   
                 
70 
Although nutrient flow rate is a major factor in biofilm growth, the chemical activity 
of reactants is equally important. If a concentration gradient is established by 
continual uptake of chemicals at the surface, increased flow of nutrients to the 
biofilm occurs. This contrasts with planktonic bacteria, for which availability of 
nutrients is diffusion controlled.
69 
Interaction of the biofilm with chemicals is 
therefore further complicated by surface properties such as charge, hydrophobicity 
etc. 
Therefore, for a successful biofilm community a balance must be reached by which 
the medium is not overly nutrient heavy (increased viscosity) or nutrient poor 
(decreased growth rate). Other factors influencing the growth of biofilms include 
environment, bacterial components and modes of attachment.
68 
1.2.3 Inherent resistance of biofilms 
Naturally occurring and infection based biofilms have been proven to resist various 
bacteriophage, amoebae, chemical biocides and human immune system 
48,71 
responses. For example, a 600­fold increase in the biocide chlorine is required to 
kill biofilm cells of Staphylococcus aureus versus the planktonic variety
72 
and P. 
aeruginosa resistance to antibiotics is up to 100­times greater as a biofilm.
55 
It has 
been proposed that bacterial communities avoid antibiotic action via a concerted 
effort of several defence mechanisms.
46 
Biofilm structure (EPS matrix) slows the diffusion of antibiotics, which allows 
46,54 
deactivation via a penetration barrier, although this may be overcome during 
long­term treatment.
49 
The inherent negative charge carried by the EPS matrix also 
serves to chelate positively charged antibiotic ions.
27 
Core cells in biofilm structure are nutrient deficient, existing in a slow/non­growing 
49,54­55 
or ‘starved state’, which is not very susceptible to antimicrobial agents (fig. 
1.6) Cell viabilities reduce from around 100% in the planktonic phase to around 10% 
in a biofilm.
55 
Curiously however, slow­growing P. aeruginosa biofilm cells have 
shown decreased tolerance to chlorine under anaerobic conditions when response to 
conventional antimicrobials remains constant.
73 
Experimental work has proven that 
                       
                       
                       




                       




                    
                         
          
                             
 
                     
                   
                         
                 
                           
                         
                       
                           
                         
               
 
 
planktonic P. aeruginosa is significantly less affected by antibiotics in the stationary 
phase,
74 
correlating to that of biofilm core cells. However, planktonic bacteria and 
sheared­off biofilm once again become susceptible to antibiotics upon dilution in an 
appropriate medium as nutrients become available and cell­to­cell signalling is 
reduced.
75 
Figure 1.6: Core, ‘starved state’ cells which have low susceptibility to antibiotics 
survive and re­grow after antimicrobial treatment
49 
Structural and bacterial heterogeneity of biofilm provides dual defence method:
46
 
a) Differentiated structure ensures cells are in a variety of metabolic states, therefore
 
denying blanket metabolically directed action.
 
b) Possibility that at least one species of bacteria may be resistant to antibiotic attack.
 
In addition to biofilm­specific modes of antibiotic action, existing knowledge of
 
planktonic bacterial protection mechanisms include the expulsion of foreign bodies
 








Indeed, it has been suggested that there is a link between antibiotic action and
 
programmed cell death (PCD)
76
, whereby an antimicrobial agent damages a cell to a
 
degree, causing it to self­destruct. If some bacteria contain defective genes coding
 
for PCD, then they will persist and are able to replicate again once antibiotic
 
treatment has ceased. Evidence of such a mechanism may justify current concern in
 
the medical world regarding over use of antibiotics.
54
 
       
                       
                         
                           
                       
                       
                     
                     
                   
       
 
     
                       
                   
                 
 
 
                   
                        
 
                       
                     
                         
                         
                 
                           
                 
                   
             
 
                 
               
                     
                   
1.3 Current antimicrobial approaches 
The prevention of bacterial infection and potential biofilm formation in medical and 
industrial environments is required as once an infection begins and a biofilm takes 
hold, it is very difficult to remove without serious harm. Much work has therefore 
been carried out to engineer antimicrobial methods and materials in recent years 
which protect against biofilms and their associated problems. Such work has focused 
primarily on areas of preventing cell adhesion and proliferation of microorganisms 
both in solution and on surfaces. Surface­active polymeric coatings often prove 
advantageous over monomeric antimicrobials due to the inherent properties of non­
volatility and chemical stability.
77 
1.3.1 Non­fouling approaches 
Antimicrobial properties can be greatly influenced by the topography of surfaces e.g. 
factors such as hydrophobicity and roughness.
78 
The physical modification of 
medical devices by tailoring of surface properties for microbe repulsion
79 
or 
development of ultra­smooth surfaces
20 
have been attempted, which rely on 
preventing the initial stages of biofilm formation namely initial attachment of cells. 
A variety of functional groups on surfaces can encourage and discourage cell 
adhesion e.g. ion­ion, ion­dipole interactions with proteins of bacteria and growth 
factors. Positive interaction can lead to the initial stages of biofilm formation or 
conditioning of the surface for this process.
8,80 
Most studies have shown a clear 
correlation between the hydrophobicity of surfaces and detachment or reduced 
attachment of cells.
8 
If positive surface free energy of adhesion is imparted on the 
interface, cell attachment is reduced. However, electrostatic considerations are 
usually small under physiological conditions, meaning such approaches are limited 
for use in applications such as implants. 
Microbe repulsion techniques generally involve the formation of non­charged 
hydrogel­forming coatings e.g. polyethylene glycol (PEG)
81
, polyethylene oxide 
81­82
(PEO) , ultra hydrophobic e.g. Lotus effect surfaces which exhibit very high 
83­84 
water contact angle or the development of Teflon­type technology using 
                           
             
 
         
                         
                     
                     
                       
                 
                     
                       
                       
                         
                       
                                 
                     
   
 
                 
                  
                   
                   
                     
                     
                       
                       
   
 
                     
                     
                 
                         
85­86 
fluorocarbons. It is important to note that these methods do not provide an totally 
or indefinitely repulsive surface to all bacteria.
8,79 
1.3.2 Antibiotic and biocidic approaches 
Antibiotics are commonly and have historically been used in the aqueous phase and 
can be administered orally to combat general infections
87 
e.g. flucloxacillin. More 
recently, work has been undertaken to produce surfaces impregnated with antibiotics, 
which can allow the initial attachment but subsequent killing of cells whilst 
simultaneously releasing antibiotic into solution to prevent proliferation of 
planktonic phase bacteria. Proteins or synthetic binding agents can ionically trap 
antibiotic e.g. ciprofloxacin
77 
and release on contact with an appropriate medium e.g. 
blood.
25 
However, studies have shown that activity of antibiotics such as biguanides 
is reduced 1000­fold by biofilm formation.
55 
Only two new classes of antibiotic have 
been developed since 1968 though and due to emerging resistant bacterial strains, 
antibiotics are set to be superseded in coming years. In their place is likely to be a 
promising class of antimicrobial macromolecules which mimic the natural activity of 
host­defence peptides.
88 
Chemical modifications such as the incorporation of biocidic agents into 
20,29,79 
polymers have been employed. Alternatively, methods of loading traditional 
antiseptics such as chlorhexidine glucontate
29 
into existing polymeric coatings by 
dipping, padding or spraying
44 
have shown good efficacy against antibiotic­resistant 
Staphylococci, yet safety concerns and potential for resistance have blighted this 
approach. Other approaches include tackling enzymes such as GlmU, responsible for 
cell wall production.
27 
Proteins such as these can be deactivated by thiol­specific 
units, although such broad spectrum activity will inevitably lead to problems with 
eukaryotic cells. 
Quaternary ammonium compounds (QACs) are cations of the general formula NR4
+
, 
e.g. tetraethylammonium bromide. They are widely used as disinfectants in the 
aqueous phase, acting on microorganisms by cation targeting the negatively charged 
exterior of the cell and fatally releasing potassium ions and other vital cell 
                     
                     
                   
                       
               
 
                       
                       
                         
                     
                     
 
     
                       
                       
                                       
                   
   
                           
                           
                   
                           
                         
                     
                       
                  
                       
             
                         
                       
                     
                         
components. 
77 
Recent work has shown that long­chain QA­polymers can be grafted 
from surfaces
89 
or polymerised onto surfaces
9 
to good antimicrobial effect. However, 
QACs are associated with causing anaphylactic reactions to neuromuscular blocking 
drugs during general anaesthesia in surgery
87 
and skin and respiratory irritations,
9 
so 
their incorporation into medical equipment or materials seems unlikely. 
Natural remedies have also been reconsidered in recent years due to bacterial 
resistance to modern antibiotics. Tea tree oil for instance, consisting of terpene 
hydrocarbons and associated alcohols is proposed to act in a manner similar to 
QACs, by disrupting cell membrane structure and function.
90 
Unfortunately there is 
very little clinical evidence of activity of such remedies against micro­organisms. 
1.3.3 Metal­based approaches 
91 92 
Metals ions, particularly silver, copper, bismuth and zinc have been shown to 
reduce microbial growth. Metals are ranked thusly in order of general antimicrobial 
activity: Ag > Hg> Cu > Cd > Cr > Ni > Pb > Co > Zn > Fe.
93 
Consequently most 
attention has been focused on silver as an antimicrobial metal. 
1.3.3.1 Silver 
Silver is non­essential to cell function, but the use of silver as an antibacterial agent 
94­95 
is well known since ancient times and in addition to biocidal activity, appears to 
93,96 
have anti­inflammatory properties. At the same concentration levels as chloride, 
silver is 500­times more effective as an antimicrobial and on a par with antibiotics 
such as tobramycin
97 
but has shown to be effective against MRSA in the 
nanocrystalline dressing Acticoat.
98 
Silver is one of the most popular biocidic 
materials, as unlike antibiotics and halogens, it does not display toxicity or 
carcinogenicity in relatively low concentrations;
99 
although acute poisoning at 
higher concentrations (>0.35 mg/day) can result in allergic reactions such as toxic 
epidermal necrolysis, hepatic dysfunction, nephropathy and leukopaenia.
100 
Prolonged exposure to colloidal silver has proven to be physically harmless but can 
lead to argyria, a condition evidenced by the primary symptom of blue/grey skin.
101­
102 103 
Silver also displays high thermal stability and long­term activity. Simple 
application use is in water purification, dental fillings
104 
and in treatment of burns 
                     
                               
                     
                           
               
                       
 
                       
                 
                       
                         
                         
                           
                     
                     
    
 
                     
                     
                   
                       
                     
                     
                       
                             
                       
                           
                   
                      
 
                     
                     
                     
                         
and wound bandaging, in the form of silver sulfadiazine.
22 
Low concentration 
solutions of silver nitrate are used in baby’s eyes under statutory law in the US and 
104­105 
many other countries to prevent infection, yet in common with silver 
sulfadiazine is limited in activity due to the rapid deactivation of free ions by 
93,100 
complexation under physiological concentrations of chloride and protein.

However, the silver ion remains the number one topical antimicrobial in burn care.
106
 
Many studies have shown the antimicrobial properties of silver, but very few
 




example, in the mid­nineties work was done on impregnation of collagen catheters
 
with silver ions, in order to inhibit bacterial growth and prevent migration. While
 
effects were seen, the biodegradable nature of collagen meant depletion of all Ag
+
 
ions in as little as five days.
108 
More recently, galvanic deposition of elemental silver
 
28,109 
onto prosthetic surfaces has also been investigated and while in­vivo testing 
showed reduced infection rates, elevated silver concentrations were seen in blood 
and organs. 
Another potential method of incorporating silver onto medical surfaces is via 
95 96 
magnetron sputtering at high pressure and under RF plasma, although these 
require too high a temperature for practical applications. However, coatings 
containing silver have been produced using a cold plasma sputtering technique,
82 
and 
magnetron sputtering combined with a neutral atom beam
96 
or ion beam 
implantation
110 
which allow the deposition of silver nanoparticles into a polymeric 
matrix, in comparison to wet polymerisation methods. Such a coating provides silver 
ions at the surface without waste in the bulk, so maximising the efficiency of the 
material. These techniques however, do not allow precise control over thickness and 
silver content
94 
and if a material releases silver too readily, cytotoxicity will result by 
which the material becomes harmful to human cells.
96 
Consequently, implanted 
medical devices containing purely silver are limited by leaching and toxicity.
28 
A recent development has been encapsulation of silver nanoparticles into polymeric 
matrix via dip coating.
111 
This approach utilises anionic carboxylate functionality of 
polymethacrylate copolymer and ion­exchange with Na
+ 
ions replaced by Ag
+ 
ions, 
before UV irradiation reduces the silver to nanoparticulate form. It has also been 
                           
                         
                           
                   
                   
                     
                     
                             
                         
                       
 
 
                         
                 
                   
                   
                       
                   
                       




                     
 
suggested that the high surface area inherent in colloidal particles may allow a high 
level of antibacterial drug delivery.
94 
Use of such particles which can be controlled 
by external forces such as magnetic fields, would be useful in bulk solutions and 
piping, but less effective for practical applications on biomedical surfaces. 
Dendrimer­silver complexes as nanocomposite solutions have also shown effect, but 
with similar difficulties.
112 
A silver iontophoretic catheter has been proposed as 
another alternative treatment,
22 
consisting of silver wires wound around the catheter 
and connected to an electrical source creating a field of silver ions. This method has 
shown some antimicrobial activity and is shown to be non­toxic during long term 
animal model in­vivo studies, although practical human studies have yet to be 
evaluated. 
Recent work has taken the logical progression and combined the obvious benefits of 
non­fouling coatings with silver materials. Copolymers loaded with silver 
nanoparticles resulted in a material containing hydrophobic chains which both 
inhibits microbial attachment and prevents attachment (fig. 1.7).
79 
Another approach 
is that of surface grown polyelectrolyte brushes, ion­exchanged to trap silver ions 
within the matrix.
113 
Unfortunately, this material does not provide lasting 
antimicrobial action and as is common with many current antimicrobial methods
24 
is 
not long­lasting due to facile release of silver. 




                             
                     
                       
                         
                         
                 
 
                     
                   
                     
                               
                       
                             
 
 
                     
                   
                               
                         
                           
                             
                   
                         
                           
    
 
                   
                           
                         
                     
                     
                     
1.3.3.2 Other metals 
Copper and zinc, despite being essential to cell function, can be toxic to both humans 
114­115 
and microorganisms at high concentrations, (or low concentrations as free ion)
116 117 
inhibiting many enzymatic activities and cell reactions. A safe level of copper 
intake for humans has been recommended at between 1.5­3.0 mg per day, although 
the actual requirement may be less than 1.5 mg daily.
118 
The recommended daily 
allowance of zinc is much higher, around 15 mg.
119 
Copper is required by human enzymes such as cytochrome oxidase, copper­zinc 
SOD, and metallothionein; with the main function being catalysis of oxidation­
reduction (or electron transfer) reactions involving oxygen.
115 
Copper toxicity is not 
as apparent as silver, at around 10 mg per day but is manifested in liver cirrhosis, 
hemolysis and damage to renal tubules, brain, and other organs. Typical applications 
of copper as an antimicrobial are as fungicide in ponds and copper door knobs in 
hospitals. 
Zinc acts as an essential antioxidant and anti­inflammatory agent,
120 
without which 
humans suffer slow healing, immune system dysfunction and growth retardation.
114 
It is used in over three hundred enzymes, which is far more than other trace metals, 
including iron.
121 
Consequently, it is far more bio available than other metals and 
therefore far less toxic to humans in high concentrations, unlike all other pre­ post­
and transition metals. However, zinc is still harmful to humans at levels of over 100 
mg/day, causing nausea, vomiting, epigastric pain, cramps and diarrhoea.
119 
Zinc 
toxicity to microorganisms is utilised in toothpaste
117 
and zinc oxide is typically used 
in cream form for protection against skin irritation, a historical solution to nappy rash 
in babies.
122 
Surface­based copper­ and zinc­containing antimicrobials have been developed in a 
similar vein to those with silver, but to a much lesser extent. For example, ion 
implantation reminiscent of the method discussed for silver can be used to introduce 
a large amount of copper into medical grade polyethylene, thereby imparting long­
lasting activity against microorganisms.
78 
Implantation of metal in this manner does 
not alter bulk properties of the polymer.
110 
Additionally, nanocrystalline copper films 
                     
                     
                   
                       
             
 
                         
                       
                       
                         
                             
                
                         
 
     
                   
                 
                     
                 
                     
                           
                         
       
 
                         
                     
                         
                       
                 
                     
                   
can be prepared using magnetron sputtering techniques
123 
and loading into cellulose 
fibres,
124 
although these methods suffer from ion leaching. A promising new 
development is wet incorporation of copper nanoparticles into a polymer matrix, 
analogous to the silver approach, which shows fair antibacterial surface activity and 
significant retention of metal in the polymer.
125 
Less work still has centred on zinc exclusively, with most research focused on 
monomeric compounds and suspensions like zinc oxide. Both copper and zinc oxide 
nanoparticles have proven to be useful antimicrobials.
126 
Studies have shown that the 
efficacy of metal oxides is reduced when immobilised on surfaces,
127 
but activity can 
be improved by up to 50% by coating with carbon and introducing into a polymeric 
network.
128 
Zinc cations have been incorporated into poly(esteramide­urethane) 
materials with good microbial efficacy but require high levels of zinc for activity.
129 
1.3.4 Antimicrobial challenges 
Current surface­active antimicrobial materials appear to have a multitude of different 
advantages associated with inherent flaws. Traditional antibiotics and antimicrobial 
agents are becoming less useful as bacteria build resistance through overuse.
6,88 
Some multidrug­resistant bacteria currently have no known treatment methods.
2 
In­
built resistance mechanisms of planktonic bacteria and biofilms, in conjunction with 
the need for agents which are non­toxic to humans, brings about the requirement for 
more subtle techniques as treatment than the simple use of chemicals such as 
chlorine as an antibiotic. 
Modification or coating of abiotic surfaces in order to prevent the initial attachment, 
accumulation and growth of microorganisms has become quite popular, although no 
satisfactory solution has been found as yet.
20 
Treatment of surfaces with metal ions 
or nanoparticles has received a great deal of attention, but problems experienced 
include lengthy and labourious processing,
93 
consumption of hazardous materials 
and in­situ use of solvents
111 
(e.g. dipping); alongside activity­based problems such 
as solvent encapsulation,
130 
overloading and the facile release of active 
                     
       
 
                         
                   
                         
                   




                       
                       
                   
                     
                         
                   
                 
 
 
                 





manifested in apparently effective tests which in fact result in 
cytotoxicity and quick depletion. 
Despite the obvious need for new antimicrobial agents, development on this front is 
waning.
2 
Focus has switched to engineering material solutions using existing 
antimicrobials, yet in light of increasing resistance and problems of current agents it 
is suggested that a synergistic approach of creating novel antimicrobials designed 
with cell targets in mind alongside material development would best suit future 
developments. 
1.4 Plasma processing 
One of the most promising areas for biomedical coatings and surface modifications 
in recent years is that of plasma processing. Properties such as inertness, 
hydrophobicity, nano­patterning, sterilisation, and most importantly in the context of 
this work, non­fouling chemistry and selection of chemical group functionality may 
be imparted on surfaces.
82 
The major advantages of plasma use include ability to 
alter surface chemistry and physical properties without altering the bulk components, 
inherent sterility and potential of up­scaling for industrial applications.
131 
Figure 1.8: Schematic of plasma polymerisation: monomer fragments depositing
 
onto a substrate alongside a soup of ions radicals, photons and electrons, a plasma
 
                     
                           
                         
 
                     
                     
                           
                     
                     
                       
                   
                               
                     
                         
                   
 
       
                       
                   
                   
                       
                       
                       
                         
                 
                   
                   
                         
                 
       
 
                     
                       
Plasma polymerisation or deposition involves grafting of molecules onto a substrate 
in a glow discharge chamber to form a thin, pin­hole free, conformal organic or 
inorganic film.
132 
The plasma glow is a combination of electrons, photons, ions and 
radicals
131 
(fig.1.8). Plasma is usually ignited using a 13.56 MHz radio frequency 
(RF) modulator (although atmospheric plasma also exists)
103 
and monomer units are 
introduced via vapour flow from an external chamber and can be deposited onto a 
variety of substrates.
133 
For this reason, all potential monomers (usually small 
organic compounds e.g. alcohols, carboxylic acids, anhydrides etc)
134 
must have a 
relatively high vapour pressure in addition to capability of ionic or radical 
polymerisation.
131 
Pseudo­conventional polymers can be formed in a plasma glow, 
although repeat units are usually oligomeric at only 3 groups in length and tend to be 
highly crosslinked e.g. oligo ethylene oxide.
135 
Film structure is typically dependent 
on reaction conditions such as monomer flow rate, RF input power, plasma on/off 
time (pulsing), reaction time and pressure (discussed in chapter 2).
136 
1.4.1 Application of plasma 
Plasma reaction conditions can be tailored to produce polymers of precise surface 
functionality under low temperature and pressure,
135 
so allowing for simple 
biomedical application. For example, the polymerisation of PEO under mild reaction 
conditions shows high retention of ethylene oxide groups, which provides very good 
non­fouling properties.
137 
In one study, this reaction has been coupled with silver 
atom sputtering to produce an antibacterial material, although this suffers from metal 
ion leaching.
82 
Deposition in this manner is a simple one­step, one­pot, clean, dry 
process, allowing the simple modification of three­dimensional surfaces
131 
which 
compares favourably to multi­step conventional polymerisation reactions as it does 
not require the use of environmentally damaging reagents.
103 
However, comparison 
of resulting films from different reactors is difficult due to the non­conformity of 
reaction chamber characteristics such as reactor dimension, electrode configuration 
and positioning of substrates.
70 
The use of organic molecules in plasma polymerisation is important for bio­
applications, for instance groups such as amines may be incorporated into films, 
                 
                      
                     
                 






                          
                       
         
                                  
               
                     
            
                                
                           
                          
                         
                            
                 
               
     
                   
                              
   
                                  
       
                          
                   
 
                   
which can influence protein adsorption
71 
and provide immobilisation of 
biomolecules.
138 
Alternatively, monomers like acrylic acid can be used to produce 
films providing a similar function and improve the adhesion of eukaryotes on 
surfaces.
80 
Additionally, metal­containing species have previously been deposited in 
139­141 
this manner albeit resulting in thin metallic films evocative of traditional 
chemical vapour deposition. 
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Chapter 2: Instrumentation and theory 
The general experimental process of this work was multi­step, as shown in fig. 2.1. 
The approach was taken to investigate each novel monomer system through plasma 






Film characterisation Bacterial testing 
Bacterial testing 
Figure 2.1: The general experimental approach to antimicrobial surface generation 
Most concepts, instruments and equipment utilised in this work were therefore 
common to each section of results. Consequently, the universal theoretical subject 
matter and instrument application is presented in this section along with technical 
information on the equipment used. 
     
   
                           
                       
                              
                                 
                           
                           
         
 
 
                   
 
 
                         
                             
                           
                           
                           
                         
                     
                    
2.1 Plasma reactor 
2.1.1 Plasma 
States of matter are generally split into three groupings: solid, liquid and gas in 
which a substance may exist according to environmental factors such as temperature 
and pressure. However, more than 99% of all universal matter is in the form of 
plasma, a state above that of gas in energy.1 Despite this it is not readily seen on 
Earth, although humans regularly observe it in stars (the Sun) and the aurora borealis 
(fig. 2.2). Man­made plasmas exist in the form of neon signs, fluorescent bulbs, arc 
welders and sodium vapour lamps. 
Figure 2.2: The aurora borealis (Northern lights), a plasma discharge2 
Altering the state of matter generally involves heating or cooling until the desired 
state is achieved. Heating a solid until the enthalpy of fusion (ΔfusH
ө) is added at the 
melting temperature causes the change of state to liquid. Until this point, the thermal 
motion of molecules contained within the solid is restricted, but may allow a small 
vibration about a mean position. If the liquid form is heated further, it evaporates 
upon addition of the enthalpy of vapourisation (ΔvapH
ө), where the kinetic energy of 
molecules becomes larger than their potential energy.3 Addition of more energy 
(typically thousands of degrees centigrade) until the enthalpy of ionisation 
                                 
                           
 
 
                           
                           
                             
                     
                         
                     
                                 
                           
             
 
                           
                               
                           
                       
                               
                       
                     
                     
                       
                             
                   
                     
                           
                   
 
     
                       
                       
ө + ­(ΔionH , X(g) → X (g) + e (g) ) is reached, causes the gas to first dissociate and then 
ionise creating a mixture of ions, electrons, neutral gaseous atoms and light quanta; a 
plasma.1,4 
Plasma was first named by Irving Langmuir in 1928, during his studies of electrified 
gases in vacuum tubes,4 although it was previously described by Crooks in 1879 as 
‘a world where matter may exist in a fourth state’.5 Plasma can be formed by 
physical treatment other than temperature change, for instance plasma created using 
an electric discharge is known as low­temperature, or cold plasma.4 Due to the 
instantaneous loss of plasma energy to the environment, laboratory plasma study 
requires use of electric discharge in order to supply energy as quickly as it is lost. In 
addition, reduced pressure (~10­2 Torr) can be used to perpetuate the plasma state at 
a lower input energy than atmospheric plasma.6 
Electric energy suitable for the generation of plasma includes direct current (DC) at a 
frequency of 50 and 60 Hz or alternating current (AC) of greater than 60 Hz. AC 
methods include 10 or 20 kHz audio frequency, 13.56 MHz radio frequency or 2.45 
GHz microwave frequency. Power can be supplied to a reaction chamber containing 
atoms and molecules directly via a pair of electrodes.6 In the case of a DC glow 
discharge, power is transferred from an electric field to electrons. AC glow 
discharges are dependent on the frequency of alternation. Low frequency is 
comparable with DC glows, but with alternating polarity. At increased frequency 
positive ions become immobilised due to the extremely fast field polarity changes, 
until at around 500 kHz the half­cycle becomes so short that all electrons stay within 
the inter­electrode volume. Therefore, the system sustains charged particles much 
better than DC discharges and becomes dependent on internal collisions to 
perpetuate the plasma, allowing an external electrode source to be used in place of 
contact electrodes, at a much lower voltage e.g. copper coil.5 
2.1.2 Plasma physics 
Plasmas are extremely complex in terms of physical considerations, due to the 
various states present, movement and interactions of these species, and the effect of 
                       
                 
     
 
                     
                       
                           
                             
                     
 
                 
                         
               
 
                   
                           
                       
                           
                         
                           
                         
                 
 
                       
                       
           
 
                     
                             
       
 
                           
                         
external sources. Energy is transferred by particle collision and photon absorption to 
achieve ionisation. Collisions occur in atom­atom, atom­ion, atom­electron, ion­ion, 
ion­electron and electron­electron systems. 
The fact that plasma contains both positively, negatively and non­charged particles;7 
means plasmas are described as ‘quasi­neutral’. Neutrality is maintained by what is 
known as Debye shielding, where it is necessary for many charged species to exist 
within a sphere with a radius of Debye length, λD a parameter of plasma. The 
concentration of charged species in the sphere, ND is shown below: 
4 3
Equation 2.1 N = n πλ > 1D e D
3 
Concentration of charged species within the sphere of Debye length, where ne is the 
concentration of electrons (i.e. ne = ni, ionic concentration)6 
Therefore, if ion concentration is equivalent to electron concentration; negatively 
charged ion quantity is negligible. In addition plasma length, L must be expanded to 
longer than Debye length. These conditions are satisfied in experimental use of 
plasma6 where a Debye sheath region exists when plasma is in contact with a 
substrate that contains an excess of positive ions which are accelerated toward the 
negative charge of the substrate.8 This situation occurs due to the high energy of 
electrons relative to their mass, which escape the sheath region and charge the 
substrate resulting in positive ion movement toward the substrate. 
Since electrons and positively charged ions are the major components of plasma, 
their interactions must be considered. Electron behaviour in an electric field is 
governed by Newton’s law (equation 2.2). 
q
Equation 2.2 a = E 
m e 
Newton’s law; where a is electron acceleration, q its electric charge, me its mass and 
E an electric field.
4 
An electron subject to a continuous electric field will continue to accelerate (i.e. gain 
energy) until a collision occurs. Collisions involve transfer of energy K from an 
                           
             
 
                           
                       
 
                           
                             
                           
                           
                               
   
 
                   
                             
                       
 
 
                           
                   
 
                           
                   
 
                     
                            
                               
                                   
                     
 
                           
                               
                     
              
 
electron to an electron in an atom. The effect of electron­atom collision can therefore 
be quantified using the magnitude of K: 
• K > qVi , where Vi is the ionisation potential of the atom. The atom becomes 
ionised by an inelastic collision and becomes positive with a +q charge. 
•	 qVi > K > 0 , an inelastic collision where an electron in the atom is excited to 
a higher energy level, but below that of the ionised state. After a short period 
of time (~108 s), the electron returns to the ground state, possibly via lower 
energy levels as it cannot persist in the excited state. An excess energy gained 
is released by the electron in the form of a photon, the frequency of which is 
described below. 
Equation 2.3	 hν = E − E m n 
The energy released by an electron upon return from an excited state (Em) to the 
ground state (En), where h is Plank’s constant and ν is photon frequency.
4 
•	 K = 0 , an elastic collision where electrons in the atom remain in the ground 
state and no structural effect is seen to the atom.4 
The number of collisions an electron experiences for time Δt and energy lost during 
these collisions in a plasma is seen in equation 2.4. 
⎛ 3kTe ⎞⎛ Δt ⎞	 meEquation 2.4	 a) N = ⎜ ⎟⎜ ⎟ b) Q = 4kTe⎜ ⎟⎜ ⎟m λ	 m⎝	 e ⎠⎝ e ⎠ m 
a) The number of electron collisions, where k is the Boltzmann constant, Te is 
electron temperature and λe is the mean free path of electrons; b) Energy lost by an 
electron in a collision where mm is the mass of neutral atom or molecule and Te > Tm 
(Tm is the atom or molecule temperature), true in plasma conditions.
6 
Therefore electrons encounter a great deal of collisions and lose energy, but due to 
the very low me/mm ratio, do not lose a large amount of their kinetic energy upon 
collision in plasma. Electrons can then participate in multiple inelastic collisions, 
thus perpetuating the ionisation of the plasma. 
                         
                           
              
                 
     
                               
                           
                         
                   
 
                     
                   
                         
                       
                       
                     
         
 
                     




                         
                       
 
 
                     




The reasoning behind the very high electron temperature in plasma is shown in 
equation 2.5. Since the ratio of mm/me is very high in plasma, the electron 
temperature is extremely high (ca. 104 K). 
⎟⎟
⎠






























 m e 
Electron temperature, Te 
Ion temperature, on the other hand is much lower (ca. 500 K) because ions have a 
near equivalent mass to neutral atoms and molecules, therefore lose a great deal of 
energy during collision. In fact, average ion temperature is only slightly higher than 
the atom and molecule temperature in plasma (ca. 300 K). 
In addition to collision ionisation, photons created either externally (sunlight) or 
internally (excited states) may participate in plasma formation. Photons of 
wavelength λ possess energy of hc/λ, where c is speed of light. Photo­ionisation 
occurs when atoms absorb photon energy which is greater than the ionisation 
potential (equation 2.6). Photo­excitation is possible in a similar manner to the 
inelastic collision qVi > K > 0 , if absorbed energy is greater than excitation energy 







Photo­ionisation of an atom, where φ is the ionisation potential in eV
6 
2.1.3 Plasma processes 
The principle process in initiation and maintenance of the plasma state is clearly 
ionisation. However, several other types of collision occur which are also discussed 
here.4 
Ionisation, as discussed above results primarily from collisions where the energy 
imparted by an incoming electron meets or exceeds the ionisation potential of an 
atom: 
                   
         
 
                   
                     
                       
         
                       
                 
 
                 
         
 
                               
               
 
                 
           
 
                             
                           
                               
                         
                     
 
 
                 
           
 
                       
                         
                       
                     
                             
− + −He + e → He + 2e
Equation 2.7 
Ionisation of a helium atom
 
In addition to simple electron collision, at extremely high temperature molecule­

molecule collision may result in ionisation. Thermal ionisation occurs where the
 
kinetic energy (kT) of a collision becomes larger than the ionisation potential,
 
similarly to the electron­atom process.
 
Formation of excited states during an inelastic non­ionising collision with a lower
 
energy electron is an alternative to the ionisation pathway:
 
− * −He + e → He + e
Equation 2.8 
Excitation of a helium atom 
In the majority of cases, the excited electron returns to the ground state after a very 
short time via radiative decay, as described earlier: 
He * → He + hν
Equation 2.9 
De­excitation of an excited helium atom 
Some excited states however, can persist for 1 ms or longer. These states are known 
as metastable states. Although such a state is not supplied with enough energy to 
ionise, it may reach this level via impact with another electron. If an electron of the 
energy e1 collides with a metastable atom with energy qVm and provides ionisation 
energy of the atom e1 ≥ q(Vi −Vm ) , the metastable atom becomes ionised (equation 
2.10). 
* − + −He + e → He + 2e
Equation 2.10 
Ionisation of a metastable helium atom 
Metastable states may also play a part in plasma catalysis. Penning (1937) 
discovered that metastable neon atoms are of a higher energy than the ionisation 
energy for argon. Metastable neon can therefore catalyse ionisation of argon atoms, 
themselves returning to the ground state upon collision (equation 2.11). Indeed, 
addition of only 0.1% argon to a neon gas lowers voltage required to initiate plasma 
                               
               
 
              
             
 
                 
                   
                           
                             
                         
                           
                         
     
 
                     
                               
                           
                               
   
 
                
               
 
                         
                         
                           
                           
               
 
                
                   
 




can be catalysed in this manner provided . 
* + −
Equation 2.11 Ne + Ar → Ne + Ar + e 
Catalysis of argon ionisation by metastable neon 
Unlike electron­atom interactions where ionisation, excitement and non­change are 
the three pathways available, electron­molecule collision involving a low energy 
electron can result in an inelastic collision where an elastic collision would be seen 
in an atom. This is due to the presence of quantised vibrational and rotational levels 
that are available to molecules consisting of atoms, at energy generally much lower 
than electron energy levels. The result of this is that more inelastic collisions take 
place in molecular gas than atomic gas and subsequently electrons lose more energy 
in molecular gas. 
Negative ion formation occurs in plasma where highly electronegative atoms exist, 
such as F, Cl, Br, I and O. Electrons can be captured upon impact with these 
elements due to the high electron affinity they possess (equation 2.12). If energy in 
the amount qVa is added to the negative ion, liberation of an electron and a neutral 
atom occurs. 
(i) Cl2 + e 
− → Cl − + Cl 
Equation 2.12 
(ii) Cl − → Cl + e − 
(i) Neutral ion formation and (ii) dissociation 
Charge transfer can occur between an ion and neutral atom, where an electron 
passes from an atom to the ion species during collision (equation 2.13). These 
collisions are important in the context of ion flow in a discharge system. For 
instance, an ion with high velocity may collide with a molecule with low velocity, 
therefore transferring charge to a slower moving species. 
Ar + H + → Ar + + H
Equation 2.13 
Charge transfer between a hydrogen ion and argon atom 
                       
                       
                         
                       
                             
 
                 
                 
 
                     
                             
                         
                         
                           
   
 
                
               
 
                     
                         
                       
                         
                           
                  
 
     
                   
                   
                 
                   
Charged species collisions have less significance in a plasma glow discharge than 
those between neutral atoms and molecules as neutral species predominate in a 
partially ionised gas. However, they do occur in the form of electron­ion and ion­
ion recombination (equation 2.14), with ion­ion the more frequent reaction of the 
two. Gas phase recombination results in release of a photon of energy qVi + K. 
(i) Ar + + e − → Ar + hν 
Equation 2.14 − +(ii) O + Ar → O + Ar 
(i) Electron­ion (gas phase) and (ii) ion­ion recombination 
Due to the favouring of ion­ion interactions, recombination in electronegative gases 
(e.g. O2) tends to follow negative ion formation. This is also the case for surface 
recombination, where the surface (S) is first activated by formation of a negative 
ion, then neutralised by recombination with a gas phase ion with positive charge 
(equation 2.15). Such a process raises the temperature of the surface by absorption of 
excess energy. 
(i) S + e − → S − 
Equation 2.15 − +(ii) S + Ar → S + Ar 
(i) Electron­surface followed by (ii) ion­ion recombination 
Fragmentation of molecules is an important plasma process caused by electron 
bombardment of a chemical bond. This can lead to homolytic or heterolytic fission 
of the bond, thereby allowing formation of free radicals in plasma. Indeed, 
dependent on the chemical content of the plasma, free radical concentration may be 
up to six orders of magnitude higher than ionic concentration. This process has a 
major role in polymerisation of organic molecules in plasma.4 
2.1.4 Plasma polymerisation 
Plasma polymerisation (PP) is essentially a low temperature derivative of plasma­
enhanced chemical vapour deposition (PECVD)9 but is quite removed from 
traditional ‘wet’ polymerisation and chemical vapour deposition methods despite 
many similarities. The closest forms of polymerisation are radiation polymerisation 
                     
                       
                           
                         
     
 
                         
                     
                       
                      
 
                     
                 
                       
                         
                       
                             
                    
                         
                       
                     
        
 
                       
                         
                           
                         
                         
           
 
 
(RP) involving ionisation of monomers as an initiation step and Parylene 
polymerisation (PAP), by which polymer deposits in a vacuum. However, RP does 
not allow deposition in a vacuum and PAP is not initiated by ionisation. Therefore, 
plasma polymerisation can be viewed as a hybrid of the two,6 combined with 
chemical vapour deposition. 
Polymerisation in plasma can only take place where organic gases or vapours are 
present, inorganic gases such as O2 perform non­polymeric etching and atom 
implantation reactions. Once introduced to the plasma, an organic gas will deposit 
polymer­like products onto the surfaces of all substrates in the reactor. 
Unlike conventional polymerisation where a polymer formed has the same elemental 
composition as the monomer, plasma polymers generally show distinguished 
differences such as the possession of less hydrogen and more oxygen content 
regardless of monomer composition. This is due to the presence of residual radicals 
in deposited films reacting with atmospheric oxygen upon removal of the substrate 
from a reactor.10 Polymers created in a plasma glow also do not show regular repeat 
units like conventional polymers.11 Consequently, the irregularity of film structure 
leads to broadening of spectral peaks in FTIR and XPS analysis.11 Plasma polymers 
can also be formed from monomers containing no discernable starting point for 
polymerisation such as saturated organic compounds, due to the fragmentation and 
recombination processes in plasma.4,6 
Plasma polymerisation in this work was undertaken using a home­made reactor (fig. 
2.3) which is explained in detail in section 2.1.5. The chamber (centre) was 
evacuated using a high level vacuum, with organic vapour allowed to flow from a 
Youngs flask. Plasma was ignited using RF power via copper wire wrapped around 
the chamber (blue), and polymers were deposited onto the substrate located in the 







           
 
       
                       
                       
                     
                 
     
 
                
                       
       
 
                 
                       
                   
                       
                         
                 
                     










Figure 2.3: Schematic of plasma reactor12 
2.1.4.1 Plasma polymerisation mechanism 
The mechanism of plasma polymerisation is highly complex and not very well 
elucidated, although it is understood to be radical mediated,7 with recent work 
implicating ion fragmentation contribution.13 It has been proposed by Yasuda4 that 
rapid step­growth, rather than chain­growth polymerisation is responsible for 
polymerisation in plasma: 
* * 
Equation 2.16 [Mm + Mn → Mm ]N+n 
Step­growth plasma polymerisation, where M* is a reactive species and N the 
number of similar reactions
4 
This process differs from conventional step­growth polymerisation, where the 
reaction occurs between molecules. A reaction is initiated by plasma processes, with 
monomer groups forming primarily radical species. Free radicals detected via 
electron spin resonance (ESR) in plasma polymers seem to suggest radical growth 
methods. The reactive species may be free radical groups, leading to the termination 
of growth; radical­molecule, creating a larger radical; diradical­radical, again 
creating a larger radical; diradical­molecule, or diradical­diradical, leading to a larger 
diradical. This process is summarised in the schematic shown in fig. 2.4. 
                  
                     
 
 
                         
                     
                       
                                 
                         
     
 
                           
                       
                         
                           
                       
      
 
Figure 2.4: The bicyclic step­growth mechanism of proposed plasma 
polymerisation, where Mi, Mj and Mk are different sized reactant groups
4 
As can be seen from this visualisation, there are two cyclical step­growth reaction 
pathways; (i) where the reaction is repeatedly re­initiated via plasma after 
termination, (ii) by perpetuation of the diradical species. This mechanism of plasma 
film growth is widely accepted but likely to be too simple as it does not account for 
ion contribution, e.g. in the sheath region, which could be quite significant under 
certain plasma conditions.13 
It is assumed that monomeric gas travels through an ‘active’ zone of bulk plasma 
where radical formation takes place, then enters the sheath region resulting in 
recombination.14 Deposition of the polymer onto a substrate occurs upon the loss of 
kinetic energy, or from formation of a chemical bond with the target atom or 
molecule.4 The deposited polymer is usually highly cross­linked15 due to the reaction 
mechanisms and conformal.16 
         
                           
                     
                             
                  
 
                         
                       
                 
                     
                       
                         
                       
 
                           
                         
                             
                       
                       
                 
 
                
                       
                           
 
 
                       
               
             
               
                     
                         
                  
2.1.4.2 Effect of deposition parameters 
Due to the complex nature of plasma glow discharge, it is difficult to exert 
homogeneity and retain functional groups present in the monomer in polymeric 
composition. In recent years, much work has been done in this area to provide ways 
of controlling chemistry of films deposited in this manner. 
Good functional group retention and a decrease in cross­linking in polymers is seen 
at low input power. A boundary exists between two deposition conditions, the 
power­deficient (very low power) and monomer­deficient regimes (high power). 
This boundary provides the optimum deposition power in continuous plasma, where 
maximum polymer deposition rate is achieved.17 However, at very low input power 
the degree of cross­linking becomes so low that problems arise with adhesion to 
substrate,16 with more fragmented films shown to produce a more stable film.18 
Pulsing of the input power allows a high degree of film chemistry control and 
functional group retention, far more than that of PECVD for instance.9 Pulse is 
generated by applying a determined frequency of plasma on and off times via the use 
of an oscilloscope which allows for initiation of reaction pathways unavailable in 
continuous wave (CW) mode.19­22 Equivalent input power can be determined by the 
product of peak power and duty cycle (equation 2.17). 





t⎝ ton + off ⎠ 
Equivalent power (Peq) for pulse plasma polymerisation, where Ppeak is the input 
19­20,23 
power, ton is the pulse on time and toff is the pulse off time
There are two distinct reaction regimes at work under pulse plasma polymerisation, 
monomer activation/surface activation (UV irradiation, ion or electron 
bombardment) followed by conventional radical­mediated polymerisation i.e. 
initiation­propagation.24 Pulsing allows polymerisation under conditions where less 
ion bombardment is seen on the substrate, therefore providing lower surface 
temperatures and reduced UV effects. The lack of constant exposure to ions means 
the resulting films are generally stronger and more flexible.25 
                           
                   
                       
               
                     
                             
                         









                         
                           
                           
                         
                         
                     
                       
                           
                     
                       
                       
                     
 
                     
                             
                       
It has been seen that low RF duty cycle polymerisation produces less branched and 
more highly ordered polymers with greater functional group retention than 
conventional high power CW plasma.21 Indeed, in the case of maleic anhydride 
pulsed plasma polymerisation (PPP), anhydride functionality incorporation is 
favoured at short on­times and long off­times.20 The proposed reaction mechanism 
for PPP using maleic anhydride as a model is summarised in fig. 2.5. Essentially, the 
reaction is initiated during the on­time by radical step­growth as described above, the 
polymer is deposited then a chain­growth mechanism takes over during the off­time. 
 
Figure 2.5: The proposed chain­growth of a polymer chain during the pulse­off 
period of PPP20 
Due to the similarity between the deposited material and monomer at long off­times, 
it has been shown that such material has a very low degree of polymerisation, 
(similarly to very low­input power CW films) with a great deal of soluble and non­
covalently bonded material on the surface. It is thought that the bulk material 
undergoes additional reactions due to availability of free radicals in the system, so 
providing greater stability at depth.26 Pulse plasma suffers from potentially large 
amounts of unreacted monomer and adhesion problems9 during long toff times and 
low input wattage, or surface activation (ablation) by ions during ton phase of high 
duty cycle reactions.18 Adhesion can be improved by oxygen­plasma activation of 
polymer surfaces prior to deposition, or the use of self­assembled monolayers on 
metallic substrates.9 Surface activation in this manner is also subject to changes 
ranging from cleaning through to etching depending on the input energy.7 
Monomer flow rate affects the polymerisation process by influencing the structure 
of deposited film. A pinhole­free solid film is generally formed at high flow rate and 
low pressure, whereas lower flow rate and higher pressure results in powder 
                         
                
 
              
                               
             
 
                                       
                       
     
 
                     
                     
                         
                             
                     
 
                   
                       
                       
                       
                       
                 
 
     
                           
                             
                   
 
depositing10. Flow rate can be calculated from change in pressure when the vacuum 



































Monomer flow rate (χ) in mol min
­1 
when Ps is starting pressure (Pa), Pf is final 
pressure (Pa), T(K), V(m
3
) and Δt (minutes)
10 
. 
As one mole of an ideal gas at STP occupies 2.4 x 104 cm 3, the value χ in moles per 
minute can be converted to standard cubic centimetres per minute (sccm) by 
multiplying this figure. 
Co­polymerisation in which a mixture of monomer gases are deposited concurrently 
can provide control over concentration of surface functionality and increase adhesion 
properties of polymers.16 For example, in the plasma glow of 1,7 octadiene and 
acrylic acid the former compound acts as a dilutent of the latter, allowing control of 
acrylic acid functional group concentration and improving stability of the coating. 
Additional factors affecting the products of plasma polymerisation include substrate 
temperature, which is largely dependent on input power, flow rate and pressure; 
reactor geometry,7 which determines the plasma glow size and varies from reactor 
to reactor; and substrate position, where it has been demonstrated that positioning 
‘downstream’ from the main plasma zone allows further control of film structure,19 
for example decreased cross­linking due to reduced ion bombardment.25 
2.1.5 Plasma reactor 
Two plasma reactors were used during this work. Both were of a home­made design 
with one built with help from Dr. Stuart Fraser of the University of Sheffield based 
on the design described by Bullett et al16 (fig. 2.6). 















                         








         
 
 














Figure 2.6: The plasma reactor in use in the University of Bath Chemistry 
department 
The second, newer reactor was built with assistance from Dr. Renate Förch of Max­




Faraday cagePyrex cylinder and copper coil 
Gas inlet 
Monomer chamber 
Figure 2.7: Second plasma reactor
 
                         
                             
                               
                       
                           
                           
                               
                               
                           
                               
                           
                       
                           
                             
                             
       
 
     
                     
                     
                       
 
       
                 
                 
                           
                           
                                 
                    
 
Each reactor comprised a Pyrex cylindrical tube, 30cm long and 10cm in diameter. 
Reactor one had a round stainless steel flange at either end, reactor two had the 
vacuum line exit moulded as part of the cylinder design with a heat jacket at the 
other end. Substrates were positioned at an optimised point for deposition according 
to the conditions and monomer used. The system was kept under vacuum by an 
Edwards RV5 pump (ca. 10­2 mbar), gases for reactor cleaning or film tailoring (e.g. 
oxygen) fed in via a gas control valve and monomer vapour allowed to flow from the 
Youngs tap (far right in fig. 2.6), rate of which was controlled by adjustment of the 
tap and/or external heat applied to the monomer chamber. Power was supplied via a 
13.56 MHz RF coaxial system and connected to the reactor via a coil of solid copper 
wire of 2mm diameter and was earthed through the electrodes or vacuum line. A 
manual matching network was used to adjust input impedance so that maximum 
power was transferred from the generator to the load. The RF power supply was 
introduced in CW or pulse mode by control use of a pulse generator. An oscilloscope 
was used to alter the width and amplitude of the pulse, allowing high levels of 
control over reaction conditions. 
2.2 Characterisation methods 
Following the synthesis of compounds and plasma polymerisation in this work, 
identification of molecule and polymer composition was required. In order to 
appreciate the value of the analytical techniques, some brief background is provided 
here. 
2.2.1 Fourier­transform infra­red spectroscopy 
Fourier­transform infra­red (FTIR) spectroscopy is primarily used to determine 
energy differences between vibrational states of molecules. FTIR spectroscopy 
requires the change in dipole moment of a molecule upon vibration and is realised 
when an antisymmetric stretch occurs, or the bending of a bond results in departure 
of the dipole moment from zero. This is true for such bonds as N­H, C=O, C­N etc 
so can be applied for use in functional group characterisation. 
                       
                             
                         
                         
                       
                       
                     
                       
                     
                   
                     
               
     
                       
                           
                           
                     
                               
                           
                             
                   
     
 
                     
                           
     
 
               
                               
                       
                           
           
As discussed in the plasma physics section, photo­excitation can occur in molecules 
where a photon of the correct energy is absorbed. This is the basis if IR 
spectroscopy. If a photon of infra­red radiation of frequency ν is absorbed which 
matches the separation in vibrational levels, the molecule is excited to a higher 
vibrational level. Bonds vibrate at certain energy according to their components, so 
an IR spectrum may be obtained by measuring percentage transmission or absorption 
of an IR beam against wavenumber after data processing (Fourier­transform). The 
chemical composition of a molecule may then be determined from this spectrum.27­28 
Two FTIR spectrometers were primarily used during this work, a Nicolet­Nexus 
spectrometer for transmission work using potassium bromide pellets and a Perkin­
Elmer FT­IR spectrum 100 spectrometer with an ATR attachment for absorption 
spectra, which offers multiple reflections from thin films. 
2.2.2 Self­assembled monolayers 
Plasma polymers can be deposited onto a variety of substrates including glass, 
plastics and metals, depending on the ability of the surface to attract and interact 
with deposition material. As described in 2.1.4.2, oxygen plasma is a useful way of 
activating a substrate for attachment.19 Alternatively, the surface may be activated 
prior to a substrate being placed into the reactor. An advantage of using a metal such 
as gold as a substrate is that molecules may self­assemble themselves on the surface 
for this purpose. Another useful property of gold is that it may be used in 
conjunction with the phenomenon of surface plasmon resonance (SPR) for 
measuring film thickness.29 
LaSFN9 glass (Berliner glass) with high refractive index (1.8502) and borosilicate 
glass (BK7) was used as a base substrate for gold evaporation using an Emitech 
thermal gold evaporator. 
Surface­assembled monolayers (SAMs) are ‘ordered molecular assemblies formed 
by the adsorption of an active surfactant on a solid surface’ (fig. 2.8).30 Order in these 
systems results from a spontaneous chemical reaction at the interface, as equilibrium 
is reached. A comparable system in nature is the formation of lipid bilayers, which 
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Figure 2.8: The preparation of a self­assembled monolayer30 
Molecules such as thiols, which can possess long chain hydrocarbons with sulphur 
containing head groups, have the ideal structure for SAM formation. Sulphur has a 
strong affinity for heavy transition metal surfaces such as gold, and many gold­
organosulphur SAMs have been reported. Reaction between gold and the sulphur 
head group is thought to be driven by exothermic release of hydrogen, as seen 
below: 
1 1R − S − H + Au → R − S − Au + H2 2 2
 
Figure 2.9: The formation of a gold­organosulphur SAM30
 
The most widely studied thiol is propan­2­ene thiol, or allyl mercaptan. This is a 
very short chain molecule, so forms a monolayer very readily. Tails of SAMS do not 
generally appear perpendicular to the substrate, but are angled slightly. The presence 
of an unsaturated tail is the basis for interest in plasma polymerisation, as radical 
reaction with free monomer units may provide a useful form of adhesion. This 
process is shown in fig. 2.10, where plasma polymerisation of N­substituted 








                     
                             
                             
                           
                           
                         
                         
                     
                         
                 
 
                     
                             
                         
                       
         
 
EtOH 



























Figure 2.10: The application of thiol SAMs in plasma polymerisation 
2.2.3 Nuclear magnetic resonance 
Nuclear magnetic resonance (NMR) is a technique for studying molecular structure 
and shape where magnetic nuclei are present (e.g. spin of greater than zero). Since a 
nucleus is a charged particle in motion, it will develop a magnetic field. When a 
magnetic field is applied, nuclei line up parallel to the applied field either spin 
aligned or spin opposed. The more highly populated state is the lower energy spin 
aligned state. In NMR, electromagnetic radiation ‘flips’ the alignment of spin to the 
higher energy spin opposed state and the energy of transition is measured by 
observing the frequency of the resonant electromagnetic field. Fourier transform is 
employed to process the data and an absorption spectrum presented, with the peaks 
at frequencies corresponding to transitions between nuclear energy levels. 
NMR transition frequency depends on the local magnetic field a nucleus 
experiences. The position of an NMR peak is given in terms of chemical shift, δ, 
which is dependent on the difference between the resonance frequency of the nuclei 
studied and a reference compound (e.g. tetramethylsilane (TMS) is used as a 
reference for 1H and 13C): 
                 
           
 
                         
                     
                         
               
 
                       
                           
                             
                           
                         
                                     
                             
                                       
                         
                                 
                                     
   
 
                           
                                 
                     
                                   
                         
   
 
                           
                       
⎛ν −ν ⎞ 
Equation 2.19 δ = ⎜ ref ⎟⎟10
6 ppm⎜ ν⎝ ref ⎠ 
Chemical shift in an NMR spectrum
27 
Where chemical shift is negative, the nucleus involved is shielded relative to the 
reference standard and positive chemical shift indicates deshielded nuclei. The extent 
of shielding is dependent on such factors as the proximity of neighbouring atom 
electron density and the environment of the nucleus. 
In addition to chemical shift, spin­spin coupling of nuclei provides information on 
the position of atoms in a molecule. The magnitude of spin­spin coupling is often 
greatest when two atoms are directly bonded to each other and is stated as the spin­
spin coupling constant, J. Coupling in this manner causes splitting of peaks (J) on 
the spectrum, according to the spin­active nuclei ‘seen’ by the nuclei in question 
using the equation 2nI + 1, where I is the spin of nuclei ‘seen’ and n the number of 
nuclei. For example, coupling of 13C with two 1H nuclei in a ­CH2­ moiety provides 
a triplet in the NMR spectra, as two I = ½ nuclei are seen, therefore (2x2x½) + 1 = 3. 
The relative intensities of each split peak (multiplet) are given by Pascal’s triangle 
(e.g. 1:2:1 for coupling to two spin ½ nuclei), as there are four ways of orienting two 
spin ½ nuclei; +1, 0, 0 and ­1, therefore intensity of the 0 state is twice that of the 
other states. 
The relative integrated intensity of a peak in an NMR spectrum correlates to the 
number of nuclei in the set, so can be used as a quantitative measure. The nuclei 1H 
(natural abundance 99.99%), 13C (1.11%), 15N (0.37%), 31P (100%) and 107/9Ag 
(100%) for instance are all spin I = ½ , so making NMR a useful tool for their 
analysis.3,27 Copper (II) on the other hand, is paramagnetic so cannot be observed 
using NMR. 
Certain 1H NMR were run on a Bruker AV250 MHz spectrometer and the remaining 
1H, 13C and 31P NMR run on a Bruker AV300 MHz spectrometer. 
     
                     
                   
                     
              
 
                         
                       
                           
                         
                       
                             
                     
                     
                     
   
 
                           
                             
                           
                               
                         
                       
                         
                       
                         
                     
         
 
                           
                           
                       
                       
2.2.4 X­ray crystallography 
X­ray diffraction (XRD) is the least ambiguous method for precisely determining 
molecular structure. X­ray structure determination is more important for inorganic 
compounds than organic as inorganic molecules and solids are more structurally 
diverse and frequently contain more varied bonding. 
A crystal sample is required for XRD, which is usually made using recrystallisation 
of a solid product. Recrystallisation allows the purification and structural analysis of 
a compound. The standard method for recrystallisation is to dissolve a solid into the 
minimum amount of solvent in an attempt to grow crystals from the resulting 
solution. The pure compound desired drops out to form crystals first, leaving 
impurities in the solution and the more slowly a solution is cooled, the larger the 
individual crystal growth. Trial and error using various solvents should eventually 
allow crystals of suitable size for XRD, although like­dissolves­like so generally 
polar solvents should be used with polar compounds, non­polar solvents with non­
polar compounds. 
XRD involves the irradiation of a single crystal mounted in a diffractometer by an x­
ray source of a fixed wavelength. The crystal position and that of an x­ray detector 
are controlled by a computer. At certain orientations of the crystal relative to the x­
ray beam the crystal diffracts the beam at a fixed angle and intensity is measured by 
the detector when placed in the direction of the diffracted beam. The computer 
allows the detector to scan through each reflection (over 1000) whilst storing 
intensities and obtaining more than ten reflections for each structural parameter to be 
determined (positions of atoms and a number of locations associated with their 
thermal motion). A ‘trial’ structure is established by the computer and refined by 
systematic shifts in atom position until agreement between the observed and 
calculated XRD intensities is achieved.27,31 
XRD is useful for confirmation of the monomer structure in this work and provides 
other data such as bond lengths and angles. Data collection was implemented on a 
Nonius Kappa CCD diffractometer, using Mo­Kα radiation (λ = 0.71073 Å). Data 
were corrected for Lorentz and polarization effects, and structure refinement was by 
                     
                 
                     
               
 
       
                             
                           
                         




                     
                         
                           
                         
                   
                     
         
 
                           
                             
                     
                   
 
                  
                             
                   
 
full­matrix least squares on F2. Structure solution and refinement was performed 
using SHELX­8632 and SHELXL­9733 software, respectively. Data was uniformly 
corrected for Lorentz and polarisation. Hydrogen atoms were included at calculated 
positions throughout, and refined using a riding model. 
2.2.5 Melting point analysis 
The melting point range of a monomer gives an indication of its purity. A narrow 
melting point range means the product is purer than a wide ranging melting point. 
Melting point is also useful as a diagnostic tool to ensure monomer reproducibility. 
Melting point readings of monomers were taken using a Stuart SMP10 melting point 
apparatus. 
2.2.6 Atomic absorption spectroscopy 
Atomic absorption spectroscopy (AAS) is a method of quantitatively assessing a 
sample for elemental content and is widely used to analyse samples for metal 
content.34 The principle relies on the excitation of electrons in a sample to higher 
energy levels. Elements absorb light of a particular wavelength which is specific to 
electron excitation in that element. Atomic absorption spectroscopy exploits this 
property, meaning the technique is highly element specific and makes the 
identification of elemental composition unequivocal.35 
The energy required for each transition of a particular metal is known, so providing 
the energy put in is known and the energy transmitted is detected, the amount of 
energy absorbed can be calculated and the corresponding number of transitions 
correlated to elemental concentration using the Beer’s law (equation 2.20). 
⎛ I ⎞ 
Equation 2.20 kC = log⎜ ⎟⎜ ⎟I⎝ 0 ⎠ 
Beer’s law; absorption in an atomic gas where C is concentration, I0 and I light 
intensity before and after absorption, and k is a constant 
                               
                             
                         
                         




                  
 
 
                           
                       
                     
                         
                         
               
 
       
                         
                     
                               
                       
                               
              
 
                       
                           
A typical AAS set­up (fig. 2.11) uses a flame to atomise a sample solution into a 
beam of light at the selected wavelength specific to the element which is to be 
analysed for. Incident light is then absorbed by atoms and transmitted light carries 
onto the monochromator and onward to the detector. The intensity is recorded and 
outputted to the appropriate data system.34 
Light source Atomised gas Monochromator Detector Amplifier Display 
Flame 
Sample 
Figure 2.11: Schematic of a flame atomic absorption spectrometer35 
In order to quantify concentrations of metal in samples, the AAS is calibrated using 
standard solutions of known concentration of the specified metal. If absorption is 
plotted versus concentration, a calibration curve is obtained from which metal 
content in unknown samples can be derived principally in parts per million (ppm). 
This analytical method was used to determine the leached metal content in solution 
and the metal content of dissolved plasma films. 
2.2.7 X­ray photoelectron spectroscopy 
X­ray photoelectron spectroscopy (XPS) is a surface analysis tool which is used to 
quantitatively examine elemental composition within the top layer of a material.36 
The basic principle is that a sample is exposed to an x­ray beam and the kinetic 
energy and numbers of electrons which are ejected are measured. Detection limits 
are typically in the region of parts per thousand and XPS is primarily used to monitor 
surfaces to a depth of around 10nm. 
XPS is element specific, as each element ejects electrons of binding energy 
characteristic of electron configuration e.g. 1s, 2s, 2p etc. If the input energy i.e. x­
                           
               
 
                
                           
             
 
                           
                     
                         
                             
                           
                             
                           
                           
                         
 
                             
                           
                         
                       





               
 
 
                             
                           
                           
ray wavelength is known and the kinetic energy of electrons is detected, then the 
binding energy may be determined using equation 2.21. 
Equation 2.21 E = E − (E +ϕ)b p k 
Binding energy Eb, where the x­ray energy (Ep), kinetic energy of electrons (Ek) and 
work function of spectrometer (φ) is known 
The number of ejected electrons that are detected at each binding energy is directly 
correlated to elemental composition in the area analysed. This information is 
processed to produce an XPS spectral plot of number of electrons detected versus 
binding energy in electron volts. Peaks in an XPS plot may be subject to deviation 
which provides further information such as the oxidation state of an element in a 
film. If an element is in a higher oxidation state then the binding energy increases 
from the neutral atom due to greater interaction between the ionic core and the 
electron being ejected. An additional consideration is splitting of p, d and f orbitals 
due to spin­orbit coupling, which is evident at high resolution of spectral peaks. 
An XPS system schematic is shown in fig. 2.12. In order to prevent collision of 
electrons with gas particles, an ultra high vacuum (UHV) is required. A sample is 
loaded into the vacuum chamber and is irradiated by an x­ray source (commonly Al­
Kα or Mg­Kα radiation) with the resulting ejected electrons dispersed and detected 
according to their kinetic energy. 
X-ray source 
Sample 







Figure 2.12: Schematic of an x­ray photoelectron spectrometer36 
XPS was used to analyse the surface of thin films generated by plasma deposition. A 
Kratos Axis Ultra spectrometer operating at a base pressure of 3x10­9 Torr was used 
in this work. Samples were irradiated with Al­Kα X­rays (1486.6 eV) using an X­ray 
                               
                  
 
     
                       
                         
                         
                          
 
                   
                         
                     
               
                       
                         
                             
                           
                       
                           
                           
                         
                           
                               
                     
 
 
         
                     
                             
                       
                         
analysis spot size of 700 µm x 300 µm and ~225 W power. Additionally, an Axis 
Ultra DLD spectrometer producing 450 W power was used. 
2.2.8 Mass spectrometry 
Mass spectrometry (MS) is an extremely accurate way of effectively weighing a 
molecule in order to determine its molar mass. Molecules are ionised and the mass­
to­charge number ratio (m/z) of all ions is measured, with the resulting mass 
spectrum presented as a plot of relative abundance of produced ions against m/z. 
Macromolecules are generally difficult to ionise without fragmentation, and although 
this isn’t such a problem for plasma treated surfaces where fragmentation has likely 
taken place, it is for identification of pure compounds. Matrix­assisted laser 
desorption/ionisation (MALDI) and electrospray ionisation (ESI) are techniques 
which avoid this problem. Using ESI uncharged compounds are ionised by adducts 
such as protons and sodium ions available in solution (e.g. from glassware). Positive 
or negative ions may be formed, depending on the choice of ionisation for a sample. 
Positive ESI is the ionisation method used in this work, in combination with a time­
of­flight (TOF) ion detector. A sample undergoes ESI, followed by the acceleration 
of particles using an electric field of known strength, then received by the TOF 
detector. The TOF detects ions in real­time according to their m/z and velocity at 
high vacuum. For example, larger ions carry less velocity as they require more 
energy to accelerate them so are received later by the TOF detector than smaller 
ions. From the time recorded at the detector, very precise m/z of an ion can be 
determined and subsequently the molecular structure may be deduced from fragment 
size.3,37 
2.2.9 Secondary ion mass spectrometry 
Secondary ion mass spectrometry (SIMS) is a highly sensitive surface­specific form 
of mass spectrometry, able to detect elements in the parts per billion (ppb) range. By 
bombarding the surface with highly energetic ions, atoms are thrown from their 
original positions as secondary ions. These ions can then be detected, identified and 
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in some cases, related back to their original positions on the surface. Static secondary 
ion mass spectrometry, SSIMS is used to study monolayer coverage of surfaces as 
the ion beam penetrates around 10nm into the surface, ejecting neutral and a small 
amount of ionised molecules from the top surface.38 SIMS is conducted within a 
UHV, with pulsed primary ions (source is usually Cs+ or more recently cluster ions 
e.g. C60 
+)38 fired at the sample and secondary ions are sputtered from the surface. 
Secondary ions are then electrostatically accelerated (given the same kinetic energy) 
towards a time­of­flight detector, where ions arrive according to their mass to charge 
ratio and outputted to a spectra of intensity versus mass to charge ratio. Mapping of 
ion distribution can be achieved by recording the image position on an immersion 
lens whilst simultaneously detecting secondary ions.39 
SSIMS was used in conjunction with ion mapping to analyse plasma deposited films 
using an ION­TOF spectrometer, with a bismuth ion beam for impacting the surface. 
The SIMS software also allowed imaging of the surface, looking at the variation in 
surface density of various ion fragments. 
2.2.10 Electron microscopy 
Electron microscopes are used to magnify surfaces far beyond the capabilities of an 
optical microscope, up to a thousand times greater. This is achieved through use of 
an electron beam in place of a photon of light, which has a much smaller wavelength 
and consequently results in improved resolution using equation 2.22. 
λ 
Equation 2.22 R = 0.5 
(µ sin α ) 
The resolution of a microscope, where λ is the wavelength of the incident beam, µ is 
the refractive index of the medium between specimen and lens and α is the semi­
angle of the lens
40 
There are two principle types of electron microscopes, scanning and transmission. A 
scanning electron microscope (SEM) relies on reflectance of electrons that are fired 
at a sample surface as a beam is scanned across a designated area by rapidly 



















































                             
                         
             
         
                     
                             
                           
                           
                       
                             
                             
                         
                           
                   
                             
           
 
                                    
                         
               
 
 
                     
                       
                   
Greater resolution is observed in TEM as the smaller sample area allows for a more 
powerful objective lens. However, very thin samples are required and only a small 
area of the sample may be covered. 
2.2.10.1 Energy dispersive x­ray spectroscopy 
Energy dispersive x­ray spectroscopy (EDS) is an additional analytical tool offered 
by electron microscopy. It works in a similar vein to XPS, with a similar sensitivity 
of ca. 0.1%. Unlike XPS which monitors electrons ejected by a sample, EDS works 
by detecting the x­rays produced by the impact of electrons on the surface. X­rays 
are evolved when incident electron bombardment excites an electron and ejects it 
from its shell creating an electron hole, which a higher energy electron from an outer 
shell fills resulting in excess energy being released as an x­ray in the process. In 
common with XPS the technique is element­specific; the x­rays evolved as a result 
of excess energy in the atom are characteristic of this atom, although x­ray energies 
evolved from different elements may overlap.40 X­rays are collected concurrently 
with electrons by different detectors and presented as spectra in a plot of x­ray count 
versus energy in eV or KeV. 
Figure 2.14: The Scanning (l) and transmission (r) electron microscopes used at the 
University of Bath Centre for electron optical studies40 
A JEOL JSM6310 scanning electron microscope (fig. 2.14) with EDS capabilities 
was used during this work to generate images of plasma deposited films. 
Additionally, a JEOL JEM1200 transmission electron microscope with an Oxford 




                         
                               
                 
                         
                             
                         
                     
                     
 
                       
                       
                     
           
 
                
                           
                                  
     
 
                             
                         
                     
 
     
                       
                         
Instruments INCA x­sight x­ray detector was used for attempts at further resolution 
of samples. 
2.2.11 Quartz crystal microbalance 
A quartz crystal microbalance is a highly sensitive miniature balance used to monitor 
very slight changes in the weight of thin films down to nanogram scale. It utilises the 
piezoelectric (pressure­electric) effect inherent in certain crystalline materials, for 
example quartz. Essentially, the frequency of resonance can be measured in a crystal 
upon application of an electric field. If the mass of a crystal is increased by 
deposition of a film then the resonance frequency decreases and the difference in 
measured frequencies yields change in mass.41 The crystal frequency is measured 
using a quartz crystal oscillator circuit connected to a frequency counter. 
This technique was employed to obtain mass readings for plasma deposited films. 
An Oxford electrodes quartz crystal oscillator circuit was used in conjunction with 
Fluke PM6680B frequency counter. The Sauerbrey equation (2.23) was used to 
derive film masses from frequency readings. 
Δm A µQ ρQ
Equation 2.23 = − 
Δf 2 f0
2 
The Sauerbrey equation; where Δm = mass change, Δf = frequency change, A =area 
of the crystal, µq = shear modulus of quartz, ρq = density of quartz and f0 = 
frequency of resonance
42 
For the quartz crystals used in this work,42 area was 0.2 cm2, shear modulus was 
2.947 x 1011 gcm ­1 s2 and density 2.648 gcm­3; resulting in a measured frequency 
change corresponding to a mass increase with Δm Δf = ­1.05 ng Hz­1 . 
2.2.12 Alpha­step profiling 
Alpha­step profiling (α­step) is a simple method of measuring film thickness and 
provides topographical information on surfaces. A stylus tip is applied to the surface 
                                 
                 
 
                         
                           
                               
                           
            
 
   
                       
                         
                             
                             
                         
         
 
                           
                     
                             





                             
                           
 
of a film and the vertical movement as the tip is rastered across the surface is directly 
proportional to surface characteristics, reminiscent of atomic force microscopy. 
α­step was used in this work to provide plasma film thickness information. Films 
were deposited onto silicon wafer and the surface was scratched with a steel pin, 
providing a zero depth for thickness to be measured against. A stylus tip of a width 
of ca.5�m was passed across the surface using a TLC Tencor P­10 α­step profiler, 
with a 50�m/s scan rate. 
2.2.13 SPR 
Surface plasmon resonance (SPR) is a growing tool for measuring surface properties 
such as biomolecule attachment and film thickness. SPR is an energy wave caused 
when visible light is coupled to the electron field (plasmon wave) in a thin metal 
film. This wave extends out to the dielectric material on the metal film and decays 
exponentially.43­44 Gold and silver are the most commonly used metals due to their 
noble character and inherent stability. 
The propagation constant of a SP wave is always higher than the optical wave 
propagation in the dielectric therefore SPR cannot employ incident optical wave 
only. The momentum of the incident optical wave must be enhanced to match that of 





Figure 2.15: The basic SPR setup showing a prism using ATR to couple laser light 
to the metal film. The dielectric is on the underside of the metal film46 
                                 
                             
                           
                           
                               
                         
 
 
                     
 
 
                             
                             
                       
                             
                     
 
                       
     
 
A glass prism may be used to couple laser light into the metal film using ATR (fig. 
2.15) and at a certain angle of incidence, maximum coupling of the light with the 
surface plasmon occurs. At this angle, light is not reflected but interacts with free 
electrons in gold to form a resonant energy wave (surface plasmon).29 This is known 
as the angle of resonance, and is detected by a sharp minimum in the reflected light 
monitored (fig. 2.16) as all the light is fed into the surface mode.45 
Figure 2.16: An SPR curve showing minimum as angle of resonance47 
As the angle of resonance is dependent on refractive index, the thickness of a film 
may be estimated from this angle. In addition, the change in resonance angle can be 
followed in real­time allowing the attachment rate of biomolecules in a label­free 
manner or swelling properties of a film to be monitored.44,47 In this work, SPR was 
used to determine the thickness of deposited films on gold discs. 
Experiments on polymer coated gold discs were made using a home­made SPR 
instrument (fig. 2.17). 





                           
                 
                         
                       
                     
                             
                  
 
Figure 2.17: The SPR set­up in the University of Bath Chemistry department 
2.3 Microbiological assays 
2.3.1 Microbiology 
Microbiology is essentially the study of organisms that may only be seen through a 
microscope48. This encompasses viruses, bacteria, archaea, fungi and protista. 
Microbes can be split into three distinct groupings (or kingdoms) according to DNA 
structure; Bacteria, Archaea and Eukarya. The former two kingdoms have what is 
known as prokaryotic cell structure, the latter eukaryotic cell structure. Eukaryotes 
are a more advanced form of cell, not just restricted to microbes but include higher 
plants and animals, of which humans are one example. 
   
     
                         
                       





             
 
 
                               
                         
                       
    
 
                           
                   
                       
                     
                       
                         
                     
                           
             
2.3.2 The cell 
2.3.2.1 Prokaryotic cell 
Bacteria are around 0.1­750µm in diameter and contain a large amount of variation 
in appearance, although two particular shapes predominate, in the form of cocci 





Figure 2.18: Diagram of a prokaryote cell48 
The exterior of most bacterial cells consists of a rigid cell wall, made of sugars and 
amino acids (peptidoglycan), with a plasma membrane internal to this. The cell wall 
acts as a protective sheath, preventing lysis resulting from osmotic pressure and 
providing shape. 
The plasma membrane separating the interior of the cell from the environment is a 
semi­permeable lipid bilayer around 5­10nm thick. Phospholipids consisting of a 
polar head group attached via glycerol to two long­chain, non­polar fatty acids 
constitute this bilayer. Self­assembly occurs so that the hydrophilic head groups 
interact with water molecules in solution, with the hydrophobic fatty acid groups 
orientated away from aqueous media, due to the thermodynamic drive to achieve the 
lowest energy conformation. Due to the hydrophobicity of the membrane interior, 
charged species such as ions are repelled. This is part of the simple defence 
mechanism bacteria have against uncomplexed metal ions. 
                               
                           
                         
                         
                           
                         
                         
                         
 
                       
                         
                       
                         
                     
                         
                               
                                 
                   
 
   
                               
                       
                     
                     
                         
                         
           
 
     
                         
                         
Flagella are situated on the outside of a cell and provide a form of propulsion for 
bacteria. The position and number of flagella a cell possesses is commonly used for 
classification. Flagella are rigid protein structures bound to the membrane of a cell, 
rotation of which is driven by the basal body. Counter­clockwise rotation drives the 
cell forward and clockwise rotation allows the cell to tumble. The direction a cell 
moves is determined by chemotaxis, or movement to or from a chemical source 
according to signals received by a cell. For instance, in biofilm formation, the 
surface acts as an attractant so flagella movement is a response to this. 
Prokaryotic cytoplasm is aqueous and contains a cocktail of molecules, proteins (e.g. 
ribosomes) necessary for cell function and RNA. Prokaryote DNA is also found in 
the cytoplasm, which consists of a single chromosome, varying in size between 
different species of bacteria. The DNA is tightly wound and associated with proteins 
to form structure. Additionally, metal cations associate with DNA to allow 
replication to take place, a process which, as mentioned previously can be disrupted 
by presence of silver ions. As the DNA is not bound by a membrane, this allows 
simple access for such ions. The area in the cell where DNA resides is known as the 
nucleoid, which is accompanied by additional small DNA molecules called 
plasmids.48 
2.3.2.1.1 Gram­staining 
Bacteria are often split into two groups according to the structure of the cell wall and 
its response to staining. Gram­positive bacteria have a thick layer of peptidoglycan 
(~20­80 nm), whereas Gram­negative cell walls comprise a thin layer of 
peptidoglycan and an additional protective outer membrane. The Gram stain (crystal 
violet) once applied to Gram­positive cells cannot be washed out using alcohol, thus 
staining them dark purple. Gram­negative cells stain a much lighter purple or pink 
due to their thin cell wall.48 
2.3.2.2 Eukaryotic cell 
By comparison to prokaryotes, the eukaryotic cell is far more complex. There are 
many differences between the two types of cell, but fundamental differences are that 
                     
                     
                         
           
 
     
                         
                       
                           
                   
                       




             
 
 
                 
                             
                           
                           
                       
                   
 
       
                             
                         
the eukaryotic cell contains a distinct nuclear membrane and complex organelles 
such as mitochondria or chloroplasts, alongside mitotic cell division. Such organelles 
closely resemble prokaryotic cells and it is thought that some form of endosymbiotic 
event occurred early in their evolution.48 
2.3.3 Genotype and phenotype 
The genotype of an organism is the genetic information carried forward from the 
parent organism. These genes provide the organism with its resulting phenotype. The 
phenotype of an organism is an observable trait due to the combination of gene 
expression with environment, such as cell function, behaviour and appearance. 
Therefore, organisms may contain the same (or very similar) genotype but exhibit 
very different phenotype or vice­versa.49 
Without pili With pili
�
Figure 2.19: Phenotype variation in Pseudomonas aeruginosa 
This is evidenced in Pseudomonas aeruginosa bacteria where phenotypical 
expression is altered in cells with identical genotype due to their position in a biofilm 
structure e.g. starved state cells at the centre of a biofilm slow metabolism compared 
to cells at the periphery of a biofilm. Equally, some P. aeruginosa cells have 
different genotype resulting in differing phenotype such as those with and without 
pili (fig. 2.19) which show different attachment characteristics to surfaces. 
2.3.4 Bacterial cell growth 
Bacteria can be grown (or cultured) in aqueous or solid media by the inoculation of 
the media with a small amount of cells. Most bacteria have individually defined 
                     
                           
                         
                   
                 
                             
                     
                        
 
                             
                     
                           
                         
                           
                             
                         
                           
                         
                             







         
 
minimum, maximum and optimum growth temperatures, ranging from ­10◦C to over 
80◦C, although the majority of pathogenic bacteria tend to have an optimum of 37◦C, 
or human body temperature. Equally, bacteria can grow in a range of oxygen 
concentrations, pH and water content; although culture shaking can facilitate 
dynamic aerobic growth whereas static cultures predominantly grow anaerobically. 
The most important cells for study in this work are those which grow best in 
conditions experienced in the body. Thus, incubators with and without shaking 
capabilities were used during this work at a set temperature of 37ºC. 
The method of growth in bacterial cells is called binary fission, that is, each cell 
divides in two and cultures grow exponentially. Cells first accumulate nutrients; 
grow to a critical size where DNA replication takes place, then divide by the 
formation of a new inter cell wall. Upon inoculation in growth media bacterial 
cultures do not initially grow, as cells must adapt to their new environment and 
increase in size. This is known as the lag phase. Following this stage is the 
exponential growth phase, where very fast cell division takes place and is dependent 
on the division time of the bacteria involved. Due to the limited availability of 
nutrients, growth after a certain period slows and eventually levels off as cell 
division is balanced by cell death. The final stage of culture growth is where cell 
death becomes greater than division, cells lyse and the culture becomes less turbid 






























Figure 2.20: Bacterial culture phases
 
     
                           
                       
                             
                            
 
      
                   
                           
                       
                             
                         
                             
                         
                         
       
 
     
                         
                       
                     
                       
                   
                           
                     
                 
                 
                   
               
                         
2.3.5 Model organisms 
The bacteria used in antimicrobial tests in this work were chosen due to their 
importance in the context of nosocomial infection, owing to the potential application 
fate of these materials. As shown in chapter 1, two of the most important bacterial 
types in these environments are P. aeruginosa and S. aureus, hence were used here. 
2.3.5.1 Pseudomonas aeruginosa 
A Gram­negative bacterium, P. aeruginosa is an opportunistic pathogen which 
naturally resides in damp habitats such as marshes and has the ability to colonise 
mammalian hosts. P. aeruginosa is characterised by its fast growth rate and 
propensity to form large green clusters. It is motile, propelled by flagella and at the 
microscopic scale appears as a unicellular rod, typically 0.5­1.0 µm in width and 1.5­
4.0 µm in length.51 P. aeruginosa is a major source of infections in humans, the 
major reason for which is its prolific biofilm­forming nature aided by speed of 
growth, which also allows for antibiotic resistance.52 The strain used in this work 
was Pseudomonas aeruginosa PAO1. 
2.3.5.2 Staphylococcus aureus 
S. aureus is a Gram­positive organism first isolated in pus from human wounds. 
Cells are spherical (hence ‘coccus’) non­motile, ranging from 0.8­1.0 µm in diameter 
and typically cluster together to form golden­coloured chains. The name derives 
from this characteristic in the Greek for ‘bunch of grapes’ and ‘berry’. 
Predominantly an aerobic bacterium (although can respire anaerobically), S. aureus 
requires a medium containing a sugar source and amino acids in order to propagate 
and is mesophilic, growing optimally between 35­40ºC.53 As discussed previously it 
is responsible for hospital­ and community­acquired infections. The strain 
‘methicillin­resistant’ Staphylococcus aureus (MRSA), as its name suggests has 
developed resistance to methicillin antibiotics. Along with another evolved strain, 
‘vancomycin­resistant’ Staphylococcus aureus (VRSA), these organisms create a 
huge problem in hospital settings where antibiotics are the major source of infection 
                       
         
 
     
                       
                         
                           
                         
                            
                         
           
 
     
                           
                           
                       
                 
 
                     
                         
                   
                         
                       
                       
               
 
     
                       
                       
prevention.54 Due to safety concerns, the strain used in this work was ‘methicillin­
susceptible’ Staphylococcus aureus, MSSA 476. 
2.3.5.3 Micrococcus luteus 
M. luteus is a close relation to Staphylococcus, albeit non­pathogenic and forms 
yellow clusters rather than golden ones. The other notable difference from S. aureus 
is the inability to anaerobically ferment glucose.53 Found in soil, air and the natural 
flora of human skin, M. luteus is ubiquitous and even colonises human respiratory 
tracts.55 M. luteus was used as a model organism during preliminary work owing to 
safety concerns regarding more pathogenic strains. It has also been proposed as a 
potential nosocomial pathogen to immunocompromised patients. 
2.3.6 Bacterial detection 
Due to the inherently small size of micro­organisms, it is difficult to observe them 
without using special equipment. In the context of this work, it was important to 
determine whether bacteria which interact with plasma films and free compounds are 
viable so microbiological methods were employed to enable this. 
There are several methods for bacterial observation and qualitative or quantitative 
assessment of cell viability, of varying age and accuracy in determining both the 
numbers and homogeneity of bacteria present. Quantitative methods can only 
estimate numbers present in cultures, which can exceed 1010 cells per millilitre so 
making direct counting difficult. Methods used in this work included culturing cells 
as larger visible colonies, using cell light scattering properties, fluorescent tagging of 
cells and direct viewing of cells through microscopes. 
2.3.6.1 Colony counting 
The simplest method of detecting bacteria is through cell culture in appropriate 
media followed by streaking onto solid nutrient agar and incubation at optimal 
                     
                             
                       
                           
                     
 
 
                           
 
 
                             
                     
                         
                             
                       
 
     
                       
                       
                             
                           
                     
                     




growth temperature. After a strain­dependent period of time (usually ca.18h) visible 
cell colonies appear on the agar surface, (fig. 2.21) each of which corresponds to an 
initial cell which has reproduced sufficiently. Therefore by counting cell colonies it 
is possible to estimate a quantity of bacteria which were present in the original 
solution, typically expressed as colony forming units per millilitre (CFU ml­1).48 
Figure 2.21: M. luteus cell colonies on an LB­agar plate grown from individual cells 
This is the ‘gold standard’ of bacterial detection as it provides both an estimation of 
cell quantities and shows any contamination within the culture e.g. other micro­
organisms. Downsides to this methodology are that it is a lengthy process requiring 
an entire day to estimate cells present in a stock solution and does not necessarily 
present all viable cells as those which cannot replicate do not show. 
2.3.6.2 Solution turbidity 
A more facile yet slightly more inaccurate and indirect approach to cell 
quantification is utilising solution turbidity or the light scattering properties of cells. 
Due to the fact that cell propagation results in a less transparent solution than pure 
media alone, the difference in light absorption can be measured and related back to 
the initial bacterial concentration.48 This is typically achieved using a UV­vis 
spectrophotometer, with the transmission of light through a known path length 




                     
                             
           
 
 
                         
                             
                     
                         
                         
                               
                           
                             




                         
                         
                         
                             









OD = λ 
Cuvette containing bacterial solution 
Figure 2.22: UV­vis measurement (l) resulting in an optical density measurement 
(r), where I0 = incident beam intensity, I = transmitted beam intensity and λ = 
wavelength of incident light (typically 600nm) 
Optical density is plotted versus CFU ml­1 generated by colony counting the same 
sample at various known dilution factors to yield a calibration plot. This plot is used 
to easily determine the bacterial concentration of solutions, but is highly strain­
specific so a calibration plot must be generated for every bacterial strain under 
particular experimental conditions. Also, due to the small nature of bacterial cells a 
great deal of them is required to scatter sufficient light to monitor by UV­vis, but too 
many and light cannot pass through. Therefore, the limit of detection of this method 
is in the region of 105­108 CFU ml­1 and cell viability cannot be deduced. The UV­
vis spectrophotometer used in this work was a Thermos Helios Gamma single beam 
model. 
2.3.6.3 Bright­field microscopy 
A method of directly viewing cells, bright­field microscopy has been used for a 
number of years. Using visible light (as opposed to electron sources for electron 
microscopes) to illuminate a specimen mounted on a stage, the image is magnified 
up to 1000­times by the objective and ocular lenses (fig. 2.23) to reveal the structure 






               
 
 
                         
                     
                     
                         
       
 
     
                           
                       
                           
                           












Figure 2.23: Components of a basic light microscope 
This methodology is useful for detecting the presence and position of cells on 
surfaces but is limited as quantification is difficult on heterogeneous or three­
dimensional substrates and no cell viability information can be obtained. The bright­
field microscope used in this work was a combination microscope which was also 
used for fluorescence microscopy. 
2.3.6.4 Fluorescent tagging 
Bacterial cells may be tagged with a fluorescent dye in order to identify their 
presence and/or viability. Such dyes utilise the principle of fluorescence, which is 
evidenced by decay of short­lived excited states in an atom or molecule through the 
emission of a photon. Such states are created by the excitation of fluorophores with 
light of a certain wavelength (fig. 2.24). 
                          
                                 
         
 
                       
                     
                     
                       
                       
                         
                         
                     
                     
                   
 
     
                     
                           
                     




             
 
 
                         
                   






S + hν → S0 ex 1 
S → S + hν + heat1 0 em 
Figure 2.24: The basic principle of fluorescence, where S0 is the ground electronic 
state, S1 is the first excited state, hνex is the energy of excitation and hνem is the 
energy of the emitted photon 
Conventional fluorescent dyes for investigating cell viability use a single dye which 
only binds bacteria with intact membranes or functioning metabolism. Newer dyes 
have dual­function combination dyes which bind both viable and non­viable cells.56 
The dye used in this work was the Invitrogen Molecular probes LIVE/DEAD 
Baclight cell viability kit (Live/Dead stain), which consists of two dyes; SYTO­9 
and propidium iodide which both stain the nucleus of bacteria. The SYTO­9 element 
tags all cells with green fluorescence while propidium iodide enters and tags those 
cells with damaged membranes with red fluorescence, displacing SYTO­9 in the 
process. Fluorescently labelled cells can be detected via two methods, fluorescence 
microscopy for surfaces or use of a fluorimeter for solutions. 
2.3.6.4.1 Fluorescence spectroscopy 
A spectrofluorimeter is an instrument which both excites fluorophores and detects 
emission of fluorescence (fig. 2.25). Light of a defined wavelength emitted by a laser 
or lamp is monochromated and irradiates the sample solution. Fluorophores within 
the sample are excited and the resulting emitted photons of light are detected either 
singly or simultaneously. 
Xe lamp Excitation 
monochromator 
Sample cell Emission 
monochromator 
Detector 
Figure 2.25: Schematic of a basic spectrofluorimeter 
The spectrofluorimeter used in this work was an Ocean optics USB4000­FL with a 
multichannel detector. The emission/excitation maxima for the Live/Dead stain are 
480/500nm for SYTO­9 and 490/635nm for propidium iodide. This technique was 
                     
                       
 
         
                       
                       
                       
                     
                         
     
 
                       
                     
                     
                             
                           
                               






       
 
             
 
principally employed for measuring bacterial viability in solutions of cells removed 
from plasma films and control substrates by the ratio of green/red fluorescence 
counts. 
2.3.6.4.2 Fluorescence and confocal microscopy 
Light microscopy can be adapted to utilise fluorescence in visual representation of 
cell viability. In place of visible light used in bright­field microscopy, ultraviolet 
light is the light source in a fluorescence microscope. Fluorophores are excited 
similarly to fluorescence spectroscopy and emit photons which can be viewed 
optically.48 This method was used to take images of plasma­ and non­treated surfaces 
post bacterial attachment. 
Along the same lines as a conventional fluorescence microscope is the confocal 
scanning laser microscope (fig. 2.26), which allows the construction of a three­
dimensional sample image. Typically, incident light is passed through an objective 
lens and onto the sample. Emitted light then passes onward to the detector via a 
pinhole which allows detection of light from the focal plane only. The sample is 
scanned in the x, y and z directions, with the detected light processed by a computer 







Figure 2.26: Confocal scanning laser microscope set­up
 
                         
                       
                         
                     
        
         
                         
                             
                             
                             
                       
                           
 
 
                         
                       
                             
          
 
                         
                             
                   
                    
 
         
                       
                     
                       
                       
                         
                   
Of particular advantage is the ability to assess bacterial viability when attached to 
surfaces, although each confocal scan can take around 15 minutes. The confocal 
microscope used during this work was a Dual laser Nikon Eclipse 90i microscope. 
Confocal imaging was of use in examining three­dimensional materials exposed to 
bacterial cultures e.g. non­wovens. 
2.3.7 Microbial safety and sterility 
In order to work safely with bacterial samples, maintenance of sterile conditions was 
required. All work was carried out with class II pathogens (MSSA 476, PAO1) in a 
class II safety cabinet. Such a cabinet comprises a glass screen to protect the user 
with an air circulation system containing filters. A small opening at the front of the 
cabinet allows access to work with samples safely and without disrupting sterility. 
Disinfection of surfaces outside of the cabinet was through use of bleach or 70% 
alcohol. 
Sterilisation of media and equipment is generally achieved by use of heat, commonly 
in the form of an autoclave. Autoclaving is essentially decontamination of materials 
with pressurised steam and in order to sterilise, an autoclave must run at 121ºC and 
15 psi for 15 minutes.48 
Although samples which were to be exposed to bacteria could have been sterilised 
using an autoclave, it was decided to use a quick and dry method of UV/ozone 
treatment. An ultraviolet light source attacks bacteria on contaminated surface 
through high energy bombardment of chemical bonds within the cell. 
2.3.8 Antibacterial evaluation of materials 
There are a multitude of methods for measuring the antimicrobial properties of 
solutions and surfaces. Although there are American and Japanese standards for 
example, to date there is no definitive method or procedure for assessing 
antimicrobials. The methods used in this work were chosen according to their 
applicability and are detailed here. Common amongst all assays of course was the 
need to test all potential antimicrobials against a non­treated control. 
       
                         
                           
                         
                         
                           
                       
                       
                     
 
 
       
                       
                       
                     
                             
                           
                           
                           
               
 
     
                                 
                                 
                         
                         
                       
             
 
2.3.8.1 Disc diffusion assays 
A simple way of qualitatively assessing the effectiveness of free compound or the 
leaching properties of plasma films is to place the antimicrobial onto a solid growth 
medium coated with bacteria and gauge visible colony growth or otherwise after a 
defined period of time. If a zone of clearing surrounding the antimicrobial is 
evidenced, then it can be assumed that diffusion of the agent has inhibited microbial 
growth. Although this method is a useful indicator of antimicrobial efficacy and 
helpful for comparing material leaching, it is not necessarily reliable for comparing 
different free compounds which can exhibit vastly different solubilities in aqueous 
media. 
2.3.8.2 Minimum inhibition assays 
Another method for determining the efficacy of free compounds is to quantitatively 
assess the minimum concentration of an antimicrobial to inhibit microbial growth in 
solution. Differing quantities of antimicrobial agent are dissolved in an appropriate 
media for bacterial growth, with a set concentration of bacteria added to the mix and 
incubated at optimum growth. After a defined time period, OD of each sample is 
taken and a plot of OD or CFU ml­1 versus antimicrobial concentration is plotted. 
Commonly assessed is the ability of the antimicrobial to inhibit either 50% or 90% 
of bacterial cell growth compared to the control. 
2.3.8.3 Solution assays 
If an antimicrobial agent is leached from a surface, it is useful to know how it affects 
bacterial growth in solution. In order to do this, a solution of bacteria which is in the 
vicinity of an antimicrobial surface can be tested for bacterial cell viability through 
use of colony counting, optical density or Live/Dead stain. Due to the high 
concentration of bacterial cells in some solutions, multiple dilutions and platings are 
required when utilising the colony count method. 
     
                     
                         
                             
                       
                           
                     
                           
     
 
                             
                           
                       






                     
            
                            
   
                 
                   
                    
   
                          
             
                                
     
                                
2.3.8.4 Surface assays 
A simple method of assessing surface­active antimicrobials is by allowing growth 
for a set period of time and comparing visual biofilm formation. Other visualisation 
methods include the use of a light or fluorescent microscope. In order to quantify the 
surface­activity of antimicrobials it is necessary to remove those cells which have 
attached to the surface. Typically, the surface is lightly rinsed to remove free cells, 
replenished with fresh media and vortexed to remove surface­attached cells. These 
cells can then be assessed by colony counting, OD or fluorescence in the same 
manner as solutions. 
This general assay type was employed for a range of substrates from plastics to glass 
to gold, with some modifications along the way. A Japanese industry standard (JIS L 
1902) for quantification of bacterial growth on textiles which follows a similar 
method was also used. 
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Chapter 3: Experimental methods
 
In keeping with chapter 2, all common experimental methods used are detailed here. 
3.1 Plasma reactor 
3.1.1 Monomer deposition 
Use of the reactor for plasma polymerisation required loading of substrate to the 
main chamber, then adding monomer to the Young’s flask and proceeded as detailed 
in appendix. In brief, the chamber was evacuated, allowed to reach a suitable base 
pressure, the monomer tap was opened and either continuous wave or pulse plasma 
was ignited using the radio frequency source. 
A continuous wave plasma reaction can be seen below: 
Figure 3.1: Plasma polymerisation in reactor 1 
3.1.2 Pulse plasma 
Pulse plasma deposition was operated using the standard monomer deposition 
procedure. Duty cycles of 1/40 (T=41ms) 10/40 (T=50ms) and 40/40 (T=80ms) were 
                     
                           
     
                       
                               
                       
 
 
       
     
                         
                       
                   
                         
                       
                         
     
                             
                             
                         
                           
                     
     
                           
                             
                           
commonly employed by altering on/off times on the oscilloscope to give equivalent 
input powers of 1.2W, 10W and 25W respectively at a peak power of 50W. 
3.1.3 Oxygen/fluorocarbon treatment 
Oxygen and fluorocarbon gas sources were introduced to the plasma chamber via 
inlet taps on the flange of reactor 1 and the glass attachments of reactor 2. Treatment 
using these gases was used before or after the deposition of complex, never 
concurrently. 
3.2 Plasma film characterisation 
3.2.1 Substrate preparation 
Plasma films were deposited onto a wide range of substrates including NaCl and 
KBr discs, glass slides, SAM coated gold slides, polystyrene petri dishes and non­
woven materials. Preparation of polymeric surfaces for the acceptance of plasma 
films or for use as controls in microbiological assays was achieved using either 
oxygen plasma or UV/O3 treatment. The preparation of gold films however, required 
a series of procedures to clean glass, deposit gold and coat with SAMs. 
3.2.1.1 Glass preparation 
Slides of glass were cleaned by sonication with KI/I3 solution for 15 minutes in an 
ultrasonic bath to remove old gold and rinsed 20 times in MilliQ water. They were 
then sonicated for 15 minutes with 2% Hellmanex (an alkaline solution), rinsed 20 
times in MilliQ water and sonicated twice in absolute ethanol for 15 minutes. Slides 
were then dried with nitrogen and stored under nitrogen at 4
◦
C. 
3.2.1.2 Gold evaporation 
Slides for gold evaporation were subjected to UV radiation, before being placed in a 
gold evaporator. Gold of mass 118mg was cut from a reel of gold wire (diameter 
0.5mm), sonicated in ethanol for 10 minutes and dried in a nitrogen stream. Clean 
                           
                                 
                             
                         
                                 
                           
 
     
                             




                           
                           
                               
                           
                         
                           
       
     
                     
                           
       
 
gold was then coiled and placed in the appropriate basket of the evaporator. The 
system was put under high vacuum until a pressure of 3 x 10
­6 
was reached, at which 
point evaporation of gold took place at 3­4 amps. This allowed deposition of a gold 
film around 50nm thick. After evaporation, gold coated slides were placed in an 
oven at 550
◦
C for 1½ minutes to allow the gold to anneal. Once cool, the slides were 




3.2.1.3 SAM preparation 
Gold slides were placed in a solution of 5mM allyl mercaptan in ethanol for 30 
minutes, then dried in N2 immediately prior to plasma deposition. 
3.2.2 FTIR 
3.2.2.1 Transmission spectra 
300 mg anhydrous potassium bromide was ground to a fine powder using an agate 
mortar and pestle. The minimum amount of powder was then placed in between two 
anvils of a stainless steel dye under vacuum and a pressure of 7 tonnes was applied 
to the dye for 15 seconds, yielding a homogenous KBr disc of 13mm diameter. 
Plasma films were deposited onto the discs and FTIR measurements of the discs 
taken after a background reading. For each sample, 128 scans were recorded at a 
resolution of 4 cm
­1 
. 
3.2.2.2 Absorption spectra 
Plasma films were deposited onto SAM­coated gold chips and FTIR measurements 
taken after a background reading. For each sample, 32 scans were recorded at a 




                             
                               
                   
                         
                             
                       
 
   
                       
                   
 
     
                     
                       
                       
                               
                     
                         
           
 
   
                               
                             
                           
                           
                       
   
 
                 
3.2.3 AAS 
Plasma films were deposited onto glass slides and either placed in 2 ml of phosphate 
buffered saline for 24 h or dissolved using 2 ml of ultra pure nitric acid. The 
resulting solutions were subsequently fed into an atomic absorption spectrometer 
after calibration with the appropriate metal­containing standards (Ag = 1, 2.5 and 5 
ppm; Zn = 0.4, 1 and 2 ppm) and elemental concentration results were obtained. All 
operations were carried out by Alan Carver at the University of Bath. 
3.2.4 XPS 
Plasma films were deposited onto Si­wafer after UV/O3 treatment to activate and 
sent for analysis at either CERAM (Stoke) or NPL (Teddington). 
3.2.5 Electron microscopy 
Samples for electron microscopy were prepared in different manners according to 
the method i.e. scanning or transmission used. For SEM, plasma films were 
deposited onto Si­wafer after UV/O3 treatment to activate or SAM­coated gold chips 
and then coated with a thin film of carbon or gold to increase the conductivity. For 
TEM, plasma films were deposited onto carbon coated copper grids. Electron 
microscopes were operated by Hugh Perrot at the Centre for Electron Optic Studies 
(CEOS) at the University of Bath. 
3.2.6 SPR 
SPR cells were set up with a LaSFN9 glass prism placed on top of the non­coated 
side of slides, with immersion oil separating them. The coated side was placed onto a 
Teflon base containing a rubber O­ring and then secured into the SPR holder. Once 
in place on the SPR instrument, the holder platform axes were varied until total 
internal reflection of incident light was achieved. The angle was then scanned 
through from 19
◦ 
until after the resonance angle was reached (minimum reflectance) 
                             
                       
                   
                       
                      
                         
                           




                     
                       
 
and the SPR curve plotted on a computer programme. In order to obtain a plasma
 
film thickness measurement, bare gold was scanned and a curve recorded before
 
plasma deposition to allow comparison. A fitting programme (WINSPALL, Max
 
Plank Institute for Polymer Research, Mainz, Germany) was then used to determine
 
an estimated thickness using the parameters for the bare gold slide:
 
­ Prism: thickness = 0, dielectric constant (real) = 3.404, (imaginary) = 0)
 
­ Gold layer: thickness = 50nm, dielectric constant (real) = ­12.5, (imaginary) = 1.5)
 
­ Air: thickness = 0, dielectric constant (real) = 1, (imaginary) = 0)
 
The resulting curve simulation was fitted to the experimentally observed curve 
(critcal angle and resonance angle) to estimate thickness of the gold layer: 
  
                       
                           
                           
 
                         
                     
 
   
                   
                         
                     
 
Thickness of the plasma film was estimated by entering the following parameters: 
­ Plasma film: thickness = 30nm, dielectric constant (real) = 2.25, (imaginary) = 0) 
­ (Optional) Water: thickness = 0, dielectric constant (real) = 1.778, (imaginary) = 0) 
The simulated curve was fitted to the experimental curve by only allowing for 
change to plasma film thickness parameter, so yielding this value post­fitting. 
3.2.7 QCM 
Plasma films were deposited onto SAM­coated 10 MHz gold ITO crystals. The 
crystals were weighed prior to­ and post­ deposition by attachment to a potentiostat, 
placement in a Faraday cage and recording the frequency after five minutes. 
     
                     







                           
                           
                           
                                 
                     
                         
                   
     
                           
                         
                     
   
                           
                         
                     
                       
         
3.2.8 α­step profiling 
Films were plasma deposited onto Si­wafer after UV/O3 treatment to activate. 
Profiling was performed by Alex Lotz at Max Plank Institute for Polymer Research, 
Mainz, Germany. 
3.3 Monomer characterisation 
3.3.1 FTIR 
3.3.1.1 Transmission spectra 
A small amount of sample (ca. 3mg) was added to 300 mg anhydrous potassium 
bromide and ground to a fine powder using an agate mortar and pestle. The 
minimum amount of powder was then placed in between two anvils of a stainless 
steel dye under vacuum and a pressure of 7 tonnes was applied to the dye for 15 
seconds, yielding a homogenous KBr disc of 13mm diameter. An FTIR 
measurement of this disc was taken after a background reading. For each sample, 
128 scans were recorded at a resolution of 4 cm
­1 
. 
3.3.1.2 Absorption spectra 
A small amount of sample was placed on the crystal of the FTIR spectrophotometer 
and crushed. An FTIR measurement was taken after a background reading. For each 




Samples for NMR analysis were prepared by adding a small amount (<5mg) to the 
minimum amount of solvent in a clean NMR tube. All NMR experiments were 
carried out in either deuterated chloroform or dimethyl sulfoxide solvent, depending 
on solubility of the monomer. Samples were immediately loaded to the appropriate 
spectrometer queue and run automatically. 
    
                       
                     
                       
         
 
     
                               
                               
                               




                     
                           
                       
                               
                         
   
     
                         
                         
                       
                       
                         
3.3.3 XRD 
Crystals suitable for single crystal X­ray diffraction studies were formed by the 
recrystallisation of crude monomer from an appropriate solvent followed by slow 
evaporation of solvent. Samples were submitted to Dr. Andrew Johnson at the 
University of Bath for analysis. 
3.3.4 Melting point 
Glass capillary tubes were melted at one end and allowed to set, blocking one end. A 
small amount of sample was loaded to the open end and moved to the blocked end. 
The blocked end of the tube was then loaded to a melting point apparatus and the 
melting point observed by slow heating. 
3.4 Microbiological techniques 
Biological work was undertaken in both Biology and Biochemistry, and Chemistry 
at University of Bath under the supervision and guidance of Dr. Nick Waterfield and 
Pete Jewell. Safety precautions taken when working with microbes included lab coat, 
gloves and use of a flow hood. Work with class II pathogens was undertaken in a 
class II safety cabinet. Any contaminated waste was disposed of via autoclave and/or 
use of bleach. 
3.4.1 Aseptic techniques 
Of utmost importance during microbiological work is sterility, both for the safety of 
the user and to prevent cross­contamination of samples. As such, all equipment used 
for contact with microbes (e.g. pipette tips, tubes) was either pre­sterilised, filter 
syringed or autoclaved at 121ºC. Prior to microbiological work the safety cabinet 
interior, pipette fillers, gloves and exterior of bottles etc were sterilised with 70% 
                     
                         
                                 
           
     
               
 
                               
                           
     
 
              
 
                             
                               
                             
                     
               
 
                       
                         
                             
                                 
                     
 
                           
                             
                     
 
ethanol. During microbiological work, great care was taken to prevent contamination 
by minimising lid­removal time, avoiding contact of pipette fillers with the inside of 
tubes and jars, and use of new pipette tips and tubes for each sample. Post assay, the 
area was decontaminated with 70% ethanol. 
3.4.1.1 Bacterial culture 
Cultures of bacteria were prepared in two ways: 
1.	 Inoculation of a solution with a streak of bacteria. A sterile loop was used to 
pick several colonies of bacteria from a stock plate, added to 10ml LB broth 
and incubated at 37 ºC for 24 hours to allow growth. 
2.	 Inoculation of a solution with a single colony of bacteria. A sterile pipette tip 
was used to pick a single colony of bacteria from a stock plate, added to 10ml 
of LB broth and incubated at 37ºC for 24 hours with shaking at 200rpm to 
agitate growth. Each culture was prepared in triplicate against a negative 
control of pure LB to identify contaminated media. 
The second method was preferred for latter work as it provided greater 
reproducibility of culture. After incubation, 1ml of each culture was centrifuged for 3 
minutes at 1200 r.p.m. and excess media poured off to be replaced by fresh media. 
100µl of culture was added to 900µl of fresh media and OD taken at 600nm versus a 
zeroed control of pure LB in order to estimate CFU ml
­1 
. 
Stock solutions of bacteria were made adding 800µL of a grown culture to 800µL 
glycerol and storing at ­80
◦
C. These stocks were then used to create fresh cultures by 
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concentration range by serial dilution. DMSO was used due to the insoluble nature 
of monomers and of high purity to avoid presence of contaminants such as iron, 
which is seen in >98% pure DMSO. Once the initial dilution series was made up, 





resuspended bacterial culture in LB. Samples were incubated at 37
o
C for 18 hours, 
then removed from incubation and the optical density was determined by UV­vis 
spectrophotometry at 600nm versus a zeroed blank of 9:1 LB:DMSO. Optical 
density was correlated to bacterial growth by cell counting calibration and plotted 
against the monomer concentration range. An MIC50 for each compound was 
estimated at 50% bacterial growth reduction. 
1/10 
1 2 3 4 n 
Serial dilution of
monomer in DMSO 
1/10 
+ 100 µl bacteria 










I0 I  
1/10 1/10 
Figure 3.3: Minimum inhibition concentration assay
 
         




   
 
             
 
       
                     
                     
                 
 
                         
                               
                         
                             
                         
                         
                         
 
     
                       
                           
3.4.3 Plasma film microbiological assays 





Plasma deposit Add bacteria Wash surface/vortex 
Growth 
Figure 3.4: General method of antimicrobial surface­activity 
3.4.3.1 Petri dish assay 
Monomer was plasma deposited onto three 50mm diameter Petri dishes in three 
separate depositions, post 10min O2 50W CW plasma. Control Petri dishes were 
subjected to 10min UV/O3 treatment in order to sterilise. 




in either minimal 
LB (10x dilution of regular LB) or regular LB media. 40�l of culture was added to 





. Dishes were incubated at 37ºC for desired time period. After this time, 
effluent media was poured off and the surface indirectly washed with 2x 2ml 
physiological saline (0.9% w/v NaCl). 1ml of physiological saline was applied to the 
dish surface before each dish was wrapped in parafilm and vortexed for 30s. 
3.4.3.2 JIS assay 
Monomer was plasma deposited onto three 9x9cm strips of non­woven (PP), which 
were subsequently cut into three sets of two 3x3cm squares (end pieces only used). 
                       
         
 
                           
                             
                         
                       
                         




                               
                         
                     
                         
   
 
                     
                         
                     
                             
             
 
     
                     
                             
              
 
Control non­woven were cut into 3x3cm squares and subjected to 10min UV/O3 
treatment in order to sterilise. 




in LB media, 200�l 
of which was added to each square of non­woven in a sterile 50mm petri dish. 
Infected non­woven was incubated at 37ºC for a specified time. After this time, non­
woven squares were removed from the Petri dish, lightly washed in 2ml 
physiological saline (0.9% w/v NaCl) dips and placed into a 50ml tube containing 
20ml of physiological saline. Each tube was then vortexed for 5 x 5s. 
3.4.4 Antibacterial analysis 
3.4.4.1 Colony count 
100�l of the vortexed solution in 3.4.3.1 or 3.4.3.2 was applied to the surface of a 





­times dilution in physiological saline were also made and 
spread in the same manner. Plates were incubated for 18­24h until bacterial colonies 
were observed. 
After incubation, agar plates containing colonies of bacteria were assessed for viable 
cell count. A dilution factor was chosen where individual colonies were evident, but 
at countable and statistically viable levels (ca.30­300). Colonies were then counted 
and scaled up (multiplied by 10x dilution factor) to give an estimation of viable cell 
count, colony­forming units per millilitre (CFU ml
­1
). 
3.4.4.2 Live/Dead analysis 
Live/Dead stain stock solution was prepared by adding pre­measured quantities of 
SYTO­9 and propidium iodide in the Baclight kit to a common 5ml of sterile water. 
This solution was stored under foil at ­18ºC. 
                             
                           
                       
                   
                         
 
 
                         
                           
            
 
   
                   
                       
                     
 
     
                       
                   
                    
 
                             
                           
                                 
                       
                       
                   
                     
    
 
                             
900�l of the vortexed solution in 3.4.3.1 or 3.4.3.2 or of the effluent solution was 
added to 100ml of Live/Dead stain, shaken and allowed to diffuse for ten minutes. 
After this time, samples were loaded to 1.6ml disposable cuvettes and fluorescence 
spectra obtained at an excitation wavelength of 490nm. Emission intensities 
observed at the appropriate wavelengths for the two dyes were used to estimate 
bacterial viability. 
In order to create a calibration plot, bacterial cultures of estimated live/dead ratios 
were created using live cultures and identical dead cultures; cells were killed by heat 
shock at 60ºC for 30 minutes. 
3.4.4.3 Microscopy 
Samples were prepared for fluorescent microscopy by staining washed but non­
vortexed surfaces on appropriate substrates with 50µl of Live/Dead stain. After 10 
minutes, samples were observed on either a fluorescence or confocal microscope. 
3.5 Cytotoxicity tests 
The cytotoxicity of plasma films was studied by culturing cells from embryonic 
Swiss mouse fibroblasts (NIH 3T3) and human neonatal epidermal keratinocytes 
(HEK102­05n) and monitoring growth on treated and non­treated glass coverslips. 
NIH 3T3 cells were seeded onto coverslips at high density and allowed to grow for 
24h. HEK 102­05n cells were much slower growing and were only available for use 
at a lower density, so were allowed to grow on the treated coverslips for 72h prior to 
cytotoxicity testing. An XTT/MPMS assay
1 
was used to assess cell viability after 
this time, where XTT tetrazolium is converted to orange formazan crystals by 
mitochondrial enzymes in live cells, thereby giving a colourimetric response 
measured by light absorption. Therefore, greater cell viability is indicated by 
increased absorption. 
PMS stock was diluted to 1:100 and 5�l XTT was added per ml. The resulting 
                           
                             
                             
     
 
                          




         
                       
                 
           
                       
                 
                           
                     
                     
                   
                     
                       
                             
               
                           
                     
                       
                         
           
                       
                     
 
solution was added to media containing the cells to be tested (pre­prepared) in a 1:4 
ratio, shaken and incubated at 37ºC for 2h under 5% CO2. Media was removed from 
cultures after this time and added to a 96 well plate, and then absorbance was 
measured at 450nm. 
(1)	 Lechpammer, S.; Asea, A.; Mallick, R.; Zhong, R.; Sherman, M. Y.; 
Calderwood, S. K. Int. J. Hyperthermia 2002, 18, 203. 
3.6 Appendix 
Detailed operation of plasma reactor: 
•	 Reactor cleaned manually: the reactor chamber and both flanges (reactor 1) 
were washed using acetone, water and ethanol, allowed to dry 
•	 Reactor cleaned using oxygen plasma 
•	 Monomer loaded to Young’s flask. Freeze thawed several times (3+) by 
cooling flask with liquid nitrogen followed by gentle heating 
•	 Substrate loaded to the main chamber at one end: Vacuum was removed, one 
electrode was detached using wing­nuts (reactor 1) or retaining strap (reactor 
2), the substrate loaded, lines reattached and vacuum applied. System was 
allowed to reach base pressure (ca. 2 x 10
­2 
mbar) 
•	 Monomer chamber was opened to vacuum, pressure was allowed to stabilise 
•	 Monomer flow rate was measured by closing the vacuum tap for 30s, 
pressure readings were taken at start (Ps) and end (Pf ) of this time period 
then applied to equation 2.18 of chapter 2 
•	 The RF generator was switched on, mode set to ‘CW’, plasma ignited (RF 
on) and desired input power set. (If pulse required, see 3.6.1) 
•	 Input impedance was manually matched using ‘Tune’ and ‘Load’ to minimise 
the reflected power. The reflected power was reduced to <0.5% of the input 
power at all times during deposition 
•	 Deposition pressure was recorded along with the input and reflected power 
•	 Deposition was stopped after desired time, then the monomer chamber was 
closed 
                       
             
                           
                         
           
 
   
                               
                   
                         
                     
           
                           
                     
                       
                           




                               
         
                         
           
                           
               
               




• The substrate was removed after allowing the reactor to cool, then generally 
used immediately for analysis or biological assay 
NB: The initial step of degassing or removal of impurities was applied only to non­
melting monomers as those compounds which melt when heated or are liquid at 
room temperature instantly degas under vacuum. 
3.6.1 Pulse operation 
•	 Mode was set to ‘Pulse’ using toggle switch at the rear of the RF generator 
•	 The pulse generator and the oscilloscope was switched on 
•	 Wavelength and period was altered using dials on pulse generator. Pulse ‘on’ 
and ‘off’ appeared visually on oscilloscope. With ‘time divisions’ set to 
10ms, each square equated to 10ms 
•	 Commonly used duty cycles were 10/40, 1/40 and 40/40. 1/40 pulse was set 
by dialling ‘on’ time to 1ms and ‘off’ time to 40ms 
Some compounds struggled to maintain a plasma glow when pulse operation was 
used. If a monomer with a particularly high flow­rate was used, the flow rate was 
reduced using monomer tap. The tap was opened slowly until a pulse plasma glow 
was maintained. 
3.6.2 Oxygen/fluorocarbon treatment 
•	 Cylinder tap was opened (O2/C2F6) (to 1 bar for O2), the gas was allowed to 
flow to the inlet tap 
•	 Monomer taps were closed, the desired inlet tap opened until the reactor 
pressure reached 1­2 x 10
­1 
mbar 
•	 The RF generator was switched on, mode set to ‘CW’, plasma ignited (RF 
on) and desired input power set (usually 50W) 
•	 The reaction was stopped after desired time 




               
         
 
                     
                               
                             
                           
                   
                         




                               
                         
                         
                       
                           
                     
                       
                         
                       
                       
 
Chapter 4: A novel silver compound for the 
plasma deposition of antimicrobial films 
A novel organosilver complex was synthesised, characterised and found to inhibit 
the growth of M. luteus, P. aeruginosa and S. aureus. The complex was used as a 
monomer unit in the plasma deposition of thin films and these films were found to 
inhibit microbial growth on a range of substrates by a number of traditional and 
modern microbiological techniques. Films were also found to be completely 
harmless to eukaryotic cells after exposure of between one and three days. Aspects 
of this chapter were summarised in the Royal Society of Chemistry journal Chemical 
Communications in 2009.1 
4.1 Antimicrobial silver 
The use of silver as an antimicrobial agent is discussed in chapter 1, but the precise 
mode of toxic action against micro­organisms is a contentious issue. It has been 
proposed that silver cations (Ag+) act by binding strongly to electron donor groups 
containing sulphur, oxygen or nitrogen, which are plentiful in bacterial cells and 
replacing essential metal ions such as calcium and zinc.2­3 For instance, Ag+ ions can 
deactivate the enzymes required for DNA replication4 by irreversibly blocking the 
helix from unwinding.5 Silver ions may also perform activity at cell membranes, 
where they react with thiol (­SH) groups,6­7 causing damage to the microbe and 
possibly activating self destruct genes8 (fig. 4.1). Both of these mechanisms have 
been observed in electron microscope studies of cells treated with silver ions.9 
                        




                           
                         
                       
                         
                   
                     
                       
                       
 
                           
                         
                           
                       
                           
                         
                   
                       
                     
                         
                           
Ag+ a) 
b) 
Figure 4.1: Schematic of silver ion antibacterial action. a) Cell membrane damage 
via reaction with electron donor groups, b) diffusion through the membrane and 
deactivation of DNA 
Due to the multiple biocidal mechanisms employed by silver, it is believed that there 
is little chance bacteria may become resistant to it,6 although some evidence for 
resistance has been shown. Ag+ exposure has proven non­toxic to mammalian cells 
in low concentrations,3,7 but silver effects in the body can be inhibited by 
complexation with organic compounds present in biofluids,10 e.g. albumin in 
blood3,11 therefore long term release issues remain a problem with silver 
applications. Indeed, frequent treatment can allow bacterial resistance to be built up12 
and some silver coatings can be denatured by blood plasma over time.13 
A recent study has shown that silver efficacies are greatest when the free ionic 
content is lowest,5 possibly due to instant chelation or complexation in a media 
environment as silver has a propensity to form insoluble silver chloride, which is a 
sink source for silver. This study also indicates that DNA replication prevention, 
rather than membrane disruption is the key aspect of silver ion effect as an 
antibacterial agent, due to the fact that silver requires complexation in order to 
diffuse through the cell membrane and cytoplasm. Complexed silver prevents 
activation of bacterial ion efflux mechanisms,14 which actively pump out free silver 
ions in the cell and enzymatic detoxification (redox chemistry).15 Therefore, pure 
silver application is less effective where required at low concentrations, i.e. in the 
body, so the most efficient biocidal material for medical use is one which carries 
                         
           
 
     
                               
                           
                             
                           
                           
                       
                         
                     
                             
   
 
             
                           
                       
                   
                   
                       
                           
                       





silver in complexed form, but bound such that ion­exchange is possible to allow 
silver release at DNA binding sites. 
4.2 Silver chemistry 
Silver is a ‘noble metal’, found toward the right­hand side (group 11, row 2) of the 
transition metal series, the d­block. Due to the poor nuclear shielding of the 4f 
orbitals, second and third row transition metals are larger and softer than those of the 
first row.16 Silver is resistant to oxidation, or ‘noble’ with only one stable oxidation 
state (+1).17 With the exception of silver nitrate, silver (I) salts are nearly always 
anhydrous and sparingly soluble in water due to formation of a three­dimensional 
polymer network.18 The poor reactivity and high conductivity of silver lies in the 
ground state electron configuration of [Kr]5s 1 4d10. Silver preferentially forms Ag+ 
over other oxidation states as removal of the 5s 1 electron leaves a highly stable filled 
10 4d set. 
4.3 Novel silver complexes for plasma deposition 
The ideal way to incorporate silver into plasma films is through deposition with an 
organic or reactive component. Previous efforts discussed in chapter 1 have shown 
organic frameworks impregnated with silver nanoparticles can be an effective 
surface­active antimicrobial agent. However, such an approach is limited by 
unsolicited release of silver which can render the surface itself inactive. The 
approach taken here was reaction of silver salt with an organic molecule which can 
act as a polymeric linker e.g. containing double bond functionality, thus theoretically 
maintaining silver at the surface in complexed form in the polymer structure (fig. 
4.2). 
Ag X H X
 
                       
 
                       
                       
                         
                 
                   
                     
                       
                   
 
     
                           
                       
                       
                   
                     
                     
                     
                     
                   





­ ­  
Figure 4.2: The reaction of a silver salt with a functionalised alkene 
A number of organo­silver complexes have been reported over the years, although 
the inherent light and thermal instability of silver means simple silver compounds 
(Ag­R) readily decompose upon subjection to vacuum and UV light in a plasma 
monomer chamber. In addition, organo­silver complexes are inherently involatile 
and poor antimicrobials on account of their oligomeric supramolecular structure 
owing to intermolecular forces.19­20 To avoid these undesirable characteristics it is 
possible to both stabilise and reduce the intermolecular forces in Ag­R compounds 
by use of bulky ligand systems which provide steric hinderence.20 
4.3.1 Ligand selection 
Prior work in the area of plasma polymerisation has established the use of small 
organic molecules containing unsaturation as good precursors for thin films. If a 
silver containing unit could be incorporated into such a molecule, then polymerised, 
a potential antibacterial agent with desired properties of complexation and 
homogeneity would result. For this purpose, recent studies on plasma deposited 
maleic anhydride21­22 and acrylic acid23 were of interest, which demonstrated good 
compatibility with biomolecules. Unfortunately in the case of maleic anhydride, a 
bond with silver cannot form without disrupting ring structure or polymerisation 
characteristics. Alternatively, the analogue maleimide (fig. 4.3) contains an amide 
group which can undergo reaction with silver compounds to provide a silver­
nitrogen bond. 
MaleimideMaleic anhydride  




                           
                         
                         
                         
                       






                 
 
       
                   
             
                       
                       




Figure 4.3: Representations of maleic anhydride and maleimide, potential precursors 
for silver complexes 
The result of this reaction is silver maleimide (fig. 4.4). Bonding between the metal 
centre and nitrogen is relatively simple due to sp3 hybridisation of tetrahedral first 
row elements. Silver salts or precursors (nitrate, oxide) provide a source of oxidised 
silver, therefore an empty 5s orbital. If the nitrogen atom of maleimide is 
deprotonated, a situation can arise with complexation to silver which satisfies the 





Figure 4.4: The reaction of silver nitrate with maleimide 
4.3.2 Lewis adduct selection 
Several potential Lewis adducts are available for silver stabilisation including 
bipyridine (bipy) and diphenylphosphinoethane (dppe), but triphenylphosphine 
ligands were chosen due their inexpensive, highly available nature and relatively low 
toxicity. Silver binds to phosphorus very well due to interaction between the 
similarly diffuse 4d and 3d orbitals.20 
                                                        
 
                      
                     
 
 
                                   
                         
                       
                             
                       
                         
                          
 
                         
                             
                       







Figure 4.5: Triphenylphosphine: a) 3­D structure displaying the desired steric bulk 
character, b) Tollman cone angle (ө), a quantitative measurement of steric properties24 
As can be seen from fig. 4.5 a), ligands such as these provide a large amount of steric 
bulk about the central phosphorus atom (orange), which is the binding point for 
silver. When two PPh3 adducts coordinate to silver, reductive elimination is blocked 
by sterics. The Tollman cone angle for PPh3 is 145˚, which although not the largest 
steric bulk in comparison with other analogous Lewis adducts26 still allows bonding 
of the silver atom with the organic component. Higher angle phosphines such at 
PtBu3 (182˚) can only be used singularly and consequently provide less overall bulk. 
Phosphines coordinate to the metal centre through the lone pair as sigma (σ)­donors 
i.e. form a dative bond and are favoured due their ‘soft’ nature.26 Phosphines also act 
as good π­acceptors, ‘back­bonding’ with the metal through P­C σ* orbitals for 
added stability (fig. 4.6). 
                  
 
 
                       
                       











L n M L nM(PR3) PR3 
Figure 4.6: Stabilisation of a metal centre using phosphine ligands25 
Thus, triphenylphosphine when used in 2:1 molar ratio with an Ag­R complex 
provides light and air stable silver compounds. Using this rationale, the novel 
compound bis­triphenylphosphino silver maleimide was designed (fig. 4.7). 
 
 
 ­  
  
Figure 4.7: The reaction scheme for formation of novel phosphine­stabilised silver 
maleimide complex 
           
                           
                   
                         
                           
         
 
                       
                   
                         
                         
                         
                     












                       
 
4.4 Preliminary plasma study – maleimide
 
In order to ascertain the feasibility of using maleimide as a polymeric base­unit, an 
initial plasma deposition study was undertaken. Here, information on functional 
group retention and thickness at different input power and pulsing was observed. All 
plasma polymers were deposited at flow rates of around 0.27 sccm onto NaCl discs 
(FTIR) or gold films (SPR). 
A variety of parameter combinations were experimented with in order to establish 
the optimum parameters for maleimide polymerisation. At 50W peak input power 
the greatest FG retention was seen under deposition parameters which allowed a long 
pulse ‘off­time’ i.e. 1/40 duty cycle. Sharp peaks were detected for this polymer, 
presences of which were also detected as broader absorptions in CW FTIR spectra. 
For other selected duty cycles however, much broader peaks were evidenced, 
indicating less FG retention and a much more random polymeric coating (fig. 4.8). 


















































































Figure 4.8: FTIR spectra of maleimide plasma films deposited onto NaCl discs
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As can be seen from the FTIR spectra, each film showed different functionality 
according to duty cycle and each was reproducible according to the pulse parameters 
used. The main areas of functionality retained during such polymerisation appeared 
to be the N­H stretch, carbonyl region and associated conjugation. In addition, weak 
shoulder peaks due to alkane vibration were established. This was consistent with 
radical polymerisation to produce an alkane based polymer i.e. removal of alkene 
functionality. 
Further investigation of each system revealed a steady increase in transmission IR 
absorbance for each band over time, indicating increased deposition at longer 
polymerisation times. This was confirmed by film thickness measurements using 
SPR. 
4.5 bis­triphenylphosphino silver maleimide 
Initial methods for preparing the novel complex (PSSM) began using an adapted 
synthesis of Schwartz27 with a simple reaction of silver nitrate and maleimide in 
absolute ethanol and presence of base. These reactions yielded a very high level of 
decomposed silver (Ag2O and intermediates e.g. Ag­OH)
28 from the reaction of base 
with silver ions. To avoid decomposition, silver nitrate was stabilised with 
triphenylphosphine before reaction with sodium maleimide (fig. 4.9). Although this 
methodology afforded a reasonably high yield, residual base present in products still 
allowed silver decomposition. 
  
 
Figure 4.9: The stabilisation of silver with phosphine prior to reaction with base 
An alternative methodology was reaction of silver oxide with carboxylic acids 
detailed by Edwards29 with maleimide substituted as the ligand in water at 1:1 molar 
ratio. This required filtration of large amounts of excess Ag2O and a low yielding 
product (ca. 30%), which was unsatisfactory. A mixture of EtOH with water 
provided a solvent in which the majority of silver nitrate was converted to Ag­R, 
while a modified version of silver carboxylate synthesis employed by Jakob et al30 
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where EtOH with minimum MeCN to dissolve silver nitrate provided an even more 
satisfactory and high yielding solvent system for this reaction, so became method of 
choice for silver salt synthesis. Reaction of the resulting compound with two 









Figure 4.10: A two­step synthetic route to phosphine stabilised silver maleimide 
4.5.1 PSSM preparation method 
To a stirred solution of maleimide (10mmol, 0.98g) in ethanol (20ml), a 10ml 
solution of silver nitrate (10mmol, 1.70g) in an ethanol/acetonitrile mixture 
(minimum MeCN) was added and the solution stirred for 5 minutes. After this time a 
solution of triethylamine (10mmol, 1.01g) in ethanol (5ml) was added dropwise over 
30 minutes, resulting in the formation of an insoluble white precipitate. The solid 
residue was isolated by filtration, washed three times with ethanol and dried in­
vacuo, yielding silver maleimide (1.92g, yield 94%). 
Addition of silver maleimide (5mmol, 1.02g) to a stirred solution of 
triphenylphosphine (10mmol, 2.62g) in toluene resulted in the formation of a light 
yellow precipitate after 1 hour. The solid residue was isolated by filtration, washed 
three times with toluene and dried in­vacuo, yielding bis­triphenylphosphino silver 
maleimide (PSSM) (3.35g, yield 92%). Anal. Calc. for C40H36O2AgP2N: C, 65.48; 
H, 5.12; N, 1.78. Found: C, 64.7; H, 5.40; N, 1.38. Mp: 158­160ºC. 
4.5.2 PSSM characterisation 
The novel molecule, PSSM was recrystallised from minimal hot isopropyl alcohol 
and a crystal structure obtained by single crystal analysis (fig. 4.11) 
. 
                  
                 
 
               
             
               
           
    
 
                       
                 
                   
                               
                   
                       
            
 
                   
               
 
Figure 4.11: The crystal structure of phosphine­stabilised silver maleimide 
(hydrogen atoms and solvent of crystallisation omitted for clarity) 
Selected bond lengths (Å): Ag(1)–P(1) 2.4286(6); Ag(1)–P(2) 2.4948(6); Ag(1)– 
N(1) 2.239(2); N(1)–C(101) 1.356(3); N(1)–C(104) 1.347(3); C(101)–O(1) 1.215(4); 
C(104)–O(2) 1.230(4); C(102)–C(103) 1.462(5). Selected bond angles (º): P(1)– 
Ag(1)–N(1) 133.68(6); P(2)–Ag(1)–N(1) 105.24(6); P(1)–Ag(1)–P(2) 120.67(2); 
C(101)–N(1)–C(104) 109.5(2). 
The crystal structure reveals a three­coordinate silver atom central to the two 
triphenylphosphine groups and maleimide in a trigonal arrangement. Maleimide 
aligns itself perpendicularly to the electron­rich phosphine groups for reduced 
repulsion and is coordinated to silver in a similar manner to that of phthalimide in an 
analogous complex containing an Ag­N bond.28 Discrepancies between the two 
silver­phosphorus bond lengths are likely to result from electrostatic repulsion of the 
phenyl groups creating increased steric hindrance. 
Recrystallised complex was also dissolved in the minimum deuterated chloroform 





       
       
         
     
       
 
                   
 
 
                       
                       
                   
                     
                 
 
                           
                           
             
 



















































7.3 7.4 7.5 ppm 4.1 4.2 ppm 
1.4 1.6 1.8 2.0 2.2 2.4 2.6 2.8 ppm 
Chemical shift (ppm), 
multiplicity 
Assignment 
7.3, multi. Phenyl ring 
4, sep. iPrOH (CH) 
3.5, s Olefin protons (maleimide) 
1.85, s H2O 
1.2, d iPrOH (CH3) 
Figure 4.12: 
1H NMR spectra of PSSM crystals and assignment 
Fig. 4.12 shows a visual representation and direct interpretation of NMR spectra. 
Proton NMR shifts were consistent with literature values for phenyl and olefin 
groups, 27 with some solvent present from recrystallisation product. For each 
subsequent NMR observed however, the solvent contribution was ignored and only 
relevant functionality presented in formal assignment as displayed below: 
1H NMR (300MHz) (ppm): δ = 7.3 (m, 30H, P(C6H5)3), 3.5 (s, 2H, ­CH­CH­). 
13C{1H} NMR (75 MHz) (ppm) δ = 38.98, 129.28, 130.49, 133.01, 134.41. 31P {1H} 
NMR (121 MHz) (ppm) δ = 10.00. 
                             
                     
         
 








           
  
                         
                     
 
                         
                           
                   
                           
                     
                 
                   
                     
                       
             
As was the case with proton, the carbon NMR correlated to literature values for such 
functionality and presence of a single phosphorus environment confirms the bonding 
mode identified in fig. 4.11. 























































Figure 4.13: FTIR spectrum of PSSM 
FTIR peaks (cm­1): 3132, 2967 (C­H, Ph alkene); 1616 (C=O); 1478, 1433 (ring 
deformation); 1327, 1281, 1249 (conjugation); 1155 (P­C) and 997, 694 (C­H). 
Amide stretching seen in pure maleimide FTIR is not present in the novel product, 
therefore indicating the removal of the amide proton. The carbonyl peak in PSSM is 
of significantly lower wavenumber than free maleimide, dropping from around 
1700cm­1 to 1616cm­1, owing to a reduction in bond order of the carbonyl functional 
group caused by delocalisation of electron density within the maleimide ring. 
Intermolecular hydrogen bonding between the amide proton and carbonyl 
predominates in solid maleimide over resonance. Once bonded with silver, hydrogen 
bonding ability is removed and therefore conjugation dominates (fig. 4.14) which 
reduces the double­bond character of the C­O bond, creating a lower absorption 
frequency for the carbonyl peak of PSSM. 
                          
 
 
                         
                           
                           
                 
                     
                   
                         
 
 
         
                       
                           
                           
                         
                     
                           
                   
                       
                     
                       
                   
               
 
                       
                         
Figure 4.14: Conjugation effect in PSSM, reducing the bond order in the carbonyl 
stretch31 
Presence of extra bands around 3000cm­1 in the silver compound is characteristic of 
phenyl groups in addition to alkene stretching modes also present in maleimide and a 
shoulder peak attributed to the alkene stretch is also seen at around 1600 cm­1. In 
addition, carbon­hydrogen bending modes associated with cis­alkenes appear at 
around 940 cm­1 for both compounds, while additional peaks diagnostic of 
triphenylphosphine in the fingerprint region are shown, allowing for extra 
confirmation of the new molecule. These absorptions are also not seen for pure silver 
maleimide.27 
4.6 Plasma deposition of PSSM 
Due to the results of the preliminary plasma deposition experiments with pure 
maleimide it was decided to use the duty cycles which showed best functional group 
retention for PSSM studies, namely 1/40 and CW. Initial efforts were at 50W and 
100W input power for 30 mins onto sodium chloride discs. Unfortunately these early 
experiments did not yield particularly strong FTIR spectra, implying slow deposition 
of pp­PSSM (although this could also have been due to poor adhesion to the 
substrate). It appeared the stabilisation with triphenylphosphine had increased the 
stability of silver maleimide but not sufficiently increased volatility. The cause of 
this was likely π­stacking (p­p interactions), or hydrogen bonding where interaction 
of protons of phenyl groups with delocalised electron density on adjacent phenyl 
groups created a large supramolecular structure, reducing the propensity for 
monomeric units to escape to the gas phase. 
Nevertheless further study of the PSSM system was sought, with reaction time 
increased to three hours. Resulting FTIR spectra of depositions at 100W input power 
                             
                             
                     
                     
                   
                         
                     








                         
           
 
 
                       
                           
                       
           
 
for 3 hours are shown in fig. 4.15, which were readily reproducible. The 1/40 duty 
cycle film spectrum was of far lower intensity than that of the CW film indicating 
slower film growth, although some functional group retention was seen. The 
continuous wave plasma film showed broadening of FTIR peaks indicative of 
fragmentation caused by ionisation effects present under such conditions, in 
agreement with discussion in chapter 2. Due to the faster deposition rate evidenced 
in CW plasma and reasonable levels of functional group retention, early 
antimicrobial work was carried through using CW plasma deposition. 



























Figure 4.15: Comparative FTIR spectra for PSSM 1/40 and CW duty cycle 100W 
3h plasma depositions on NaCl discs 
Film thickness under these parameters was monitored using SPR, with a resonance 
angle shift of 21º observed after deposition of pp­PSSM (fig. 4.16) converted to film 
thickness of 25nm by use of fitting software. Such observed thickness was 









                     
                 
                     
                         
                      
 

















pp­PSSM on gold 
Bare gold 
Figure 4.16: SPR data displaying the resonance shift increase due to pp­PSSM film 
deposition 
Plasma films were also observed visually by the use of bright­field microscopy. 
Non­woven polypropylene material was viewed pre­ and post­plasma deposition 
with PSSM and noticeable dark deposits were evidenced (fig. 4.17), suggesting 
localised rather than homogenous spread of silver through the film. This was also 
observed in films deposited onto SAM­coated gold under SEM (fig. 4.18). 
  
 
                     




                   
 
 
                               
                     
Figure 4.17: Light microscope images of untreated (top) and pp­PSSM treated
 
(bottom) non­woven (fibre strands ca.10 µm in diameter)
 
Figure 4.18: Scanning electron micrograph of pp­PSSM deposited on gold
 
It is likely that silver exposed to intense UV radiation and high energy ions such as 
continuous wave plasma was subject to decomposition as silver nanoparticles or 






                 
 
 
                       
                       
                   
                         

























                   
 
 
                           
                               
                     
                       
                         
       
nanocrystals, regardless of stabilisation using phosphines cf. ‘wet’ nanoparticle 





Ag+ -OOC Reduction 
Figure 4.19: Conventional ‘wet’ nanoparticle formation on non­woven strands32 
Subsequent work was carried out under the slightly milder conditions of 50W 
continuous wave in order to preserve functional group structure, whilst heating the 
monomer chamber to around 50ºC. Silver decomposition within the monomer 
chamber was observed at temperatures above 60ºC and did not greatly increase the 
monomer flow rate. Standard reaction conditions and parameters are shown in fig. 
4.20, below: 















CW (50 W) 0.19 +/­ 0.05 0.012 0.2 nm min­1 1h – 3h 
Figure 4.20: Standard reaction conditions and parameters for pp­PSSM deposition 
Under these conditions the film deposition rate was increased by around 3 nm per 
hour from that seen at 100W, due to a reduction in surface etching by high energy 
particles and a slightly elevated monomer flow rate. Enhancement in characterisation 
was possible through use of ATR­FTIR in conjunction with a highly reflective 
substrate in gold. An example ATR­FTIR spectrum for a 50W deposition of PSSM 




                     
 
 
                           
                       
                         
                         
                           
                       
                 
                          
 
                         
                         
                         
                         
                           





























Figure 4.21: FTIR spectrum of 50W CW 3h pp­PSSM on gold 
As can be seen in fig. 4.21, despite the shorter deposition time, much greater 
sensitivity was observed for plasma films using gold and ATR­FTIR than was 
achieved for NaCl discs and transmission IR in fig. 4.15. Functional group retention 
is seen from the pure monomer spectrum, albeit with much broadened peaks. A 
broad absorption is seen at around 3400cm­1, indicating presence of an O­H or N­H 
group. Carbonyl functionality is retained from the monomer structure and there is 
evidence of triphenyphosphine ligand retention, although possibly oxidised by 
residual oxygen present either during reaction or post deposition on exposure to air. 
Mass spectrometry was used to evaluate film composition by washing the surface of 
a long film deposition with hot solvent and analysing the resulting solution (fig. 
4.22). Of particular interest was a strong peak between 631­633 m/z which was 
assigned to Ag(PPh3)3
+. Presence of silver is detected by isotopic ratio, i.e. two 
major peaks correspond to ions containing Ag {107} and {109}. The peak at around 
774 m/z also contained silver with presumably artefacts of ionisation within the 
plasma glow. 
                      
 
 
                         
                         
                         
                           
                     
                         
                       
                           
                   
                         
       
 
Figure 4.22: Mass spectrum of MeOH washed pp­PSSM film on glass 
In addition to evidence of silver in films from microscopic means and mass 
spectroscopy, attempts were made to quantify content within films using XPS but it 
appeared low sensitivity of this approach (ca. 0.1% at) precluded detection of silver 
(fig. 4.23). A great deal of oxygen content was presumably due to incorporation from 
air, but importantly carbon, nitrogen and phosphorus; the key elemental constituents 
of PSSM, were all detected. Significant fragmentation had occurred in the film, as 
concentrations of each were proportionally different to what may be expected and 
low levels of contaminant were also observed; likely to arise from glass substrate. It 
could be inferred that inhomogeniety of the film structure, accompanied by 
insensitivity of XPS and low volatility of the silver monomer contributed to making 
detection of silver difficult. 
                  
 
                     
                   
                     
                             
                             
                           
       
 
 
Figure 4.23: XPS spectrum of pp­PSSM on glass substrate 
Further attempts were made to quantify silver content through alternative means, 
namely atomic absorption spectroscopy. Films were deposited onto polystyrene Petri 
dish substrates, a solution of phosphate­buffered saline added and AAS reading 
taken after 24h to assess the leaching of silver into solution. This is summarised in 
fig. 4.24, where it can be seen that silver transport into solution from the surface 
results in a solution containing around 70 parts per billion of silver, whereas a non­




                       
         
 
 
                             
                         
                           




                     
                           
     
         
                     




















Figure 4.24: Atomic absorption of PBS solutions exposed to pp­PSSM treated and 
non­treated Petri dish for 24h 
Such a result confirms the presence of silver in very low levels and also provides 
information on the potential antimicrobial activity of the film. It would appear that 
leached silver is at suitably non­toxic levels to humans after this time, but at 
concentrations which are potentially lethal to bacteria. 
4.7 Microbiological assays 
A range of microbiological assays were employed to assess the antimicrobial 
properties, as detailed in chapters 2 and 3. Initial testing of pp­PSSM films was 
against Micrococcus luteus. 
4.7.1 Assays versus M. luteus 
Conditions were established with M. luteus (ML) which allowed the accurate and 
reproducible measurement of bacterial growth, with procedural modifications made 
















         





                       
           
 
 
                         
                               
                       
                       
                       
                 
4.7.1.1 Monomer zone of inhibition 
A disc diffusion assay was used to confirm antibacterial properties of PSSM, as seen 
in fig. 4.25. 
Figure 4.25: Disc diffusion of PSSM monomer (top) and silver nitrate (bottom) 
versus Micrococcus luteus on LB agar 
A halo of inhibition was observed around the PSSM monomer pellet where bacteria 
could not grow. The edge of this halo showed a dark crust, indicating an area where 
silver is possibly decomposed through catalysis by bacteria. This halo exists even 
with inherently limited solubility of PSSM, contrasting sharply to the high solubility 
of silver nitrate. Interestingly, there was a visually smaller inhibition halo for silver 
nitrate than PSSM, but a much larger solubility ring. 
           
                             
                         
                             
                           
                               
                   
                     
 
 
                         
       
 
 
                           
                           
                           
                       
           
 
4.7.1.2 Initial plasma film tests: visualisation 
A simple method used to gauge the effect of pp­PSSM films was to inspect the 
surface for bacterial fouling after exposure to a solution containing ML. The image 
in fig. 4.26 shows two Petri dishes, one which was treated with pp­PSSM, the other a 
non­treated control. A solution of minimal media and ML was applied to the surface, 
poured off after 24h and the surface lightly rinsed. It was quite clear that under these 
conditions pp­PSSM had considerable antibacterial potential as the surface was 
almost clean whereas the control showed biofilm formation on the surface. 
Figure 4.26: Visible M. luteus biofilm reduction on pp­PSSM treated Petri dish (l) 
versus non­treated control (r) 
Similarly, gold chips coated with pp­PSSM were placed in a solution of ML and 
incubated for 24h before the surface was vortexed to remove bacteria and plated. A 
visual representation in terms of colonies is seen in fig. 4.27. It was instantly 
apparent before colony counting, that bacteria from treated films were much less 
viable than those of non­treated surfaces. 
    
                           
         
 
 
                       
                       
      
 
       
                     
                       
                       
                           
               
 
 
Figure 4.27: M. luteus colonies on agar plates from pp­PSSM treated (l) and control 
(r) gold substrates after 24h 
The left­hand agar plate shows cells grown from the treated surface, the right­hand 
plate cells grown from the non­treated surface; with significantly less growth from 
the treated surface. 
4.7.1.3 Traditional counting methods 
The cell viability observed above was quantified using colony counts. Several 
dilution factors of the initial vortexed solution were plated and the most statistically 
viable (between 30­300 cells) counted and used for cell growth quantification. This 
is shown in fig. 4.28, where M. luteus growth was assessed against treated and non­






                     
       
 
 
                             
                       
                   
                     







                   





























Figure 4.28: Quantification of ML growth from pp­PSSM treated and non­treated 
gold surfaces after 24h 
As can be seen above, growth on pp­PSSM treated surfaces was reduced to around a 
third of the growth evidenced on non­treated samples, on average. This compares 
markedly to the growth­promotion effect that pp­maleimide only films produce, 
displayed graphically in fig. 4.29 which demonstrated the necessity of a silver­



























Figure 4.29: Quantification of ML growth from pp­maleimide treated and non­

treated gold surfaces after 24h
 
       
                       
                   
                     
                         
                             
                     
















                       
       
 
 
                         
                           
                         
                         
                     
                         
     
 
4.7.1.4 Live/Dead cell staining 
As discussed previously, a new method of observing bacterial viability is through 
fluorescent labelling. Before the analysis of antibacterial surfaces, a calibration plot 
of Live/Dead ratio versus cell viability was obtained by combining proportional 
quantities of fresh bacteria and heat shocked bacteria vortexed from Petri dishes over 
a range from 0% live to 100% live. Cells in each solution were tagged with 
Live/Dead stain and fluorescence measurements taken, resulting in fig. 4.30 by 
calculating the ratio of live (green) to dead (red) cells. 























































Bacterial viability (%) 
Figure 4.30: Live/Dead stain calibration for ML fluorescence readings (l) and the 
resulting calibration plot (r) 
Although the emission curves for 90% and 50% live cells appear similar with near­
identical green readings, the absolute intensity given off by the 50% live sample is 
lower therefore live/dead ratios fit nicely into the calibration plot. This plot was 
difficult to obtain as making bacterial solutions of precise viability is tricky, although 
calibration was ultimately reasonably reproducible. The calibration plot was used to 
calculate the percentage of ML cells which were viable when removed from Petri 












                       
 
 
                               
                   
                               
                           
                   
                             
                           
                             


































































Surface Emission wavelength (nm) 
Figure 4.31: ML cell viability using Live/Dead stain after 24h on surface 
The plasma input power was reduced from 100W to 50W for this assay in an attempt 
to increase functional group retention and improve still further antimicrobial 
properties. It is clear from this graph that very few ML cells were bound to the pp­
PSSM surface and around 1% of these were live, compared to virtually all for pp­
maleimide and non­treated control. This trend was reproduced in fluorescence 
microscopy of the Petri dish surface in fig. 4.32, where the early stage of biofilm 
growth was seen in the control while dead cells were observed on the pp­PSSM 
films. Dead cells were seen to clump in an attempt at self­preservation, much like the 
function of biofilm formation. 
  
 
                       
           
 
 
               
                 
                         
           
         
                               
          
Figure 4.32: M. luteus growth and viability on non­treated (top) and pp­PSSM 
treated (bottom) Petri dishes after 24h 
4.7.2 Assays versus S. aureus and P. aeruginosa 
After general antimicrobial procedures were established with Micrococcus luteus, 
the more virulent chosen model pathogens S. aureus (MSSA 476) and P. aeruginosa 
(PAO1) were introduced, starting with MSSA. 
4.7.2.1 Monomer zone of inhibition 
As with ML, disc diffusion assays were used as a tool for visual observation of free 
PSSM efficacy against bacterial lawns. 
    
                       
                 
 
 
                               
                     
                         
                       
 
                       
                         
                     
                           
                      
 
 
Figure 4.33 Disc diffusion of (clockwise from top left) PSSM monomer, silver 
nitrate, triphenylphosphine and maleimide versus MSSA on LB agar 
As observed in fig. 4.33, PSSM was active against MSSA in a similar manner to the 
action against ML, likewise silver nitrate. The activity of maleimide was extremely 
high due to very high solubility in aqueous media, resulting in complete dissolving 
of the pellet and the opposite effect was seen in the triphenylphosphine pellet. 
Zone of inhibition study for PAO1 was conducted using varying concentrations of 
potassium bromide in the pellets as a rudimentary attempt at visual quantification of 
activity (fig. 4.34). Unfortunately the inhibition halos merged at points but 
importantly a great deal of inhibition was seen overall, especially in the 100% PSSM 
pellet with correspondingly less activity as the KBr concentration was increased. 
                          
                         
             
 
 
       
                     
                       
                         






Figure 4.34: Disc diffusion of PSSM monomer versus PAO1 on LB agar. PSSM 
was pelleted with KBr in the following concentrations: 100% PSSM (1), 75% PSSM 
(2), 50% PSSM (3), 25% PSSM (4) 
4.7.2.2 Minimum inhibitory concentration 
In addition to disc diffusion, minimum inhibition concentration (MIC) assays were 
used to quantify antimicrobial activity of PSSM versus MSSA and PAO1. Solutions 
containing a range of known PSSM content were incubated with bacteria and OD 

















                       
                               
                             
                         
                           
                   
                     
                       




































































Figure 4.35: Minimum inhibition curves for PSSM versus MSSA (top) and PAO1 
(bottom) after 18h 
The MIC50 of a compound is the concentration required to reduce bacterial 
population by 50%, which was calculated for both MSSA and PAO1 as and 38 x 10­6 
and 0.8 x 10­6 mol dm­3 respectively for the PSSM system. The MIC50 for PAO1 
compares favourably with that reported for silver sulfadiazine33 at 125 x 10­6 mol 
dm­3, although it is difficult to directly compare MIC results due to differences in 
experimental procedure. As controls the starting materials silver nitrate, maleimide 
and triphenylphosphine were also subjected to MIC50 tests against PAO1, again 
requiring much higher concentrations to inhibit cell growth of 48�M, 52�M and 




                     
                         
                             







                     
       
 
 
                     
           
 
>16.5mM respectively. This result suggested a synergistic action of ligand and metal 
on cells. 
4.7.2.3 Surface assays 
pp­PSSM plasma films were tested against MSSA and PAO1 to gauge their efficacy. 
Initial colony count data when deposited on gold chips seemed to suggest similar 
activity as seen with ML (fig. 4.36), with viable cell reduction of over 50% on pp­





























Figure 4.36: Quantification of MSSA growth from pp­PSSM treated and non­treated 
gold surfaces after 24h 
Additionally, fluorescence microscopy was used to monitor the Petri dish surface 
after exposure to bacteria (fig. 4.37). 
     
                       
         
 
 
                             
                             
                         
                           
                         
                     
                       
                         
   
 
                           
                       
                       
                       
                       
                       
                     
 
Figure 4.37: MSSA growth and viability on non­treated (left) and pp­PSSM treated 
(right) Petri dishes after 24h 
Note much fewer cells overall were seen on the treated surface and the viability of 
cells was very low compared to near­100% live cells on the control. Up until this 
point all work was carried out using minimal media for bacterial growth, which 
generally doesn’t allow for rapid cell reproduction and growth. It was decided to use 
LB media in place of the minimal variety, which would exceed the favourable 
conditions found in the human body. Optimised growth conditions allowed facile 
bacterial propagation and overwhelming of surfaces by cells from solution to provide 
an extreme test of antimicrobial efficacy. Also reduced was deposition time, to a 
standardised 1h. 
As seen in fig. 4.38, bacterial viability measured in effluent solution was not greatly 
reduced in Petri dishes coated with pp­PSSM than the control. Unfortunately, it 
proved too difficult under these conditions to provide calibration of Live/Dead stain 
in solution due to large amounts of bacteria creating problems with the 
excitation/emission of light. When attempts were made to heat­shock cells, a large 
amount of clumping occurred, creating uncertainty in results. Therefore it was only 







                         
                   
 
 
                             
                           
                             
                           
                         
                       
                       
                             
                           










                           


















































Figure 4.38: Live/Dead cell ratios of MSSA (l) and PAO1 (r) from solutions 
exposed to pp­PSSM treated and non­treated Petri dishes after 24h 
The surface cell viability was not too dissimilar for MSSA than solution tests, but the 
reduction in viability of attached PAO1 was marked (fig. 4.39). For the MSSA assay 
cell viability was reduced for the Petri dish relative to the final control, but also 
evidenced was a significant amount of live cells relative to the initial control taken 
after 10 minutes. This situation was reversed in the PAO1 samples, where cell 
viability was reduced from both the initial and final controls. The discrepancy 
observed between S. aureus and P. aeruginosa susceptibility to both free PSSM 
compound and pp­PSSM films is likely due to the inability of P. aeruginosa to form 
a protective biofilm quickly enough in response to the toxin, whereas S. aureus cells 
do not use biofilms as a primary form of protection so showed better survival rates. 

















































Figure 4.39: Live/Dead cell ratios of MSSA (l) and PAO1 (r) from pp­PSSM treated
 
and non­treated Petri dish surfaces after 24h
 
                           
                         
                           
                             
                         
                     
           
 
                           
                     
                           
                           
                       
                           
                 
 
                       
                           
                     
                           




Initial control populations showed lower levels of live cells than the final control due 
to the change stage of growth the population was experiencing. When culture was 
added to the Petri dishes, the growth was likely stationary so there was considerable 
levels of dead cells in solution hence the low live/dead ratio. Once adapted to the 
environment in the Petri dish, cells which attached to the control surface experienced 
an environment ideal for their development and were consequently more viable 
when removed than the initial culture. 
The combination of data in figures 4.38 and 4.39 in conjunction with AAS data 
indicates that pp­PSSM films are surface active rather than demonstrating leaching 
meaning that they will not present a toxic hazard to humans, and provided the 
surface is not swamped with enormous quantities of cells will remain active for a 
prolonged period of time. It is possible that fragmentation and cross­linking of 
organic components of the monomer effectively act to trap the active ions within the 
film, which may only act upon interaction with bacteria. 
Another interesting study was the investigation of PAO1 cell viability relative to 
film deposition time. Fig. 4.40 shows the increasing IR absorbance as a function of 
plasma reaction length, indicating increased film deposition over time. Film content 
was compared with cell viability at each time­point and it was observed that the kill­











                           
                           
         
 
 
                           
                           
                       
                       




















































Control Au pp­PSSM 2h pp­PSSM 4h pp­PSSM 16h 
Surface/deposition time 
Figure 4.40: FTIR absorbance intensity of pp­PSSM as a function of time at 50W 
CW (top) and associated decrease in PAO1 cell viability after 24h as the film 
deposition time was increased (bottom) 
Greatest reduction in absolute cell viability was seen after 2h deposition, with a 50% 
further reduction after 4h and a four­fold decrease from this point to 16h film 
deposition. It would suggest that the initial film deposition killed a reasonable 
amount of cells but subsequent deposition only served to homogenise the surface 
activity or provide additional active material which was able to find its way to the 
surface. 
     
                           
                           
                       
                     
                     
 
                         
                     
                               
                         
                     




                   
           
 
 
                       
                           
                       
                     
  
4.7.2.4 Non­woven assays 
Up to this point all bacterial work had been carried out on largely 2­dimensional 
surfaces in Petri dishes and gold. It was decided to move onto depositing pp­PSSM 
films on 3­dimensional polymeric networks in order to assess viability of this 
procedure for treating such materials as wound dressings. Polypropylene taken from 
inlay of disposable nappies was chosen as a cheap model system. 
An initial modified disc diffusion assay was performed on a lab culture of Gram­
negative Escherichia coli DH5α. Treated and non­treated non­woven was placed on 
a lawn of bacteria and incubated in the same manner as a disc diffusion assay. The 
image in fig. 4.41 dramatically displays activity of pp­PSSM on the bacterial cells, 
where growth was almost completely inhibited below the squares of treated non­
woven, whilst the areas underneath the control non­woven showed normal growth. 
pp­PSSM treated Control non­woven    
Figure 4.41: Modified diffusion assay demonstrating effect of pp­PSSM deposited 
squares of non­woven on E. coli 
Also observed was the zone around non­woven materials, where growth was not 
inhibited beyond the limit of material in pp­PSSM or control but silver nitrate treated 
non­woven showed inhibition as a result of leaching. This further confirmed the pp­
PSSM mode of action against bacteria to be contact­killing rather than solution­
based. 
                     
                       
                           




                     
                     
 
 
                       
                         
                       
                         
                     
                       
 
Due to the multi­faceted nature of non­woven materials, confocal microscopy was 
employed to assess cell viability visually. This method also presented an opportunity 
to simply determine the best position to place samples in the plasma reactor for 
optimised activity against bacteria (fig. 4.42). 
Monomer inlet 
Figure 4.42: Confocal microscope images of MSSA cell viability on pp­PSSM 
treated non­woven after 24h and the original position in plasma reactor 
These confocal images show the greatest reduction in cell viability was further from 
the monomer source, most noticeably in the plasma afterglow region. This is in 
agreement with previous work discussed in chapter 2 where greater functionality is 
retained in the region after the main plasma glow. Consequently, this region was 
used for all subsequent pp­PSSM depositions and confocal images from non­wovens 
deposited on in this region are shown in figures 4.43 and 4.44. 
   
                         




                         
       
 
 
                   
                         
                           
                     
                           
                           
     
Figure 4.43: Confocal microscope images of MSSA cell viability on control (l) and
 
pp­PSSM treated non­woven (r)
 
Figure 4.44: Confocal microscope images of PAO1 cell viability on control (l) and 
pp­PSSM treated non­woven (r) 
Confocal images on non­wovens displayed the basic activity characteristics of 
previous assays where P. aeruginosa was more susceptible to pp­PSSM films than S. 
aureus. The reduction in MSSA cell viability was less than seen for PAO1, although 
was still significant versus the control. Plasma film efficacy was dramatic against 
PAO1, with the vast majority of cells bound to the material killed. An additional 
note of interest was bright spots on the treated non­woven which could be indicative 
of localised silver. 
                     
                           
                         
                       
                   
                             













                     
                             
                           
                       
                       
                         
                         
                           
                     
                     
A quantitative method of assessing microbial growth on non­woven materials was 
use of the Japanese industry standard assay (JIS). This technique is a derivation of 
the general assay procedure used previously, but with a much smaller amount of 
solution and a carefully controlled initial concentration of bacteria which allows easy 
comparison between assays. Squares of non­woven were inoculated with bacteria, 
incubated, then the cells shaken off and plated. Results of the first attempt at this 
assay are shown in fig. 4.45. 








































Figure 4.45: JIS assay of PAO1 on pp­PSSM treated squares of non­woven after 
18h 
Despite the antibacterial nature of pp­PSSM films displayed via alternative means, 
the JIS assay showed a slight increase in microbial growth on these films over the 
control. It was seen during application of culture to the treated non­woven that a 
great deal of hydrophilicity was imparted due to plasma deposition, which was 
possibly due to oxygen incorporation into the film as evidenced in XPS. 
Subsequently, the solution found it far easier to reach all of the non­woven extremely 
quickly carrying with it bacterial cells. This therefore not only aided transport of 
cells to the non­woven surface, but provided an ample supply of cells in solution 
suspended between fibres which were not affected due to the contact­killing 
mechanism these films employ. Additionally, it was found by confocal microscopy 
                           
                     





                       




                       
                         
                           
                       
                       
                   
                       
               
                       
that all cells were not removed from the surface by vortexing the non­woven, which 
provided another source of underestimation of film activity (fig. 4.46).To counter­act 
these effects, an additional hydrophobic layer was plasma deposited onto the pp­
PSSM film. 
Figure 4.46: Confocal microscope images of PAO1 cell viability on control (top) 
and pp­PSSM treated non­woven (bottom) post­JIS assay vortex 
4.8 Fluroinated adlayer 
As discussed in chapter 1, hydrophobic polymers and plasma films are commonly 
used to impart non­fouling characteristics onto materials. With this in mind, it was 
decided to modify plasma films containing active metals with a very thin top layer 
which would prevent or reduce initial bacterial attachment through either blocking or 
hydrophobic effects. Attempts were made within the group to use a PEG­like 
monomer (ethylene glycol diacrylate) to produce non­fouling films, with mixed 
results.34 Use of the liquid monomer was expensive and long effective deposition 
time required meant other avenues were investigated. Subsequently, 
hexafluoroethane was used as a non­fouling layer. This compound offered a simple, 
                     








                 




                       
                             




gaseous solution to non­fouling surfaces through plasma deposition. FTIR of a pp­
C2F6 reaction on polypropylene non­woven is shown in fig. 4.47. 
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Figure 4.47: FTIR spectrum of fluorinated non­woven versus non­treated non­
woven. A large peak assigned to fluorocarbon deposition was observed at 
ca.1660cm­1 
Once proof of deposition onto non­woven was observed, the plasma parameters were 
optimised to 50W CW for 30s. A short deposition such as this proved sufficient for 
significant hydrophobic behaviour (fig. 4.48). 
                      
                 
 
 
                     
                   
                   
                         
                     
 
         
                         
                       
                         
                         
 






                         
     
 
Figure 4.48: Untreated non­woven (l) and pp­C2F6 treated non­woven (r) after 
exposure to 200µl of MilliQ water for 10 minutes 
As can be seen, the plasma­treated non­woven with fluorocarbon showed vastly 
increased hydrophobicity relative to the control, which was less hydrophilic 
(absorbed water less facilely) than previous pp­PSSM treated non­woven. This 
ability was also passed over to pp­PSSM treated non­woven when subject to pp­C2F6 
adlayer, thereby reducing total liquid in contact with surface of non­woven. 
4.8.1 pp­PSSM + pp­C2F6 assays 
A fluorinated adlayer was applied after pp­PSSM film deposition in­situ and the JIS 
assay was repeated at 18h, with non­bound cells washed from the solution before the 
attached cells were vortexed into solution and plated. This gave a much better 


































Figure 4.49: JIS assay of PAO1 on pp­PSSM + pp­C2F6 treated squares of non­
woven after 18h 
                         
                             
                
 
                           
                           
                       
                       
                       
 
 












                             
         
 
 
                           
                       
                       
                               
                             
                           
                         
       
 
Less absolute cell growth (i.e. control) was observed on non­woven than without a 
wash step (~3 versus ~6 x 107 CFU ml­1) and the growth on treated material was 
reduced to about 40% relative to the control. 
All assays to this point had been conducted with a bacterial incubation time of 
between 18­24h, but with the intended use of such films in applications which may 
require shorter exposure to large amounts of bacteria such as wound dressings, 
investigation of shorter incubation time was required. As such, an assay was 






























































Figure 4.50: JIS assay of MSSA (l) and PAO1 (r) on pp­PSSM + pp­C2F6 treated 
squares of non­woven after 3h 
PAO1 growth relative to the control was around 10% after 3h exposure to treated 
non­woven. This was around a four­fold increase in the antimicrobial efficacy when 
compared to activity after 18h, which suggests further evidence for a contact­killing 
mechanism as a foundation of dead cells after this time will allow a platform of live 
cells to attach on top thereby reducing efficacy as time wears on. A common theme 
observed was greater activity of the treated film against PAO1 rather than MSSA, for 
reasons discussed previously. MSSA growth however, was still around a 6th of that 
seen for the control. 
     
                             
                     
                       
                         
          
 
                         
                   
                       
                       
                         
                       
                         
              
 
4.9 Cytotoxicity study 
In addition to antibacterial activity, an important aspect of this study in the context of 
potential application was testing for surface toxicity against eukaryotic cells. An 
independent test on pp­PSSM treated Petri dishes with a covered centre during 
deposition creating an internal control showed preference of amoeba to settle only on 
the control area through visualisation. 
In order to carry out quantitative cytoxicity tests, plasma films were deposited onto 
glass coverslips and alongside oxygen plasma treated and non­treated coverslips 
were exposed to cultures of Swiss mouse fibroblasts and human neonatal epithermal 
keratinocytes in suitable media. Due to the sensitive nature of studying eukaryotic 
cells and ease of contamination, work was carried out in conditions with the 
minimum chance of compromising sterilisation. Cells were allowed to attach to the 
films and their viability observed by optical absorbance after 1­3 days. Results of 
this experiment are shown in fig. 4.51. 
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Figure 4.51: Absorption readings from cytotoxicity tests of pp­PSSM films (red), 
pp­O2 treated (blue) and non­treated (green) glass coverslips against human 
epidermal keratinocytes (top) and Swiss mouse fibroblasts (bottom) 
No cytotoxic effect was evidenced in the tests of pp­PSSM films against either type 
of eukaryotic cell. There were negligible differences in optical density measurements 
recorded for all surface tests which related to viability of cell population. 
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Chapter 5: Novel zinc­ and copper­Schiff base 
complexes for the plasma deposition of 
antimicrobial films 
Novel zinc and copper Schiff base complexes were synthesised, characterised and 
found to inhibit the growth of P. aeruginosa and S. aureus. Both complexes were 
used as precursors in the plasma deposition of thin films, of which pp­ZSB 1/40 
pulse duty cycle parameters were found to retain much structural integrity of the 
monomer thorough FTIR, XPS and SIMS mapping. pp­ZSB films were found to 
inhibit microbial growth according to duty cycle, with a correlation drawn between 
monomer retention and efficacy. 1/40 duty cycle films were found to be 
bacteriostatic and significantly slowed bacterial growth over a period of 24h when 
deposited on polystyrene and non­woven materials. The films were also found to be 
completely harmless to eukaryotic cells after exposure of between one and three 
days. 
5.1 Antimicrobial zinc and copper 
The mechanism by which zinc and copper act against micro­organisms is, like silver, 
somewhat of a mystery and appears to be complex.1 Zinc and copper exhibit strong 
binding characteristics to intra­ and extra­cellular proteins and active sites such as 
amino groups e.g. cysteine, histidine;2 causing similar problems to silver3. Unlike 
silver, both metals are required in cell function e.g. zinc fingers and as such 
mechanisms of import and export are facilitated by proteins contained in the cell 
membrane.2 In the case of excess intra­cellular zinc, Gram­negative bacteria pump 
ions from the cell via a three­polypeptide complex and Pseudomonas contains a 
four­polypeptide complex which expels Cu (II) to maintain cationic homeostasis.4 
Due to the ubiquitous nature of zinc, the general trend of toxicity to higher 
organisms follows for bacteria with copper more harmful than zinc. As such, 







                                 
                       
                           
                             
                           
       
   
                                 
                       
                         
                         
                       
 
 
       
                       
                   
                         
                   
      
 
5.2 Metal chemistry 
5.2.1 Zinc 
Zinc is a metallic element found at the far right­hand side (group 12, row 1) of the d­
block, ground­state configuration [Ar] 4s 23d10 .6 It is a ‘harder’ element than silver 
due to less shielding effects and has one principle oxidation state of +2 resulting 
from removal of the 4s electrons. The cation Zn2+ is known as a ‘borderline hard’ 
Lewis acid, partly as a consequence of ionic radius contraction so tends to bind 
‘borderline hard’ Lewis bases.7 
5.2.2 Copper 
Copper is a metal found directly above silver and to the left of zinc in the periodic 
table (group 11, row 1). The ground­state configuration of copper, [Ar] 4s 13d10 
would suggest a tendency to form predominantly ‘soft’ Cu+ analogous to silver, but 
due to the stabilising Jahn­Teller distortions caused by the orbital degeneracy of d9 
configuration can also form the ‘borderline hard’ oxidation state (II) analogous to 
zinc.6­7 
5.3 Novel compound selection 
Previous work in the area of zinc polymer synthesis showed a bipyridyl­zinc (II)­
bicarboxylate system was stable enough for radical­initiated polymerisation into a 
coherent material.8 On account of this, work was conducted within the Jenkins group 
focused on synthesising these and analogous compounds for potential plasma 











































             
 
 
                     
                         
                   
                         
      
 
                         
                         
                           
                     
                   
                     
                     
                       
                         








   
   
  







   
    
   
  
Figure 5.2: Systematic approach to monomer selection 
Potential ligand systems were identified, synthesised and complexed with the metal, 
then characterised with a primary concern being melting point in the absence of 
thermogravimetric analysis. Monomers of suitably low melting point were subjected 
to antibacterial quantification, with a positive result giving the green light for further 
exploration using plasma. 
The first compound to be successfully produced via this systematic approach was a 
Schiff base coordination complex. Schiff bases are a class of compound formed by 
the condensation of a primary amine with a carbonyl, named after Hugo Schiff. Such 
a broad description of compound allows scope for much functional group 
substitution and complexes incorporating nitrogen and oxygen have proven excellent 
coordinators of transition metals.9 In particular, Schiff bases resulting from the 
reaction of salicylaldehyde and primary amines complexed with metals have shown 
good antibacterial efficacy10 due to metal coordination reducing the polarity of the 
metal ion, so reducing recognition by the cell and increasing lipophilicity of the 




                         
 
 
                       
                           
                 
                           
                 
 
         
                            
                           
                   
       
                     
                         
                         
                          
                     
               




                       
 
 
evidenced, albeit to a much lesser degree than when complexed by metal (ca. 10­
fold).11 
Salicylaldehyde is liquid at room temperature, as are simple primary amines meaning 
the resulting product (dependent on substitution) is likely to be liquid or of low 
melting temperature. Therefore allylamine, a short­chain alkene terminated primary 
amine was chosen to react with salicylaldehyde for the synthesis of a novel ligand 
system with the subsequent coordination of zinc and copper. 
5.4 Novel Schiff base complexes 
Synthesis of Schiff Base complexes was carried out in a two step process. The 
initial step was synthesis of the Schiff Base ligand using the general procedure of 
You et al11 followed by complexation with zinc or copper. 
5.4.1 Schiff base ligand synthesis 
Salicyaldehyde (150mmol, 15.99ml) was dissolved in 30 ml of methanol. Allylamine 
(150mmol, 10.92ml) was added and the reaction refluxed for 2 hours (figure 5.3). 
The solution was allowed to cool and the solvent was removed under vacuum 
resulting in a yellow oil. The product was re­solvated in dichloromethane and dried 
using anhydrous magnesium sulphate, which was removed via gravity filtration. The 
solvent was removed under vacuum producing (E)­2­((allylimino)methyl)phenol, a 
yellow oil. (18.11g, yield 75%). 
  







         
                     












                                   
                                 
                              
   
 
       
             
                     
                           
                         
                   
                       
                       
                     
                         
     
 
5.4.1.1 Schiff base ligand characterisation 
The ligand product was dissolved in deuterated chloroform and characterised by 










1H NMR (250 Hz) (ppm): δ = 4.2 (d, 2H, ­CH2­ (HA)), 5.2 (m, 2H, =CH2 (HB)), 6.1 
(m, 1H, ­CH= (HC)), 7.4 (m, 4H, C6H4OH (HD)), 9.9 (s, 1H, ­CH= (HE)), 11.1 (s, 1H, 
OH). 13C NMR (75 MHz) (ppm): δ = 61.7, 116.9, 117.4, 119.0, 119.3, 131.8, 132.7, 
135.2,161.6, 166.1. 
5.4.2 Zinc Schiff base synthesis 
Schiff base ligand (E)­2­((allylimino)methyl)phenol (100mmol, 16.12g) was 
dissolved in 30ml of methanol. Triethylamine (100mmol, 13.94ml) and zinc chloride 
(50mmol, 6.80g) were added and the reaction refluxed for two hours (fig. 5.4). The 
solution was allowed to cool and the solvent was removed under vacuum. The 
resulting orange/yellow oil was re­solvated in dichloromethane and water washed. 
The organic layer was removed and dried using anhydrous magnesium sulphate. The 
solvent was removed under vacuum and the yellow oil cooled to allow 
crystallisation. The yellow solid was isolated by filtration, washed with ice­cold 
hexane and dried in­vacuo to yield the zinc­Schiff base complex, ZSB. (15.03g, yield 







                       
 
     
                         
       
 
 
                   
 
               
                 
           
         
   
 
                           
                           
                               
                     




Figure 5.4: Complexation reaction of zinc or copper with Schiff base ligand 
5.4.2.1 ZSB characterisation 
The novel complex ZSB was recrystallised form minimal hot toluene and a crystal 
structure obtained (fig. 5.5). 
Figure 5.5: The crystal structure of zinc­Schiff base monomer ZSB 
Selected bond lengths (Å): Zn(1)–O(1) 1.988(2); Zn(1)–O(2) 2.048(2); Zn(1)– 
O(2)_#1 2.085(2); Zn(1)–N(1) 2.051(3); Zn(1)–N(2) 2.070(3). Selected bond angles 
(º): O(1)–Zn(1)–O(2) 99.58(9); O(1)–Zn(1)–N(1) 91.27(10); O(2)–Zn(1)–N(1) 
110.49(10); O(1)–Zn(1)–N(2) 90.43(10); O(2)–Zn(1)–N(2) 125.62(10); N(1)–Zn(1)– 
N(2) 122.65(11). 
The ligand was reacted with zinc in the ratio 2:1, but the monomeric structure 
observed was a dimer containing four ligand units to two metals. No formal bonding 
was assigned between the metal centres. It would appear that due to the ionic size of 
Zn2+ and the small nature of coordinating elements, greater coordination than 




                         
                       
                         
     
 














                                   
                               
                           
 
 
                       
                     
         
 
                      
 
nitrogen and oxygen, two oxygen atoms also acted as bridges between the metal 
centres resulting in the pentahedral coordination of each zinc ion. Bond lengths 
showed a slightly increased distance between the zinc ion and bridging oxygen over 
the non­bridging oxygen. 










1H NMR (250 Hz) (ppm): δ = 4.1 (d, 2H, ­CH2­ (HA)), 5.0 (m, 2H, =CH2 (HB)), 5.8 
(m, 1H, ­CH= (HC)), 6.8 (m, 4H, C6H4OH (HD)), 8.3 (s, 1H, ­CH= (HE)). 
13C NMR 
(75 MHz) (ppm): δ = 61.9, 113.5, 117.0, 118.6, 122.1, 132.2, 134.0, 134.7, 169.6, 
170.4. 
Reproduction of resonance shifts from the ligand NMR coupled with the appearance 
slightly further upfield due to the electropositive influence indicated the ligand was 
coordinated to the metal centre. 







             
 
                         
                     
 
                     
                       
                       
                   
                   
                             
                   
           
 
     
                       
                             
                   
































Figure 5.6: FTIR spectrum of ZSB monomer 
FTIR peaks (cm­1): 3053, 2909 (C­H, Ph aliphatic); 1613 (C=C); 1594 (C=N); 1465, 
1432 (C­H, Ph aliphatic); 1287 (C­O); 760 (C­H, Ph ortho disubstituted). 
Of interest was the identification of key functional groups from both salicylaldehyde 
and allylamine precursors, notably the presence of phenyl and C=N groups. Peaks 
characteristic of functional groups present in the Schiff base were observed in 
alkene, phenyl, carbon­oxygen and carbon­nitrogen groups; and a lack of 
characteristic carbonyl peak confirmed the complete condensation reaction of the 
ligand. Additionally, absence of an O­H peak in the 3500cm­1 region in lieu of an 
alcoholic solvent confirmed deprotonation of the alcohol group in the 
salicylaldehyde portion, therefore complexation with zinc. 
5.4.3 Copper Schiff base synthesis 
The analogous complex containing copper, CSB was prepared in an identical manner 
to ZSB with copper acetate (50mmol, 9.10g) used in place of zinc chloride. A dark 





                       




               
 
               
               
           
           
 
                             
                       
                     
                       
                     
                   
                     
                   
         
5.4.3.1 CSB characterisation 
The copper­Schiff base complex was recrystallised from hot toluene and an x­ray 
crystal structure obtained (fig. 5.7). 
Figure 5.7: The crystal structure of CSB monomer 
Selected bond lengths (Å): Cu(1)–O(1) 1.8980(13); Cu(1)–O(2) 1.8899(13); Cu(1)– 
N(1) 2.0126(14); Cu(1)–N(2) 2.0007(14). Selected bond angles (º): O(2)–Cu(1)– 
O(1) 173.43(6); O(1)–Cu(1)–N(1) 91.19(6); O(2)–Cu(1)–N(1) 88.05(5); O(1)– 
Cu(1)–N(2) 88.25(6); O(2)–Cu(1)–N(2) 92.57(6); N(2)–Cu(1)–N(1) 178.78(6). 
As evidenced from the crystal structure, CSB is unlike ZSB in that it forms a 
monomeric rather than dimeric structure. CSB also forms a square planar geometry, 
confirmed by O­Cu­O and N­Cu­N angles approaching 180º rather than tetrahedral 
geometry in a four coordinate system. This was due to copper predominantly 
forming octahedral structures in the oxidation state (II), owing to Jahn­Teller 
distortions providing increased stability through elongation of bonds along the z­
axis. Although the monomeric crystal structure appears square planar, this geometry 
was effectively maintained through interactions with adjacent groups which provided 





















             
 
                         
                     
 
                         
     
 
                             
                       
   
 
             
                         
                     
                     
                    
 
                     
                             
                       





























Figure 5.9: FTIR spectrum of CSB monomer 
FTIR peaks (cm­1): 3019, 2922 (C­H, Ph aliphatic); 1619 (C=C); 1594 (C=N); 1465, 
1428 (C­H, Ph aliphatic); 1318 (C­O); 760 (C­H, Ph ortho disubstituted). 
Slight differences in peak shift between CSB and ZSB were ascribed to coordination 
and supramolecular structure. 
Preparation of both ZSB and CSB were also attempted at up to 150mmol with no 
change in yield, proving scaleability of these synthesises which is important for 
potential application. 
5.5 Plasma deposition of ZSB and CSB 
Both zinc and copper Schiff base complexes were found to have suitably low 
melting points and acceptable minimum inhibition concentrations (see 5.6) so were 
investigated for plasma deposition. As with PSSM, plasma parameters were altered 
to obtain optimal functional group retention in the resulting films. 
First attempts at pp­ZSB and pp­CSB deposition were conducted at room 
temperature i.e. no monomer heating, in a 50W CW plasma for 1h at monomer flow 












                         
       
 
 
                       
                           
                     
                       
   
 
                   
                           
                           
                         
only a thin film was formed with little functional group retention from the monomer 
structure. 






































Figure 5.10: FTIR spectra of pp­ZSB and pp­CSB at 50W CW without monomer 
heating for 1 hour 
Therefore, monomers were heated to melting point in order to increase volatility. 
Subsequent flow rates were increased to 0.37 and 0.26 sscm3 min­1 for pp­ZSB and 
pp­CSB depositions reflecting the melting point order, with a marked improvement 
in absorption reflecting increased film deposition despite halving the reaction time to 
30 minutes. 
A problem arising from heating the monomer chamber was considerable 
condensation of gaseous complex on cold areas of glass, notably the glass neck of 
the monomer chamber leading to the plasma chamber. This had an influence on the 















                     
 
                             
                         
                   
                               
                  
 
 









Figure 5.11: Comparison of old (l) and new (r) monomer chambers 
A result of this was much improved flow rate for pp­ZSB in particular (0.53 sscm3 
min­1 versus 0.26 sscm3 min­1 for pp­CSB) which was reflected in increased film 
deposition and functional group retention. Subsequent reactions were carried out 
under a range of duty cycles (CW, 1/40, 10/40 and 40/40) in order to ascertain which 





















                               
               
 
                     
                   
                       
                             
                     
                         
                           
                     
                     
                       
   
 
                       
                       
                     
                     


























































































































Figure 5.12: FTIR spectra of pp­ZSB (l) and pp­CSB (r) films at 50W under a range 
of duty cycles with heating for 30 minutes 
Continuous wave films showed a marked improvement again from those deposited 
under the same conditions with longer­necked monomer chambers with notable 
peaks relating to the original monomer structure present. However, due to ionising 
effects the CW films showed far broader peaks in the FTIR spectra than pulse duty 
cycle reactions. Both 10/40 and 40/40 reactions showed improved film definition 
over CW conditions but as expected from theory, 1/40 duty cycle with least 
ionisation and longest off time relative to pulse on time provided the films with 
greatest functionality. This was important as the trend of functionality retention 
creating more antimicrobial films was seen in the antibacterial effects of these 
plasma films (section 5.6). Therefore, the standard deposition duty cycle used was 
1/40 pulse. 
Absorbance intensity of pp­ZSB and pp­CSB increased in the heated monomer film 
spectra from the cold monomer spectra according to the relative flow rate increase 
but there was substantial functional group discrepancy evidenced between the two 
metal centred complexes, with pp­ZSB showing more resemblance to the monomer. 




                     
                         
                           
                         
                     










                         
                   
                             
                         
                           
 
 
                   
               
 
films. Additionally, films deposited from ZSB were strongly yellow in colour 
whereas those of CSB showed no noticeable colour change in the substrate. These 
factors were possibly due to break­up of the inherent crystal structure of CSB which 
may have been necessary for complex stability and consequently did not carry over 
to the plasma film. Subsequently, the greatest film characterisation was focused on 
the pp­ZSB 1/40 system (fig. 5.13). 



























Figure 5.13: FTIR spectrum of pp­ZSB at 50W under 1/40 pulse duty cycle for 30 
mins 
pp­ZSB film structure was considered to be very close in composition to the 
precursor, indicating the mild conditions experienced during pulse plasma reactions. 
Oxidation occurred as evidenced by the insertion of a strong O­H peak in the FTIR 
spectrum, along with broadening of the band in the 1600cm­1 region. Other peaks 
present in the monomer were retained such as C­H stretches, with C=N obscured by 
peak broadening. 
Standard pp­ZSB and pp­CSB deposition parameters established and used during 














































                     
 
 
                           
                     
                       
                 
 
     




           
       
 
                       
         
 
 
                       
                   
                         
                     
                           
Monomer Monomer 
temperature (ºC) 









ZSB 140 CW, 40/40,10/40, 1/40 
(50 W) 
0.53 +/­0.07 0.020 1.1 nm min­1 30 min 
CSB 140 CW, 40/40,10/40, 1/40 
(50 W) 
0.26 +/­0.05 0.022 1 nm min­1 30 min 
Figure 5.14: Standard reaction conditions and parameters for pp­ZSB and pp­CSB 
deposition 
In place of SPR, the use of alpha­step, in conjunction with a quartz crystal 
microbalance was used to define physical film characteristics. A combination of 
these techniques was used to generate film thickness and mass measurements, which 
were processed to give estimated film properties (fig. 5.15). 
pp­ZSB pp­CSB 
Mass (µg cm ­2) 14.57 6.42 
Moles of monomer 
(nmol cm­2) 
37.80 16.67 
Thickness (nm) 32 +/­2 30 +/­4 
Density (g/cm3) 4.55 2.14 
Figure 5.15: Estimated plasma film physical properties for 50W 1/40 pulse duty 
cycle deposition for 30 minutes 
Absolute mass of films deposited varied quite considerably between ZSB and CSB, 
with the zinc­containing films containing more material despite similar thicknesses, 
which was in agreement with flow rate measurements. Density of the films was 
therefore significant as greater metal content would increase density, suggesting that 




                         
                         
 
                       
                     
                       





                             
         
 
                               
                         
                         
                         
                         
                       
                       
         
 
antimicrobial implications of the film, although the relative toxicities to of the two 
metals to bacteria (i.e. copper>zinc) meant the films may still show similar activity. 
SEM of pp­ZSB/CSB films did not provide sufficient information so the more 
sensitive approach of TEM was utilised (fig. 5.16). Zinc­containing films appeared 
to show a microstructure repeat pattern indicative of polymeric structure whereas the 
copper films were considerably smoother in microstructure but with greater 
topographical deviation. 
Figure 5.16: TEM images of pp­ZSB (l) and pp­CSB (r) films at 50W 1/40 pulse 
duty cycle for 30 minutes 
EDS did not pick up presence of zinc or copper in the films, although the inherent 
use of copper grids as base for the carbon substrate precludes the area­specific 
identification of copper. The limit of detection of around 0.1%at may also have 
caused problems in observing the metals. XPS however, which offers a similar level 
of detection picked up zinc and fluorine content in pp­ZSB/pp­C2F6 films at around 
0.1 and 1.1% respectively while showing evidence of Schiff base ligand retention 
(fig. 5.17). The survey spectrum of this film gave the following atomic compositions 









                 
         
     
 
                             
           
 
                         
                         
                       
                             
                       
                 
                       
                   
                        
 
                     
                       
                
 
Si 2p 47.51 %; C 1s 7.37 %; N 1s 0.92 %; O 1s 42.89 %; F 1s 1.11 %; Zn 2p 3/2 
0.09 % 











































Binding energy (eV) 
pp­ZSB 
1, 2, 3, 4, 5, 8, 9 = Low energy 
6, 7, 10 = Middle energy 
Oxidation = High energy 
Figure 5.17: XPS spectra of C 1s binding energies in pp­ZSB film at 50W 1/40 
pulse duty cycle for 30 minutes 
The carbon 1s peaks appeared in an approximate ratio of 3:2:1 (low­high energy), 
where the ‘low’ energy peak was assigned to hydrocarbon constituents of the Schiff 
base ligand; the ‘middle’ energy (1.0­1.7 eV higher) to amine and carboxy 
functionality; and the high energy peak to oxidation of the film (as seen in FTIR 
spectra) with C=O and O­C=O expected at around 3.0­4.0 eV above the 
hydrocarbon. Oxidation and potential fragmentation disallowed the possibility of 
accurate ligand quantification within the film. This data coupled with FTIR spectra 
show that despite potential fragmenting conditions experienced in plasma, structural 
retention can still be achieved to a high degree under mild conditions. 
In place of dissolving films for regular mass spectrometry, the surface­specific 
technique secondary ion mass spectrometry was used to identify the location and 






                         
                   
 
                         
                       
                   
 
                         
                     
                         
                     




















Figure 5.18: SIMS map and spectrum of metal and ligand content within pp­ZSB 
films at 50W 1/40 pulse duty cycle for 30 minutes 
Although at appreciably low levels confirmed by XPS, zinc (red) appeared to be 
evenly distributed throughout the film alongside Schiff base ligand. SIMS and XPS 
analysis of pp­CSB films did not detect presence of copper. 
AAS detected leached zinc and copper in solution at only 20ppb and 10ppb 
respectively, therefore confirming the reason for low density observed for pp­CSB 
films relative to pp­ZSB films. Measurement of zinc in the dissolved pp­ZSB films 
deposited under standard conditions for 30 minutes showed low concentrations of 







                     





                       




                             
                           
























Figure 5.19: Atomic absorption of zinc from dissolved surfaces of pp­ZSB treated 
and untreated glass slides 
5.6 Microbiological assays 
Assays developed for assessing the antibacterial activity of PSSM and plasma films 
were used to analyse the efficacy of zinc and copper monomers and polymers. 
5.6.1 Monomers 
5.6.1.1 Disc diffusion 
Due to the highly hydrophobic nature of the Schiff base ligand, both ZSB and CSB 
could not be pelleted for the disc diffusion assay. Instead, the compound was placed 









                           
                       
                           
                           




                       
               
 






         
 
                         
 
 
Figure 5.20: Zone of inhibition of MSSA growth caused by ZSB and CSB 
compound 
Even accounting for the lack of pellet, the zone of inhibition surrounding ZSB was 
quite considerable and the yellow colour was spread throughout the agar surface, 
indicating the volatility of the compound. By contrast, CSB did not seem to disperse 
to the same extent perhaps reflecting the crystalline nature of the complex and a 
more modest inhibition ring was observed despite the stronger antimicrobial nature 
of Cu over Zn. 
5.6.1.2 MIC 
As with PSSM, minimum inhibition concentrations were observed for ZSB and CSB 
in solution. These are summarised in fig. 5.21. 
Complex P. aeruginosa PAO1 
MIC50 (µM) 
S. aureus MSSA 
MIC50 (µM) 
ZSB 1.8 210.6 
CSB 13.5 97.6 
Schiff base ligand 900.1 2710.0 





                             
                 
                         
                         
                           
                         
                 
                             
                             
                         
                     
                             
                           
                         
   
 
       
     
                     




                       
     
 
It was clear from these experiments that the Schiff base ligand alone has a negligible 
impact on bacterial growth compared to both metal­containing moieties. 
Interestingly a counter­result to the disc diffusion assay was observed in CSB and 
ZSB solution activity against MSSA, where CSB was around twice as effective as 
ZSB, possibly as a result of liberated Cu2+ ions upon crystal structure collapse. It 
could be the case that solvent molecules acted as coordinating ligands to displace 
intermolecular forces and maintain d9 configuration, thereby altering interaction 
between complex and cells. Also of interest was a much lower MIC for ZSB versus 
PAO1 than CSB which was the opposite case than for MSSA. ZSB MIC was also 
over twenty times less than observed for zinc acetate versus PAO1, indicating the 
synergistic impact of ligand composition and perhaps coordination energy. It would 
appear that zinc acetate allows free Zn2+ ions in solution which are recognised by the 
cell and subsequently pumped out, whereas complexed zinc in ZSB is not as readily 
identified and ligand exchange may occur within the cell, causing damage to proteins 
and DNA. 
5.6.2 Plasma film assays 
5.6.2.1 Efficacy confirmation 
Initial antibacterial tests were carried out as cursory examinations on non­woven 












                           
                       
                         
                     
                 
 
                       
                     
                       
                     
                       
                       
                         
             
 










                           
             
 
 
                         
                     
                       
                         
                         
                     
                     
It was observed that analogous to pp­PSSM there was very little diffusion of active 
product while the area immediately beneath the treated fabric was almost completely 
clear of visible bacterial growth. This confirmed the viability of pp­ZSB as a contact­
killing antimicrobial surface. Subsequent assays were therefore carried out on Petri 
dishes and non­wovens to quantify the degree of activity. 
As expected from low diffusion and limited metal content in solution, bacteria 
suspended in media exposed to pp­ZSB and pp­CSB surfaces were largely 
unaffected in growth. Despite the ionising conditions in continuous wave plasma and 
subsequent fragmentation of the molecule, no noticeable difference was observed in 
Live/Dead solution tests between CW and 1/40 pulse plasma duty cycle films. 
Bacteria attached to surfaces however were much more limited in viability (fig. 
5.23). Bacteria were exposed to plasma films deposited at 50W under 1/40 duty 
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Figure 5.23: Live/Dead cell ratios of MSSA (l) and PAO1 (r) from pp­ZSB treated 
and non­treated Petri dish surfaces after 24h 
It was clear from these results that plasma reaction duty cycle and resulting 
monomer structural retention in films was directly related to antimicrobial efficacy 
of the surface. Continuous wave plasma films showed least contact­killing of both 
PAO1 and MSSA of all pp­ZSB films but were relatively more effective against 
PAO1. In terms of functional group retention, both 10/40 and 40/40 films produced 
similar FTIR spectra and consequently similar activity versus both bacterial strains; 




                         
                    
 
                       
                           
                           
                     
                       
                         
             
 
     
                               
                             
                             
                         
                       
                       
                         
                     
                       
                 
 
bacterial cells. This provided further evidence for the requirement of the metal centre 
to be coordinated to the Schiff base for optimised activity. 
As observed in FTIR and other characterisation methods, pp­CSB films did not 
contain as much monomer functionality or indeed metal content as pp­ZSB, so it was 
no surprise that reproduction of surface assays on these films resulted in less relative 
reduction in bacterial growth, although interestingly there was a large discrepancy 
between CW and 1/40 pulse duty cycle film efficacy for PAO1 again indicating 
influence of duty cycle. Therefore, the following assays were therefore all carried out 
on pp­ZSB 1/40 pulse duty cycle films. 
5.6.2.2 Time dependence 
Up to this point, all assays on plasma films had been carried out after a standardised 
incubation time of between 18­24h, with the exception of a 3h assay on pp­PSSM. In 
order to assess how film activity altered over time, an assay was conducted over a 
period of 24 hours where 72 Petri dishes were plasma treated, inoculated with 
bacteria and three control and three pp­ZSB treated Petri dishes removed from 
incubation every hour. Bacteria were removed from the surface in the standard 
procedure and between three and five dilution factors were spread on agar for 
counting the following day. It was therefore an extremely time­ and material­
expensive process but yielded very useful information on the antibacterial efficacy of 












                     
 
 
                           
                       
                           
                           
                           
                             
                           
                             
                         
                         
                 
 
 


































Figure 5.24: Time­dependence assay of PAO1 on pp­ZSB treated Petri dishes 
The results of this study were quite revealing as the bacteriostatic effect pp­ZSB has 
on Pseudomonas cells over time was clearly seen. Initial concentrations of bacteria 
were low on both the control and treated surfaces but grew extremely rapidly on 
control dishes during early hours of the assay when cell viability declined on treated 
dishes. This is seen more clearly in fig. 5.25. After this time, bacterial concentrations 
were seen to increase on pp­ZSB surfaces with a growth lag to control evident which 
stayed relatively constant for the length of the assay, resulting in large differences in 
viable cell count at the end of the assay. This effect was probably seen, because 
bacteria which attached and subsequently died during the early stages of the assay 
then provided a platform for bacterial cells growing in exponential phase in solution 
















                     
                         









                            




























Figure 5.25: First 4h of time­dependence assay in fig. 5.24 
5.6.2.3 Non­wovens 
To supplement quantitative data derived from assays on Petri dishes, treated non­
woven materials were also tested. Initial JIS assays suffered from the same problem 
of hydrophilicity imparted on the fabric as pp­PSSM non­woven assays (fig. 5.26). 













































                         
                         
                   




                         
     
 
                           
                       
                           
                   
                   
 
                           
                             
                             
   
 
Growth evidenced on the treated non­woven appeared to slightly exceed that of the 
control but essentially the same level of growth was seen. This observation was 
again contrasted by confocal microscope images of treated and non­treated non­
woven which showed much reduced viability of attached cells (fig. 5.27). 
Figure 5.27: Confocal microscope images of MSSA (l) PAO1 (r) on pp­ZSB treated 
non­woven after 24h 
Activity of pp­ZSB films observed via this method was in agreement with both MIC 
data and Live/Dead stained cells vortexed from the surface shown above, where 
MSSA was not quite as susceptible as PAO1. Nevertheless, red cells of both bacteria 
appeared on non­woven strands although interestingly live planktonic phase MSSA 
cells were also visualised, highlighting the contact­kill mechanism of these films. 
pp­ZSB films were coated with a pp­C2F6 adlayer to reduce hydrophilic effects in the 
fabric and a shorter assay run with results of the time dependence assay on Petri 












                           
                       




                         
                         
                             
                           
                           
                           
                           
           
 






























Figure 5.28: JIS assay of PAO1 on pp­ZSB + pp­C2F6 and pp­CSB + pp­C2F6 
treated squares of non­woven after 4h. Graphical data (top) and visual representation 
of bacterial colonies (bottom) from control (l), pp­CSB (c) and pp­ZSB (r) non­
woven 
A massive decrease in viable Pseudomonas cell count was observed for the pp­ZSB 
treated non­woven after four hours compared to both the initial and final controls, 
and pp­CSB films. This was important as it validated the results of the Petri dish 
assay and proved the effectiveness of deposition on a different substrate. As can be 
seen from the image of colonies present on agar plates, there were similar numbers 
of viable cells from both control and pp­CSB treated non­woven which are both of 
400x dilution. By comparison, the dish from pp­ZSB film was of 20x dilution and 




                             
                       
                         
                     
                           
                             










                           
                       
                       
 
 
The evidence of growth on pp­CSB in the same magnitude as the control showed the 
ineffectiveness of the fluorinated adlayer without a truly active base film. When 
media was initially applied to non­wovens, the pp­CSB film caused the solution to 
‘bead’ the most therefore was the most hydrophobic substrate and consequently 
would have shown most bacterial inhibition if this was a major factor alone. The 
presence of Schiff base in pp­CSB films also confirmed the need for a metal centre 
to coordinate activity against bacterial cells. 




























Figure 5.29: JIS assay of MSSA on pp­ZSB + pp­C2F6 and pp­CSB + pp­C2F6 
treated squares of non­woven after 4h. Graphical data (top) and visual representation 





                       
                         
                         
                     
                         
                         
                           












                   
 
 
                           
                           
                         
                                 
                             
                             
                         
                       
                         
 
An almost identical scenario was presented when pp­ZSB films were tested against 
MSSA (fig. 5.29) with negligible growth versus the control, albeit with slightly less 
viable growth on pp­CSB films. Due to the impressive activity of pp­ZSB films 
deposited on non­woven materials after this short time­period, the time dependence 
assay used for Petri dishes was repeated for non­wovens against both MSSA and 
PAO1 (figures 5.30 and 5.31). This assay was conducted starting with 96 treated 
squares of treated and 96 of non­treated non­woven, taking three pieces of each from 
incubation every two hours and plating the solution derived of 3­5 dilution factors 
for each sample. 
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In c u b a tio n tim e (h ) 
Figure 5.30: Time­dependence assay of PAO1 on pp­ZSB treated non­woven 
The non­woven time course assay showed an even greater lag period than for the 
Petri dish version versus PAO1, with around 10% growth on treated fabrics after 16h 
relative to the control. Importantly, all treated fabrics showed much less growth than 
the control fabric taken at the same time. The early stage of the assay was where the 
activity of pp­ZSB film was most apparent, with virtually no growth seen up to six 
hours. Growth seen after this point is likely due to multilayer formation of cell as 
discussed previously. The control meanwhile showed a drop in viable cells after two 
hours, most likely due to planktonic bacteria adapting to their environment during 













                   
 
 
                         
                           
                             
                           
                          
 
                     
                       
                     
                         
                         
                             
                       
                       
        
 
     
                   
                           

































In c u b a t io n t im e ( h ) 
C o n tro l 
p p ­Z S B tre a te d 
Figure 5.31: Time­dependence assay of MSSA on pp­ZSB treated non­woven 
Treated fabrics tested against MSSA showed a very similar trend to that seen for 
PAO1, although even less viable cells were observed at the final time point relative 
to control. Growth was also seen after six hours, albeit control growth was far in 
excess of this. Control growth followed the same pattern as for PAO1 where initial 
cell count was higher than that at two hours, which preceded rapid growth. 
Time­dependence tests of pp­ZSB against both PAO1 and MSSA were very 
instructive in helping determine the mechanism by which the surface acts on 
bacteria. It appeared initial contact­killing was seen during the hours following 
inoculation with cells, followed by a period of slow growth which was potentially 
caused by transfer of ZSB throughout the bacterial population. The effects seen in 
this assay were seen despite using a higher initial inoculated cell count of bacteria in 
stationary phase (slow growing i.e. stronger defence) than would be experienced in 
an application setting, therefore it is likely these tests still underestimate real­life 
bacterial viability on films. 
5.7 Cytotoxicity study 
Despite excellent antimicrobial properties, it was necessary to expose eukaryotic 




                     
     
 










                     
                     
               
 
 
                         




followed, using cultures of Swiss mouse fibroblasts and human neonatal epithermal 
keratinocytes (fig. 5.32). 
M ed ia o n ly O 2 p la sm a (1 ) O 2 p la sm a (2 ) O 2 p la sm a (3 ) p p­Z SB (1 ) p p­Z SB (2 ) p p­Z S B (3 ) G la ss (1 ) G la ss (2 ) 
0 .0 0 
0 .0 1 
0 .0 2 
0 .0 3 
0 .0 4 
0 .0 5 
0 .0 6 
0 .0 7 
0 .0 8 
0 .0 9 
0 .1 0 























T r e a tm e n t o f g la s s 
Me dia only O 2 pla sm a (1) O 2 p lasm a (2 ) O 2 pla sm a (3) p p­ZS B (1 ) pp ­ZSB (2) p p­ZS B (3 ) G lass (1) G la ss (2) 
0 .0 0 
0 .0 5 
0 .1 0 
0 .1 5 
0 .2 0 
0 .2 5 
0 .3 0 
0 .3 5 
0 .4 0 
0 .4 5 























T re a tm e n t o f g la s s 
Figure 5.32: Optical absorbance readings from cytotoxicity tests of pp­ZSB films 
(red), pp­O2 treated (blue) and non­treated (green) glass coverslips against human 
epidermal keratinocytes (l) and Swiss mouse fibroblasts (r) 
In keeping with pp­PSSM films, no cytotoxicity was observed as a result of 
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Chapter 6: A novel highly volatile silver 
compound for the plasma deposition of 
antimicrobial films 
A novel liquid organosilver complex was synthesised, characterised and found to 
inhibit the growth of P. aeruginosa. The complex was used as a monomer unit in the 
rapid plasma deposition of thin films, which demonstrated functional group retention 
from the precursor and considerable silver presence. These films were found to 
significantly inhibit microbial growth on non­woven polypropylene using a standard 
industrial assay. 
6.1 Altering metal compound characteristics 
As discussed in preceding chapters, antimicrobial metal­containing complexes can 
be produced quickly and cheaply through selection of the appropriate starting 
materials. Perhaps the most important single factor when choosing unsaturated 
ligands for potential plasma deposition of antimicrobial organometallics was 
inherent high volatility in the resulting product, which was not necessarily the case in 
some earlier molecules. Melting points of all compounds made previously were 
above 100ºC and consequently required heating to encourage molecules into the gas 
phase. This would be undesirable in an application setting where monomers would 
be required to have a high flow­rate for quick deposition without heating. Therefore, 
significant efforts were made to reduce melting points of compounds to avoid 
intermolecular forces holding monomeric complex units together in a 
supramolecular structure. This approach was taken in the two broad manners: (i) 





                 
                   
                       
                     
                     
                       
                     
                         
                         
                
 
                   
                       
                     
               
 
 
                 
 
 
                             
                             
                       
                 
                   
 
6.1.1 Ligand alteration 
Previous efforts had shown maleimide with triphenylphosphine as suitable 
constituents in an organo­silver complex for plasma deposition, albeit with 
reasonably low volatility. The melting point of pure maleimide was observed at 
around 91ºC, producing a silver salt silver maleimide and Lewis­base stabilised 
PSSM of melting points 228ºC and 158ºC respectively. Potential for strong 
intermolecular forces exists between monomers in PSSM, in the form of π­stacking 
and hydrogen bonding between carbonyls and protons of other maleimide olefin 
groups or triphenylphosphine groups. A route to avoid such interaction is to increase 
freedom of movement within the ligand system i.e. use ‘floppier’ ligands which are 
not as easily constrained within a crystal structure. 
Phosphine­stabilised silver (I) carboxylates have previously been reported of the 
general formula R­Ag­(PPh3)2 where R = acrylic acid and 4­pentenoic acid,
1 
so 
proved a useful starting­point for adaptation with unsaturated moieties such as 3­
butenoic acid (liquid) and maleic acid (fig. 6.1). 
Figure 6.1: 3­butenoic acid (l) and maleic acid (r) 
As seen in fig. 6.1, maleic acid has dicarboxylic acid functionality so could be used 
to introduce two units of silver per mole. Using the general synthetic route for PSSM 
preparation, silver carboxylates were made using a range of unsaturated ligands and 
subsequently stabilised with triphenylphosphine (fig. 6.2). Silver was also 
































             
 
 
                       
                             
                       
                         
                           
                           
                     
                         
                 
         
 
 
                     
 
 
                       
                       
                 

























Figure 6.2: Silver (I) allyl carboxylate synthesis 
Melting points of these compounds however, did not prove a great improvement 
upon the PSSM system (fig. 6.3). It was seen that lengthening the alkyl chain on 
linear carboxylates from 4 carbons to 5 carbons reduced intermolecular forces within 
the compound, possibly as a regular alignment and packing was less easily achieved. 
When the double bond in the pentenoic acid precursor was replaced with a triple 
bond, the melting point was seen to decrease again due to the reduction in 
availability and correct alignment of protons for intermolecular bonding. The maleic 
acid derivative showed an increased melting point over the precursor as the di­metal 
centre and triphenylphosphine structure offered interaction between phenyl and 
olefin groups on adjacent molecules. 
Figure 6.3: Synthesised silver (I) allyl carboxylates and observed melting points 
Cursory plasma deposition of these monomers was attempted but not continued due 
to low flow rates. Although altering ligand composition had some effect on 
increasing volatility in triphenylphospine­stabilised silver complexes, it was clear 




       
                   
                   
                       
             
                 
                     
                       
                          
 
 
                 
         
 
                       
                         
                         
                     
                     
               
 
                         
                           
                       
                       
                     
                     
     
6.1.2 Lewis adduct alteration 
Alongside triphenylphosphine, the options for Lewis­base stabilisation of silver salts 
include alkyl phosphines as displayed previously,
2 
which provide the ‘floppy’ 
ligands required to reduce propensity of the compound to crystallise i.e. reduce 
symmetry and intermolecular forces. Therefore, trimethylphosphine (PMe3), 
triethylphosphine (PEt3) and tri­n­butylphosphine (P
n
Bu3) (fig. 6.4) were considered 
as potential alternative Lewis bases which remove the potential for π­stacking. Tri­
tert­butylphosphine was also considered due to large steric bulk which would further 
stabilise the metal centre but was not of viable cost for potential upscale. 
Figure 6.4: Potential alkyl phosphines for silver stabilisation: trimethylphosphine 
(l), triethylphosphine (c), tri­n­butylphosphine (r) 
Initial efforts in stabilising silver maleimide with two equivalents of PMe3 were 
conducted using the same synthesis as PPh3 under inert atmosphere on a Schlenk 
line. A white solid was yielded each time which decomposed during drying in­vacuo. 
The difficulty of working with such air­sensitive compounds as alkyl phosphites 
(e.g. P
n
Bu3 is pyrophoric, Schlenk techniques must be used) alongside unstable 
products meant an alternative Lewis base was sought. 
Phosphites, a class of compound analogous to phosphines with an ester rather than 
alkyl linkage presented themselves as a viable option as they can be used under 
atmospheric conditions and are very cheap. The presence of a pre­oxidised alkyl 
chain was also favourable for ligand retention in the plasma glow. Triethylphosphite 
(P(OEt)3 was investigated for use with silver maleimide, maleate and allylacetate 
using the synthesis in 6.2.1 producing yellow, purple and colourless liquids 











                   
                       
                   
                         
                     
                         












Figure 6.5: Triethylphosphite (top) and liquid silver compounds synthesised 
(bottom) 
These complexes dramatically demonstrated the ability of phosphites to sufficiently 
reduce intermolecular forces in order to produce a highly volatile monomer for 
plasma deposition. Subsequent plasma deposition attempts with both silver maleate 
and allylacetate resulted in decomposition of silver in the monomer flask, which was 
proposed to occur via decarboxylation
2­3 
(fig. 6.6). Decomposition was not evident 
for the Ag­N bound silver maleimide analogue and this system was therefore taken 

















                     
                       
                       
                           
                           
                      
 
       
                             






             
 
   
                         
                   
                             
                       
                         
The results of this investigation into increasing silver compound volatility were 
transferred to zinc and copper compound synthesis. Attempts were made at making 
2+ 2+ 
Zn and Cu analogues were unsuccessful due to the hard­soft acid­base principle
4 
meaning phosphorus was not of suitable orbital size to interact with either ‘hard’ ion. 
It is possible that the ‘softer’ Cu
+ 
ion would be more conducive to phosphorus 
reception to create a directly analogous compound of silver (I) complexes. 
6.2 tris­triethylphosphito silver maleimide 
The novel compound (PTSM) was prepared in a two step method similar to the one 




Figure 6.7: Synthesis of tris­triethylphosphito silver maleimide 
6.2.1 Synthesis 
To a stirred solution of maleimide (20mmol, 1.96g) in ethanol (20ml), a 10ml 
solution of silver nitrate (20mmol, 3.40g) in an ethanol/acetonitrile mixture 
(minimum MeCN) was added and the solution stirred for 5 minutes. After this time a 
solution of triethylamine (20mmol, 2.02g) in ethanol (5ml) was added dropwise over 




                       
             
 
                           
                       
                         




                       
                       
               
 
                           
                           
 





           
residue was isolated by filtration, washed three times with ethanol and dried in­
vacuo, yielding silver maleimide (2.84g, yield 94%). 
To a stirred solution of silver maleimide (10mmol, 2.04g) in THF (30ml), a stirred 
solution of triethylphosphite (30mmol, 4.98g) in THF was added and the solution 
stirred for 30 minutes. After this time the solvent was removed under vacuum, 
yielding a yellow liquid, tris­triethylphosphito silver maleimide (PTSM) (6.16g, 
yield 88%). 
6.2.2 Characterisation 
Unlike previous monomers it was not possible to crystallise PTSM, therefore a 
crystal structure was not obtained. PTSM was soluble in deuterated chloroform for 
NMR study with a very clean spectrum observed. 
1
H NMR (300MHz) (ppm): δ = 6.4 (s, 2H, ­CH­CH­), 3.9 (p, 18H, P(O­CH2­CH3)3), 
1.2 (t, 27H, P(O­CH2­CH3)3). 
13
C NMR (75 MHz) δ = 16.2, 59.7, 136.0, 186.2. 
An FTIR spectrum was also obtained (fig. 6.8). 






































                       
                         
 
 
                       
                       
                       
                     
               
 
         
                         
                     
                     
                             










): 2980, 2900 (C­H, aliphatic); 1633 (C=O); 1608 (C=C); 1476, 
1444, 1390 (C­H alkane); 1310, 1181 (C­O), 1013 (C­H vinyl) and 924 (C­H 
alkane). 
In addition to peaks ascribed to silver­maleimide formation in chapter 4, absorptions 
diagnostic of triethylphosphite were seen in the PTSM FTIR spectrum. Carbonyl and 
alkene presence from the maleimide ligand was supplemented by the appearance of 
peaks relating to alkane and carboxy functionality. This gave additional confirmation 
of product formation in addition to NMR data. 
6.3 Plasma deposition of PTSM 
Due to the high volatility of PTSM and evidence of previous investigations pointing 
towards low duty cycle parameters contributing towards high levels of functional 
group retention and antimicrobial activity in the resulting films, initial plasma 
deposition of PTSM was run at 50W under 1/40 pulse duty cycle. An FTIR spectrum 
of such a deposition is seen in fig. 6.9 below: 



































                       
                         
                           
                             
               
                   
                     
                           
                         
                           
             
 
           
   












                   
 
                       
                           
                           
                         
                           
                       
               
 
   
       
           
 
                       
         
As with pp­ZSB films, a strong correlation between monomer and plasma film 
structure was seen in using IR. Key absorbances assigned to alkanes were observed 
as sharp peaks identical to the monomer, while C=O and C­O bands were broadened 
by oxidation of the film. Removal of the strong vinyl C­H bend and C=C stretch 
indicate the elimination of alkene functionality consistent with radical 
polymerisation through the maleimide unit. The strength of film absorbances 
outweighed contribution of O­H band appearance due to oxidation, indicating a 
relatively thick and less ionised film was deposited which was related to very high 
flow rate of monomer (fig. 6.10). Identical FTIR spectra were observed regardless of 
substrate position within the reactor which was presumably due to the high flow of 
monomer ensuring similar reaction conditions throughout the reactor. 
Duty cycle (peak power) Flow rate 
(sscm3 min­1) 
Base pressure (mbar) Film deposition rate Deposition time 
1/40 (50 W) 0.58 +/­ 0.10 0.034 0.46 µg cm ­2 min­1 30 minutes 
Figure 6.10: Standard reaction conditions and parameters for pp­PTSM deposition 
Reaction conditions experienced using pp­PTSM (fig. 6.10) were similar to that of 
pp­ZSB, with slightly higher flow rate seen for PTSM than ZSB despite no heat 
being applied to the liquid silver system. The deposition rate was also similar to pp­
ZSB (fig. 6.11), with a slightly higher molar deposition per reaction indicating a 
likely more antimicrobially active film due to the relatively high toxicity of silver to 
zinc. Such observations also suggest this system is more viable for potential 
application as the heat source is not required. 
pp­PTSM 
Mass (µg cm 
­2
) 13.87 
Moles of monomer (nmol cm
­2
) 19.76 
Figure 6.11: Estimated plasma film physical properties for 50W 1/40 pulse duty 




                       
                       
                       
     
 
                                       
 
                           
                   
                           
     
 
       
     




                             
           
 
 
                             
                       
                       
                           
                         
                   
Due to the low detection limit, x­ray photoelectron spectroscopy could not detect 
silver in pp­PTSM films, but potential evidence of ligand retention was observed. 
The survey spectrum of this film gave the following atomic compositions (with Si 
from underlying substrate): 
Si 2p 45.24 %; P 2s 3.14 %; C 1s 12.76 %; N 1s 0.88 %; O 1s 37.87 % 
As with pp­ZSB films, the relative intensity of carbon 1s peaks gave clues to 
functionality present within pp­PTSM films (fig. 6.12). Additionally, oxidation of 
the pp­PTSM film seen in FTIR spectrum was confirmed by the high oxygen content 









1, 3 = Low energy 
2 = Middle energy 


















































Binding energy (eV) 
pp­ZSB 
Figure 6.12: XPS spectra of C 1s binding energies in pp­PTSM film at 50W 1/40 
pulse duty cycle for 30 minutes 
The low energy peak constituted around 50% of the total C 1s intensity, the middle 
energy around 41% of total and the high energy peak approximately 9%. This 
corresponded to the ‘low’ energy peak assigned to hydrocarbon i.e. the terminus of 
the triethylphosphite group and the base of maleimide, the middle energy (ca. 1.6 eV 
higher energy) to the C­O of triethylphosphite and the high energy (ca. 3.2 eV higher 




                       
   
 
                             
                   
                         
                     
                             
                           
                     
                     





                         
                   
 
 
                             
                       
assignment were therefore consistent with monomer retention of 1 maleimide to 9 
triethylphosphite groups. 
Like pp­ZSB films, SIMS was used to map silver content on the surface of pp­PTSM 
on silicon wafers (fig. 6.13). Unlike pp­PSSM films where phosphine­stabilised 
silver was observed in dissolved films, peaks assigned to pure silver ions and 
phosphate­silver moieties were seen and interestingly no phosphite bound silver was 
detected in major quantities. It could be the case that ion impact on the surface 
caused cleavage of these bonds, or they were broken by ionisation in the plasma 
reactor. In either scenario, silver was observed inhomogenously in large quantities 
across the surface and generally accompanied by organic constituents, indicating the 


































Figure 6.13: SIMS map and spectrum of metal and ligand content within pp­PTSM 
films at 50W 1/40 pulse duty cycle for 30 minutes 
If ionisation of bonds is caused within the plasma glow it is possible that the 




                               
                         
                         
 
 
                       




                       
                     
                       
                     
   
 
       




lowering of 50W peak power or changing on or off time of duty cycle. However, if 
ionisation or fragmentation of bonds is required for plasma glow sustenance, then is 
it suggested unlikely for silver to be retained in monomeric fashion during plasma 
deposition. 
AAS showed agreement to XPS and SIMS data, with low silver concentrations 
observed in dissolved and leached films. 
6.4 Microbiological assays 
As this system was developed later on in the project, extensive microbiological 
examination was not possible. However, work was conducted on monomer and 
plasma film which allowed for comparison with previous work on other surfaces. 
Additionally the system was utilised in direct comparison with commercial dressings 
(chapter 7). 
6.4.1 Minimum inhibitory concentration 











                     
 
 
                   
                     
                         
                         
                         
                           
                             
                             
                       
                     
                         
         
 
       
                           
                     
                       




































1E­6 1E­5 1E­4 1E­3 0.01 0.1 
Concentration (mM) 
1 10 100 
Figure 6.14: Minimum inhibition curve for PTSM versus PAO1 after 18h 
Interestingly, the MIC50 of the phosphite­stabilised analogue of silver maleimide 
against PAO1 was measured as less antimicrobial than when phosphine­stabilised, at 
­6 ­3
around 51 x 10 mol dm . Triethylphosphite ligands however, showed little to no 
activity against bacteria much like triphenylphosphine with an MIC50 of over 16.5 x 
­3 ­3
10 mol dm , which leads to the conclusion that perhaps coordination number about 
the central silver atom plays a part in antimicrobial action. As ligand number was 
increased from two to three, a 50+ fold increase in MIC50 was observed from PSSM 
to PTSM. This effect may also be due to composition of coordinating ligands in that 
phosphine ligands may assist interaction with or transport through the cell membrane 
where phosphites do not. Previous work
5 
has shown silver compounds coordinated 
by phosphorus groups show no antimicrobial activity, which was clearly not the case 
with either PSSM or PTSM. 
6.4.2 Plasma film assay 
A single assay was conducted on this film with a fluorinated adlayer on non­woven 
against Pseudomonas aeruginosa, using the same conditions which gave the best 
result for pp­PSSM films (fig. 6.15). This would allow simple comparison between 













                             
                         
                           
                         
                 
                   





                              
       
                              
                 
       
                              























Figure 6.15: JIS assay of PAO1 pp­PTSM + pp­C2F6 treated squares of non­woven 
after 3h 
The result of this assay was dramatic, with a huge difference in cell viability between 
those taken from the treated and non­treated squares of material of around 99.9% 
reduction. The impact of this film decreased the number of cells from those initially 
inoculated so showing outright killing of cells on the surface, not just growth 
inhibition. This becomes significant when comparing antimicrobial surfaces for 
application. It was a disappointment that time limitations prevented further 
exploration of this highly promising system. 
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Chapter 7: Application of antimicrobial plasma 
films 
The use of plasma deposition in an industrial setting for antimicrobial surfaces is a 
viable option, especially when introduced to existing manufacturing steps utilising 
plasma. pp­ZSB and pp­PTSM films were shown to be effective antimicrobials on a 
range of substrates for a range of applications and hold their own when subjected to 
scrutiny versus commercially produced antimicrobial materials. It is quite feasible 
that such films could supplement or even supersede current methods for producing 
antimicrobial surfaces for many applications due to the ease of production. 
7.1 Application of plasma 
It was demonstrated in chapter 1 that there is a need for antimicrobial surfaces in 
hospital settings to prevent both the accumulation and transfer of bacteria which 
cause nosocomial infection. Plasma deposition of antimicrobials may provide a 
satisfactory solution. 
7.1.1 Application viability 
Plasma deposition has potential as a technique to easily impart an antimicrobial 
coating onto a range of substrates without altering the bulk properties of the material 
and can be easily incorporated into the manufacture of such materials as non­
wovens. 1 Indeed, plasma has been widely used in applications such as thin film 
vacuum coating, microelectronic deposition2 (PECVD of metallic silver3 and 
copper 4) and sterilisation of biotechnology equipment, with the plasma industry 
worth over $1 billion per annum and growing rapidly.5 However, some issues 
created by plasma processing for industry include the inherent use of vacuum 
systems and the high initial cost for equipment (pumps, chamber, RF generator etc.6 
These factors are overcome when potential for ultra­green, clean products is realised 




                 
 
 
                   
                     




                     
 
 
                             
                       
 
                       
                         
                         
                         
                             
 
 
utilised in­situ as supplementary to standard plasma processes e.g. sterilisation­
coating. 
Alternatively, an atmospheric plasma system has been developed2 which allows 
generation of a one atmosphere uniform glow discharge plasma (OAUGDP), which 
is a ‘cold’ RF glow analogous to low­pressure plasma operating on displacement 
currents (fig. 7.1). 
Figure 7.1: Atmospheric plasma system MOD VI OAUGDPTM operating in air2 
Use of a plasma technique such as this would remove the need for expensive vacuum 
systems and batch processing, so making plasma a more attractive proposition to 
industry. 
Currently, large­scale batch plasma processors are used in industry (fig. 7.2) which 
allow quick treatment of materials for a range of applications. Reels of flexible 
material e.g. non­wovens, are loaded to the reactor and pressure is rapidly reduced 
within the system in a similar manner to laboratory­scale reactors. Material is loaded 






                 
 
 
                             
                             




                   
                         
                           
                     
                         
               
 
                       
                   
                             
                   
 
Figure 7.2: The wide web plasma industrial plasma system7 
The width of material treated can be anywhere up to 60 inches, meaning a substantial 
amount of processing can occur in a very short space of time, depending on the 
volatile nature of precursor; adhesion characteristics and the required quantity of 
deposited material. 
7.1.2 Alternative methods 
Recently new chemical vapour deposition techniques have been developed which 
could provide an alternative to plasma, in iCVD and oCVD (initiated and oxidative). 
These methods also allow for the potential to apply polymers to low melting point 
substrates, much like plasma but minus the low pressure requirement, although 
thermal energy in the system (ca.300ºC) plus use of an initiator would prove 
inhibitive for stability of metal constituents, particularly silver.8 
Most other methods (e.g. spin­coating, dipping) are solvent based and therefore not 
environmentally friendly and expensive. For example, in the industrial manufacture 
of thin films, most operational cost is tied up in wastewater treatment which is many 




                   
         
     
                 
         
         
 
                     
                         
           
 
       
                         
                   
                           
                     
                             
                           
                     
                     
                       
                         
                       
                         
               
 
                   
                       
                             
               
 
Plasma deposition for industry therefore has the following major advantages: 
• Cheap long term operation 
• Highly efficient 
• Deposition onto a range of substrates (inc. 3D) 
• Films unique to plasma 
• Little/no by­products or waste 
However, as discussed previously, difficulty has been reported in transferring plasma 
deposition characteristics from one reactor to another which appears to be the biggest 
problem facing plasma deposition for application. 
7.2 Potential plasma substrates 
For industrial application of plasma deposition with minimal cost, it makes sense to 
incorporate film formation into a manufacturing process which inherently requires 
plasma. This is the case with materials such as nappy linings, wound dressings and 
medical disposables e.g. gloves, scrubs etc; so plasma depositing antimicrobials on 
the surface would require little change in the production method but with a great deal 
of added value to the finished product. With this in mind, plasma films were 
deposited onto a range of substrates supplementary to those already previously 
coated (SAM­gold, polystyrene Petri dish, silicon wafer etc) and assays conducted 
against both P. aeruginosa and S. aureus. Deposition of plasma films onto non­
woven polypropylene of nappy lining was observed for all three main systems used 
in this work with good efficacy against these bacteria already observed (chapters 4­
6). This indicates a thin coating of antimicrobial via plasma deposition could help 
make nappy rash a thing of the past. 
Other non­wovens tested included polypropylene material used in hospital scrubs, 
supplied by an industrial partner. The material was already highly hydrophobic due 
to plasma treatment and a pp­ZSB film (best efficacy at this stage) was deposited to 
















                           
           
 
 
                     
                         
                             
                       
                       
                         
     
 
                           
                       
 
























































Figure 7.3: JIS assay of MSSA (top) and PAO1 (bottom) on pp­ZSB treated squares 
of non­woven hospital scrubs after 4h 
Despite the hydrophobic effects exhibited by the non­woven and massively reduced 
cell count observed on the control squares over that seen for other control non­
woven, a huge reduction was still seen from control to treated samples in both PAO1 
and MSSA cell viability. This showed plasma deposition of antimicrobials was a 
viable second­step in manufacture of these materials in terms of bacterial efficacy 
and could provide a route to preventing bio transfer within hospitals over short 
periods of time. 
Subsequent tests were carried out on glass and polystyrene over short periods of time 
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Surface Surface 
























































Control pp­ZSB treated Control pp­ZSB treated 
Surface Surface 
Figure 7.5: JIS assay of MSSA (l) and PAO1 (r) on pp­ZSB treated squares of 
polystyrene after 2h 
Both tests showed reduced overall cell count on the surface from that experienced in 
tests with ‘regular’ non­woven which is caused by the lower surface area these 
materials possess for polymer and bacteria to bind to. Nevertheless, the trend of 
bacterial viability reduction was continued on these materials, with around a 50­70% 
decrease in S. aureus cell count observed on the treated materials versus controls. 
These assays provided information on the difference substrate composition makes to 
antimicrobial effects, possibly due to a combination of adhesion properties of the 
plasma film to the substrate, surface area and interaction of cells with the base 
substrate. 
For both bacterial strains fewer cells were viable after exposure to pp­ZSB treated 




                       
                     
                             
                           
              
 
                       
                             
                         
                         
                           









                       
         
 
     
                           
                       
                     
                         
would be expected to bond more easily with the organic components in 
polypropylene than the inorganic components of glass and therefore contain more 
antimicrobial. It could the case that active zinc Schiff base was more available at the 
surface in the glass sample whereas it was able to bind more extensively to 
polypropylene which prevented release into bacterial cells. 
These results were significant in determining antimicrobial efficacy after a very short 
period of time as similar efficacy was seen at two hours as for pp­ZSB treated non­
woven material (fig. 7.6). Incubation for around four hours rather than two appeared 
to give greatest discrepancy in cell viability between control and treated fabrics as 
active material was accumulated in cells, but dead cells had not provided a platform 
for live cells to grow, whereas bacteria on control samples can proliferate unabated. 






























Figure 7.6: JIS assay comparison of PAO1 on pp­ZSB treated squares of 
polystyrene after 2h and 4h 
7.3 Filter work 
A potential application outside of direct human contact with plasma films is that of 
filters. This could include drinking water or air conditioning systems (legionellas) or 
eye infections stemming from contamination of contact lens solution. For this 




                             
   
       
                             
                   
                         
                       




                   
 
                         
 
 
                         
                         
                             
                             
                             
                               
                           
                                 
                         
                           
                           
The filter assay (fig. 7.7) was devised to test cell viability after passing through a 
treated filter. 
7.3.1 Filter assay experimental 
pp­ZSB was deposited onto a large rectangle of Vyon HP 2mm filter (Porvair) in the 
standard manner followed by pp­C2F6 adlayer. Filter was positioned vertically 
similarly to non­wovens through support with another filter strip. The filter was cut 
into frits of 5mm diameter along with identical non­treated filter, which was 
sterilised using UV/O3 for five minutes per side. 
Agar culture dish
Vyon filter




Figure 7.7: pp­ZSB deposited filter (l), cut frits (c) and assay schematic (r) 
Frits were loaded to sterile 1ml pipette tips aseptically. Gloves were sterilised using 
70% ethanol before and after each sample was touched. Frits were loaded using 
tweezers and a 4mm cork borer, both of which were flamed in 100% ethanol and 
allowed to cool prior to each load. Frits were carefully loaded using the tweezers and 
once in position, were forced into the pipette tip using the cork borer. Treated frits 
were oriented face­on to flow. One to four frits were loaded to each pipette tip. 200µl 
of 105 CFU ml­1 overnight culture of P. aeruginosa in LB (+ tween) inoculum was 
added to each pipette tip and a 1ml pipette applied to the tip. NB: the pipette was 
sterilised prior to each use by wiping with 70% ethanol and allowing drying. 
Bacterial solution was then slowly pushed through the filter tip over the course of 




                             
               
       
                       
                       
                         
                     
                     
                         
                             
 







                       
           
 
 
                         
                       
                             
                         
                     
                         
Each nutrient agar plate was incubated at 37ºC for 18h. A control 200µl of inoculum 
not passed through any filters was also plated. 
7.3.2 Filter assay results 
The results of this assay were graphically illustrated (fig. 7.8) and clearly 
demonstrated the activity of pp­ZSB films on bacteria passed through the filters. 
Compared to the control samples, virtually no viable cells were observed in solutions 
passed through the pp­ZSB films. The greatest count of cell viability was 
unsurprisingly observed in control solution directly plated on agar, with slight 
reductions in count seen as more filters were added between inoculums and solid 
growth media due to cells attaching to the control filter surface on the path through. 




























Figure 7.8: Filter assay of PAO1 passed through filters containing pp­ZSB treated 
and non­treated Vyon HP 2mm filters 
Viability was reduced by around two orders of magnitude on treated samples by 
comparison. This was perhaps due to a combination of contact­killing as bacteria 
were passed through the treated filter and any ZSB that was liberated from the filter 
surface was able to affect bacteria on the agar surface during incubation. Treated 
filters showed the same water­passing ability of non­treated and given the wide­




                       
                         
                  
     
                         
                 
                   
                         
                     
                       
                   














ZSB films. This indicates that plasma treatment of filters with antimicrobials is 
another potential application. The use of these filters could easily be extended to air­
conditioning units where Legionnaire’s disease is a common problem. 
7.4 Wound dressings 
Supplementary to use in items such as nappies and scrubs, non­woven materials are 
also used in wound dressings. Commercially available products containing 
antimicrobial are available including ActicoatTM, discussed in chaper 1 and silver­
loaded plasters. In order to ascertain the effectiveness of the coatings created here 
against such established products, wound dressings were deposited with pp­ZSB and 
pp­PTSM under standard conditions and a JIS assay conducted versus P. aeruginosa 
and S. aureus alongside ElastoplastTM silver dressings and Boots hydrocolloid 














                       
                           
           
 
 
                             
                     
                       
                     
                           
                       




























































Figure 7.9: Antibacterial efficacy of treated wound dressings from JIS assay of 
PAO1 (top) and MSSA (bottom) after 4h. Figures are expressed as percentage of the 
non­viable cells relative to the control 
As can be seen above, close to 100% reduction in cell viability was observed in pp­
PTSM films after four hours which was directly comparable to commercially 
available dressings and in fact slightly more effective versus MSSA than the 
ElastoplastTM silver dressings. This could be explained as coordinated silver would 
be less susceptible to ion efflux mechanisms within the cell. The result for pp­PTSM 




                         
                       
                                   
                       





                          
                  
             
                         
             
                           
                           
                               
                      
                       
                      
                    
   











also much more active than pp­ZSB, which is to be expected when considering 
outright toxicity of silver and zinc. Nevertheless, pp­ZSB shows reduction in excess 
of 90% of all cells present in the dressing and there is a good chance this dressing in 
particular would be least inhibitive to wound healing. This result is hugely 
encouraging for potential use of these films in real­life application. 
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Chapter 8: Summary of process development 
8.1 Method development 
Over the course of this work the methods of compound preparation, film deposition 
and microbiological assessment of both compounds and films were constantly 
developed and improved to create materials which were viable for application. 
Improvements and the results of progress are discussed here. 
8.1.1 Synthetic approach 
The first novel complex produced here, PSSM, was designed in order to stabilise and 
increase the volatility of silver salts for plasma deposition. Many synthetic routes to 
the complex were attempted, from phosphine coordination to silver nitrate followed 
by complexation with maleimide; to a two step approach of silver salt synthesis and 
isolation followed by coordination by the Lewis base; with various solvent systems 
and silver precursors used. The preferred synthetic route eventually became apparent 
through high yielding and clean reaction products, which was subsequently adopted 
as a general procedure for production of silver­salts. Alteration of ligand systems 
through use of alternative methods (e.g. Schlenk lines) eventually resulted in the 
production of liquid silver complexes. 
The synthesis of M
2+ 
ion complexes proved simpler on the whole due to the greater 
stability of zinc and copper, but design approaches were varied according to 
volatility of monomers, resulting in ZSB and CSB complexes of reasonably low 
melting point. 
8.1.2 Plasma deposition 
The initial plasma deposition of films was conducted on NaCl discs for FTIR 




                         
                     
                           
     
 
                       
                           
                     
                       
                       
 
 
                       
                     
                         
                         
                   
                   
 
                   
                       
                   
                     
                         
                       
                        
 
     
                         
                         
                     
                         
gold chips which offered a big improvement in the sensitivity of measurement and 
removed the need for constant disc cleaning or preparation. Additionally, the FTIR 
measurement itself was greatly improved by use of an ATR­FTIR system in place of 
regular transmission FTIR. 
The volatility of plasma monomers was improved by systematic alteration of ligand 
systems but precursor flow to the reactor chamber was also improved by the use of 
shorter­necked monomer chambers and external heating of the chamber. A second 
reactor was introduced with capability for heating the monomer inlet area of the 
reactor so improving monomer flow further and reducing monomer adhesion to the 
inlet. 
Adhesion of plasma films to the substrate surface was improved by pre­treatment 
with oxygen plasma and hand­in­hand with microbiological assay results, affinity of 
liquids to the surface was reduced by formation of a fluorinated adlayer. Confocal 
microscopy of cell viability also offered insight to the ideal substrate position in the 
reactor for reduced microbiological growth. Film properties and functional group 
retention was improved by the systematic alteration in duty cycle. 
For film characterisation, several approaches were altered throughout the process. 
FTIR was supplemented by deposition onto glass for mass spectrometry of dissolved 
films, which was subsequently replaced by surface­specific mass spectrometry in 
SIMS. XPS, electron microscopy and atomic absorption spectroscopy were also used 
to analyse films. Film thickness was initially measured by SPR through angle shift 
fitting which was replaced by the more accurate alpha­stepping. Thickness was also 
allied with weight measurements through QCM to deduce the density of films. 
8.1.3 Microbiological assays 
The antibacterial analysis of free complex and plasma deposited films also received a 
great deal of attention for method development. The initial bacterial strain used, M. 
luteus, was exchanged for more pathogenic strains and representatives of both Gram­




                     
                   
                   
                         
                     
  
 
                       
                       
                         
                     
    
 
                       
                       
                     
                     
                       




       
       
                     
                         
                       
                           
                         
                 
testing pure compound were improved from early methods of disc diffusion 
visualisation to the quantitative approach of minimum inhibition concentration, with 
standardisation of this assay achieved through the solubility of compound in non­
toxic levels of DMSO. Cell counting through colony growth on solid media was 
supplemented by the use of optical density, which was calibrated using colony 
counts. 
When testing plasma film efficacy, colony counting was also supplemented by the 
use of fluorescent tagging of bacterial cells. Initial experimental assays allowed the 
development of a standard assay for assessing viability of cells removed from the 
surface, while surface bound cells were also analysed using fluorescence and 
confocal microscopy. 
A number of surfaces were tested in microbiological assays, ranging from Petri 
dishes in the first instance, to non­woven materials. The Japanese industry standard 
for testing antimicrobial efficacy of textiles was used to improve outright 
quantification of cell count from treated films and allowed comparison to 
commercial antimicrobial products. This assay was also used to test plasma films 
over a range of time periods to aid the understanding of the antimicrobial 
mechanism. 
8.2 Antimicrobial quantification comparison 
8.2.1 Japanese industry standard processing 
Alongside the quantification of antibacterial efficacy of films, the Japanese industry 
standard also defines a material as bacteriostatic or bactericidal and to what degree. 
This is achieved through measurement of bacterial cell counts on control at 
inoculation (Ti) and after incubation for a defined period of time – usually 18h (Tf). 
These numbers are processed to ascertain whether the test was effective for the 






                   
 
                               




                         
                        
 
 
                    
 
                           
                                     
                              
 
 
                         
                                 
                         
                           
               
 
       
                     






Equation 8.1 F = Mb − Ma 
Assessment of effective JIS assay where F = Growth value, Ma = log10 CFU ml
­1 
on 
Ti control, Mb = log10 CFU ml
­1 
on Tf control. F > 1.5 = effective test, F < 1.5 = 
non­effective test 
Once an effective test has been confirmed, cell numbers on treated material can 
easily be converted to bacteriostatic (S) or bactericidal (L) results (equation 8.2). 
Equation 8.2 a) S = M − M b) L = Ma − Mcb c 
Assessment of JIS assay where S = bacteriostatic value, L = bactericidal value, Ma 
­1 ­1 
= log10 CFU ml on Ti control, Mb = log10 CFU ml on Tf control, Mc = log10 CFU 
ml
­1 
on Tf treated. S > 2 = bacteriostatic, L > 0 = bactericidal test 
Provided the bacterial growth on treated surfaces is reduced from the initial control 
i.e. L > 0, the surface is deemed bactericidal. If the bacterial growth is slowed by the 
treated surface but is greater than the initial control, the surface is bacteriostatic 
provided S > 2. These values are related to activity, so the more effective 
antimicrobial tests produce higher values of L or S. 
8.2.2 JIS film comparison 
The best antimicrobial efficacy experienced for plasma deposited film system was 











































       
 
                         




                           
                             
                   
                       
                     
                  
 
                     
                   
















































Material Non­woven polypropylene 
Non­ionic 
surfactant 
Tween 20 (0.05% w/v) 
Figure 8.1: Tabulated summary of the most effective JIS assay results for plasma 
films on non­woven material versus PAO1 and MSSA 
The most effective surface from this data would appear to be pp­ZSB, although the 
assay was run over a slightly longer time than the silver films (4h versus 3h). 
Interestingly both pp­ZSB and pp­PTSM were strongly bactericidal from JIS 
quantification, with the general trend of greater effectiveness on PAO1 than MSSA 
followed. Despite the evidence of antibacterial activity in absolute cell count 
reduction, pp­PSSM films were determined as only weakly bacteriostatic. 
The bactericidal result of the zinc­containing film could be considered slightly 
inaccurate however, as bacteriostatic behaviour has subsequently been observed on 




                       
                         
                     
 
                             
                       
                             
                                  
                         
             
 
   
                           
                       
                       
                         
                   
 
                         
                             
                       
                         
                     
                     
                       
                   
                
 
                     
                   
                 
plate incubation were shown to increase slightly when plates were incubated for 
longer. Nevertheless, for the purposes of this test bacteria were suitably disabled to 
reduce viability when observed, so the result stands with this caveat. 
All tests showed a growth factor of > 1.5 and were therefore deemed effective tests. 
It may be observed that the bactericidal/static value is dependent on the effectiveness 
of the test i.e. magnitude of growth value. If more bacteria is evidenced on the 
control material at Tf relative to that at Ti in a particular test, then it could be 
inferred that more viable cells are present in solution and could therefore colonise 
the surface more easily, overloading the antimicrobial. 
8.3 Conclusions 
The need for new antimicrobial coatings and surfaces is a vital and major challenge 
facing scientists across a multitude of disciplines encompassing the areas of biology, 
chemistry, materials science and engineering. Due to the broad scope of creating 
such materials, a wide range of techniques have been employed with varying results. 
The plasma deposition of metal­containing complexes was investigated for this 
purpose. 
An initial organosilver complex, PSSM, was synthesised and used as a model system 
for deposition of plasma films with a great deal of method development. A variety of 
analytical and antimicrobial methods were used to explore the properties of these 
films, with promising results. Films were found to inhibit the growth of model 
bacterial organisms after suitable tailoring of film properties. Exploration of PSSM 
plasma films allowed progress onto monomer systems containing zinc and copper. 
The zinc system in particular being of higher volatility than PSSM allowed 
deposition of films which strongly resembled monomer structure through pulsed 
plasma and subsequently showed good activity against bacteria. 
Method development in silver compound synthesis lead to highly volatile liquid 
silver complexes which in turn showed bactericidal activity against model 




                       
                 
                     
                       
                       
                           
                           
        
 
                           
                   
                     
                   
                     
                 
                       
                         
                 
 
functionality was strongly retained in the resulting plasma films. Silver and zinc 
films were subjected to industrial­standard antimicrobial tests against commercially 
available wound dressings. Both films showed efficacy versus the model organisms 
of similar impact to the commercial products, which allows potential upscaling of 
these processes for industrial application. Low levels of observed metal content in 
films could indicate a need for a potentially antimicrobial ligand system to work in 
conjunction with the metal to show activity. Importantly, the films were shown to be 
non­harmful to human cells. 
The work undertaken here presents the ability of plasma deposition as a route to 
simple one­step preparation of antimicrobial surfaces. Although the results of 
extensive testing here proved the effect of organometallic plasma films on 
microorganisms, it would appear many avenues present themselves for future 
development of these systems depending on the potential application. Such varied 
properties as blood­interaction, mechanical strength of films, scalability and 
substrate adhesion could be investigated ad infinitum. Thus, the work conducted here 
is but a starting point, yet the techniques and surfaces developed certainly show 
promise as a new method for antimicrobial surface generation. 
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